drug,term,count
pembrolizumab,MALIGNANT NEOPLASM PROGRESSION,9435
pembrolizumab,DEATH,4728
pembrolizumab,DIARRHOEA,4370
pembrolizumab,FATIGUE,4111
pembrolizumab,OFF LABEL USE,3777
pembrolizumab,PRODUCT USE IN UNAPPROVED INDICATION,3157
pembrolizumab,PYREXIA,3047
pembrolizumab,NAUSEA,2824
pembrolizumab,RASH,2715
pembrolizumab,DECREASED APPETITE,2545
pembrolizumab,HYPERTENSION,2480
pembrolizumab,HYPOTHYROIDISM,2182
pembrolizumab,DRUG INEFFECTIVE,2115
pembrolizumab,ASTHENIA,2114
pembrolizumab,PRODUCT USE ISSUE,2114
pembrolizumab,DYSPNOEA,1942
pembrolizumab,INTERSTITIAL LUNG DISEASE,1911
pembrolizumab,MALAISE,1834
pembrolizumab,ACUTE KIDNEY INJURY,1827
pembrolizumab,ANAEMIA,1820
pembrolizumab,PNEUMONITIS,1788
pembrolizumab,PNEUMONIA,1775
pembrolizumab,VOMITING,1775
pembrolizumab,NEUTROPENIA,1690
pembrolizumab,ARTHRALGIA,1504
pembrolizumab,COLITIS,1483
pembrolizumab,WEIGHT DECREASED,1411
pembrolizumab,THROMBOCYTOPENIA,1359
pembrolizumab,RENAL IMPAIRMENT,1332
pembrolizumab,ADVERSE EVENT,1297
pembrolizumab,PLATELET COUNT DECREASED,1281
pembrolizumab,PRURITUS,1274
pembrolizumab,NEUROPATHY PERIPHERAL,1145
pembrolizumab,ADRENAL INSUFFICIENCY,1139
pembrolizumab,CONSTIPATION,1107
pembrolizumab,HEADACHE,1096
pembrolizumab,FEBRILE NEUTROPENIA,1088
pembrolizumab,PAIN,1088
pembrolizumab,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,1087
pembrolizumab,GENERAL PHYSICAL HEALTH DETERIORATION,1001
pembrolizumab,HEPATIC FUNCTION ABNORMAL,979
pembrolizumab,DISEASE PROGRESSION,969
pembrolizumab,ABDOMINAL PAIN,966
pembrolizumab,PANCYTOPENIA,951
pembrolizumab,BLOOD PRESSURE INCREASED,941
pembrolizumab,DEHYDRATION,937
pembrolizumab,STOMATITIS,922
pembrolizumab,COUGH,896
pembrolizumab,MYOCARDITIS,865
pembrolizumab,HEPATITIS,862
pembrolizumab,PLEURAL EFFUSION,855
pembrolizumab,SEPSIS,855
pembrolizumab,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,842
pembrolizumab,THERAPY PARTIAL RESPONDER,815
pembrolizumab,TUBULOINTERSTITIAL NEPHRITIS,812
pembrolizumab,MYALGIA,794
pembrolizumab,IMMUNE-MEDIATED HEPATIC DISORDER,788
pembrolizumab,DYSPHONIA,771
pembrolizumab,PULMONARY EMBOLISM,766
pembrolizumab,RENAL FAILURE,763
pembrolizumab,HYPOTENSION,740
pembrolizumab,IMMUNE-MEDIATED ENTEROCOLITIS,708
pembrolizumab,PROTEINURIA,696
pembrolizumab,HYPERTHYROIDISM,689
pembrolizumab,ALANINE AMINOTRANSFERASE INCREASED,686
pembrolizumab,DIZZINESS,675
pembrolizumab,MYELOSUPPRESSION,671
pembrolizumab,NEOPLASM PROGRESSION,665
pembrolizumab,RESPIRATORY FAILURE,656
pembrolizumab,BACK PAIN,655
pembrolizumab,CARDIAC FAILURE,639
pembrolizumab,PAIN IN EXTREMITY,638
pembrolizumab,ASPARTATE AMINOTRANSFERASE INCREASED,626
pembrolizumab,NEUTROPHIL COUNT DECREASED,626
pembrolizumab,HYPONATRAEMIA,611
pembrolizumab,URINARY TRACT INFECTION,608
pembrolizumab,CONDITION AGGRAVATED,572
pembrolizumab,TYPE 1 DIABETES MELLITUS,548
pembrolizumab,IMMUNE-MEDIATED ADVERSE REACTION,539
pembrolizumab,DYSPHAGIA,536
pembrolizumab,MUSCULAR WEAKNESS,536
pembrolizumab,NO ADVERSE EVENT,532
pembrolizumab,WHITE BLOOD CELL COUNT DECREASED,524
pembrolizumab,HEPATIC ENZYME INCREASED,513
pembrolizumab,BLOOD CREATININE INCREASED,509
pembrolizumab,ERYTHEMA,496
pembrolizumab,MYOSITIS,496
pembrolizumab,HEPATIC CYTOLYSIS,494
pembrolizumab,LIVER DISORDER,487
pembrolizumab,MUCOSAL INFLAMMATION,484
pembrolizumab,TOXICITY TO VARIOUS AGENTS,483
pembrolizumab,OEDEMA PERIPHERAL,482
pembrolizumab,HEPATOTOXICITY,480
pembrolizumab,DIABETES MELLITUS,478
pembrolizumab,INFECTION,478
pembrolizumab,IMMUNE-MEDIATED MYOCARDITIS,471
pembrolizumab,CONFUSIONAL STATE,467
pembrolizumab,IMMUNE-MEDIATED HEPATITIS,466
pembrolizumab,COVID-19,456
pembrolizumab,THYROIDITIS,450
osimertinib,DEATH,9773
osimertinib,MALIGNANT NEOPLASM PROGRESSION,2872
osimertinib,DIARRHOEA,1334
osimertinib,DRUG RESISTANCE,1022
osimertinib,FATIGUE,767
osimertinib,RASH,747
osimertinib,DRUG INEFFECTIVE,649
osimertinib,DECREASED APPETITE,640
osimertinib,DISEASE PROGRESSION,633
osimertinib,OFF LABEL USE,613
osimertinib,DYSPNOEA,578
osimertinib,NAUSEA,573
osimertinib,INTERSTITIAL LUNG DISEASE,556
osimertinib,METASTASES TO CENTRAL NERVOUS SYSTEM,551
osimertinib,PLEURAL EFFUSION,459
osimertinib,MYELOSUPPRESSION,434
osimertinib,ACQUIRED GENE MUTATION,433
osimertinib,ASTHENIA,419
osimertinib,VOMITING,378
osimertinib,PNEUMONIA,367
osimertinib,WEIGHT DECREASED,358
osimertinib,COUGH,335
osimertinib,PNEUMONITIS,320
osimertinib,PYREXIA,308
osimertinib,DRY SKIN,301
osimertinib,PAIN,293
osimertinib,PLATELET COUNT DECREASED,281
osimertinib,METASTASES TO BONE,261
osimertinib,FALL,258
osimertinib,PULMONARY EMBOLISM,252
osimertinib,PRURITUS,243
osimertinib,MUSCLE SPASMS,238
osimertinib,DIZZINESS,235
osimertinib,HEPATIC FUNCTION ABNORMAL,233
osimertinib,MALAISE,233
osimertinib,THROMBOSIS,230
osimertinib,HEADACHE,229
osimertinib,STOMATITIS,228
osimertinib,METASTASES TO MENINGES,227
osimertinib,LUNG DISORDER,224
osimertinib,ANAEMIA,219
osimertinib,THROMBOCYTOPENIA,216
osimertinib,CARDIAC FAILURE,211
osimertinib,CEREBROVASCULAR ACCIDENT,209
osimertinib,DEHYDRATION,204
osimertinib,METASTASES TO LIVER,204
osimertinib,LUNG NEOPLASM MALIGNANT,198
osimertinib,CONSTIPATION,191
osimertinib,PARONYCHIA,190
osimertinib,RESPIRATORY FAILURE,179
osimertinib,PRODUCT DOSE OMISSION ISSUE,172
osimertinib,ELECTROCARDIOGRAM QT PROLONGED,171
osimertinib,DEEP VEIN THROMBOSIS,170
osimertinib,ATRIAL FIBRILLATION,165
osimertinib,ALOPECIA,159
osimertinib,EGFR GENE MUTATION,152
osimertinib,TOXICITY TO VARIOUS AGENTS,152
osimertinib,WHITE BLOOD CELL COUNT DECREASED,150
osimertinib,CONDITION AGGRAVATED,149
osimertinib,ONYCHOCLASIS,148
osimertinib,NEOPLASM PROGRESSION,146
osimertinib,CARDIAC DISORDER,145
osimertinib,DYSPHAGIA,145
osimertinib,GAIT DISTURBANCE,143
osimertinib,PAIN IN EXTREMITY,139
osimertinib,GENERAL PHYSICAL HEALTH DETERIORATION,138
osimertinib,PERIPHERAL SWELLING,138
osimertinib,ARTHRALGIA,135
osimertinib,BACK PAIN,134
osimertinib,NEOPLASM MALIGNANT,132
osimertinib,LIVER DISORDER,131
osimertinib,CHEST PAIN,128
osimertinib,METASTASES TO LUNG,128
osimertinib,NAIL DISORDER,128
osimertinib,RENAL IMPAIRMENT,125
osimertinib,SEIZURE,124
osimertinib,MYOCARDIAL INFARCTION,120
osimertinib,PRODUCT USE ISSUE,120
osimertinib,HYPOTENSION,116
osimertinib,METASTASIS,116
osimertinib,ERYTHEMA,112
osimertinib,PULMONARY OEDEMA,112
osimertinib,INSOMNIA,105
osimertinib,COVID-19,103
osimertinib,PANCYTOPENIA,101
osimertinib,URINARY TRACT INFECTION,101
osimertinib,MYALGIA,99
osimertinib,PRODUCT USE IN UNAPPROVED INDICATION,99
osimertinib,RENAL FAILURE,99
osimertinib,PERICARDIAL EFFUSION,98
osimertinib,MALIGNANT TRANSFORMATION,95
osimertinib,BLOOD CREATINE PHOSPHOKINASE INCREASED,94
osimertinib,EJECTION FRACTION DECREASED,94
osimertinib,VISUAL IMPAIRMENT,94
osimertinib,DRUG INTOLERANCE,91
osimertinib,INFECTION,91
osimertinib,SKIN DISORDER,91
osimertinib,DERMATITIS ACNEIFORM,88
osimertinib,DRUG INTERACTION,88
osimertinib,VISION BLURRED,88
nivolumab,DEATH,11078
nivolumab,MALIGNANT NEOPLASM PROGRESSION,9372
nivolumab,OFF LABEL USE,5207
nivolumab,DIARRHOEA,4654
nivolumab,FATIGUE,3738
nivolumab,PYREXIA,3475
nivolumab,INTENTIONAL PRODUCT USE ISSUE,3331
nivolumab,NAUSEA,2819
nivolumab,RASH,2769
nivolumab,DECREASED APPETITE,2602
nivolumab,DYSPNOEA,2530
nivolumab,PNEUMONIA,2279
nivolumab,COLITIS,2083
nivolumab,PNEUMONITIS,2045
nivolumab,ASTHENIA,1909
nivolumab,VOMITING,1883
nivolumab,HYPOTHYROIDISM,1837
nivolumab,ACUTE KIDNEY INJURY,1745
nivolumab,WEIGHT DECREASED,1669
nivolumab,DRUG INEFFECTIVE,1651
nivolumab,ANAEMIA,1632
nivolumab,PRURITUS,1608
nivolumab,GENERAL PHYSICAL HEALTH DETERIORATION,1503
nivolumab,INTERSTITIAL LUNG DISEASE,1481
nivolumab,MALAISE,1414
nivolumab,ARTHRALGIA,1392
nivolumab,PRODUCT USE IN UNAPPROVED INDICATION,1380
nivolumab,ADRENAL INSUFFICIENCY,1240
nivolumab,CONSTIPATION,1220
nivolumab,HEADACHE,1209
nivolumab,SEPSIS,1205
nivolumab,PAIN,1153
nivolumab,ADVERSE EVENT,1136
nivolumab,IMMUNE-MEDIATED ENTEROCOLITIS,1134
nivolumab,HEPATIC FUNCTION ABNORMAL,1079
nivolumab,COUGH,1076
nivolumab,THROMBOCYTOPENIA,1063
nivolumab,PLEURAL EFFUSION,1058
nivolumab,BACK PAIN,1046
nivolumab,DEHYDRATION,948
nivolumab,MYOCARDITIS,925
nivolumab,LIVER DISORDER,895
nivolumab,HYPERTHYROIDISM,888
nivolumab,HEPATITIS,869
nivolumab,HYPOTENSION,857
nivolumab,ABDOMINAL PAIN,848
nivolumab,RESPIRATORY FAILURE,836
nivolumab,HYPONATRAEMIA,811
nivolumab,NEUTROPENIA,790
nivolumab,DIZZINESS,772
nivolumab,FEBRILE NEUTROPENIA,762
nivolumab,ASPARTATE AMINOTRANSFERASE INCREASED,751
nivolumab,ALANINE AMINOTRANSFERASE INCREASED,749
nivolumab,STOMATITIS,744
nivolumab,HYPOPHYSITIS,742
nivolumab,RENAL FAILURE,742
nivolumab,DISEASE PROGRESSION,734
nivolumab,PULMONARY EMBOLISM,730
nivolumab,FALL,729
nivolumab,HYPERTENSION,714
nivolumab,MYALGIA,674
nivolumab,DIABETIC KETOACIDOSIS,659
nivolumab,PLATELET COUNT DECREASED,648
nivolumab,MYOSITIS,646
nivolumab,CHILLS,645
nivolumab,MUSCULAR WEAKNESS,636
nivolumab,INFUSION RELATED REACTION,634
nivolumab,CARDIAC FAILURE,631
nivolumab,PEMPHIGOID,628
nivolumab,CONDITION AGGRAVATED,618
nivolumab,URINARY TRACT INFECTION,616
nivolumab,LUNG DISORDER,612
nivolumab,NEUROPATHY PERIPHERAL,609
nivolumab,PRODUCT USE ISSUE,600
nivolumab,PAIN IN EXTREMITY,596
nivolumab,ATRIAL FIBRILLATION,585
nivolumab,TYPE 1 DIABETES MELLITUS,580
nivolumab,DIABETES MELLITUS,573
nivolumab,PRESCRIBED UNDERDOSE,566
nivolumab,BLOOD PRESSURE INCREASED,563
nivolumab,CONFUSIONAL STATE,559
nivolumab,IMMUNE-MEDIATED HEPATITIS,554
nivolumab,CHEST PAIN,548
nivolumab,METASTASES TO CENTRAL NERVOUS SYSTEM,542
nivolumab,DYSPHAGIA,541
nivolumab,ERYTHEMA,539
nivolumab,ARTHRITIS,534
nivolumab,OEDEMA PERIPHERAL,528
nivolumab,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,526
nivolumab,FULMINANT TYPE 1 DIABETES MELLITUS,517
nivolumab,AUTOIMMUNE DISORDER,508
nivolumab,THYROIDITIS,505
nivolumab,HYPOKALAEMIA,502
nivolumab,INFECTION,502
nivolumab,HYPERGLYCAEMIA,496
nivolumab,RENAL IMPAIRMENT,493
nivolumab,IMMUNE-MEDIATED LUNG DISEASE,484
nivolumab,BLOOD CREATININE INCREASED,482
nivolumab,CYTOKINE RELEASE SYNDROME,482
nivolumab,AUTOIMMUNE HEPATITIS,476
abemaciclib,DIARRHOEA,4125
abemaciclib,FATIGUE,1503
abemaciclib,NAUSEA,1367
abemaciclib,VOMITING,802
abemaciclib,MALIGNANT NEOPLASM PROGRESSION,775
abemaciclib,DECREASED APPETITE,645
abemaciclib,DRUG INEFFECTIVE,641
abemaciclib,DEATH,638
abemaciclib,ASTHENIA,547
abemaciclib,WHITE BLOOD CELL COUNT DECREASED,479
abemaciclib,ANAEMIA,454
abemaciclib,NEUTROPENIA,437
abemaciclib,DEHYDRATION,426
abemaciclib,CONSTIPATION,415
abemaciclib,ABDOMINAL PAIN UPPER,398
abemaciclib,ABDOMINAL PAIN,370
abemaciclib,HEADACHE,356
abemaciclib,WEIGHT DECREASED,353
abemaciclib,ALOPECIA,345
abemaciclib,MYELOSUPPRESSION,341
abemaciclib,BLOOD CREATININE INCREASED,321
abemaciclib,DYSPNOEA,320
abemaciclib,DISEASE PROGRESSION,304
abemaciclib,INTERSTITIAL LUNG DISEASE,295
abemaciclib,PAIN,295
abemaciclib,ARTHRALGIA,293
abemaciclib,DIZZINESS,290
abemaciclib,MALAISE,281
abemaciclib,RASH,274
abemaciclib,PLATELET COUNT DECREASED,248
abemaciclib,PNEUMONIA,237
abemaciclib,ACUTE KIDNEY INJURY,235
abemaciclib,ABDOMINAL DISCOMFORT,232
abemaciclib,THERAPY CESSATION,231
abemaciclib,OFF LABEL USE,230
abemaciclib,PRODUCT DOSE OMISSION ISSUE,230
abemaciclib,THERAPY INTERRUPTED,211
abemaciclib,HAEMOGLOBIN DECREASED,203
abemaciclib,PYREXIA,201
abemaciclib,COUGH,192
abemaciclib,DRUG INTOLERANCE,185
abemaciclib,PNEUMONITIS,182
abemaciclib,PRURITUS,180
abemaciclib,COVID-19,178
abemaciclib,NEUTROPHIL COUNT DECREASED,175
abemaciclib,PULMONARY EMBOLISM,160
abemaciclib,INSOMNIA,156
abemaciclib,THROMBOCYTOPENIA,154
abemaciclib,FEELING ABNORMAL,153
abemaciclib,HOT FLUSH,142
abemaciclib,THROMBOSIS,142
abemaciclib,HEPATIC FUNCTION ABNORMAL,141
abemaciclib,URINARY TRACT INFECTION,135
abemaciclib,RENAL IMPAIRMENT,134
abemaciclib,PAIN IN EXTREMITY,131
abemaciclib,TASTE DISORDER,129
abemaciclib,ALANINE AMINOTRANSFERASE INCREASED,128
abemaciclib,ILLNESS,127
abemaciclib,RED BLOOD CELL COUNT DECREASED,127
abemaciclib,ASPARTATE AMINOTRANSFERASE INCREASED,125
abemaciclib,STOMATITIS,123
abemaciclib,HEPATOTOXICITY,121
abemaciclib,METASTASES TO BONE,121
abemaciclib,HOSPITALISATION,119
abemaciclib,BACK PAIN,114
abemaciclib,MUSCLE SPASMS,112
abemaciclib,DYSPEPSIA,110
abemaciclib,FALL,110
abemaciclib,METASTASES TO LIVER,110
abemaciclib,RENAL FAILURE,103
abemaciclib,ABDOMINAL DISTENSION,101
abemaciclib,DRY SKIN,99
abemaciclib,ANXIETY,98
abemaciclib,GAIT DISTURBANCE,98
abemaciclib,BONE PAIN,97
abemaciclib,NEUROPATHY PERIPHERAL,95
abemaciclib,GASTROINTESTINAL DISORDER,94
abemaciclib,PLEURAL EFFUSION,94
abemaciclib,HYPOKALAEMIA,91
abemaciclib,PERIPHERAL SWELLING,91
abemaciclib,DEEP VEIN THROMBOSIS,89
abemaciclib,HYPOTENSION,89
abemaciclib,MYALGIA,88
abemaciclib,SEPSIS,88
abemaciclib,INFECTION,87
abemaciclib,LIVER DISORDER,87
abemaciclib,DYSPHAGIA,82
abemaciclib,THERAPY CHANGE,80
abemaciclib,DECREASED IMMUNE RESPONSIVENESS,79
abemaciclib,DEPRESSION,78
abemaciclib,LEUKOPENIA,78
abemaciclib,DRUG-INDUCED LIVER INJURY,77
abemaciclib,FULL BLOOD COUNT DECREASED,77
abemaciclib,BREAST CANCER METASTATIC,76
abemaciclib,HEPATIC ENZYME INCREASED,76
abemaciclib,LUNG DISORDER,74
abemaciclib,HYPOAESTHESIA,73
abemaciclib,HEPATIC FAILURE,71
abemaciclib,CHEST PAIN,69
abemaciclib,DRUG INTERACTION,69
pertuzumab,DIARRHOEA,3770
pertuzumab,OFF LABEL USE,2765
pertuzumab,FATIGUE,1812
pertuzumab,NAUSEA,1794
pertuzumab,ALOPECIA,1514
pertuzumab,NO ADVERSE EVENT,1398
pertuzumab,DISEASE PROGRESSION,1264
pertuzumab,VOMITING,1203
pertuzumab,DYSPNOEA,1136
pertuzumab,DEATH,1103
pertuzumab,MYELOSUPPRESSION,1096
pertuzumab,PYREXIA,1093
pertuzumab,NEUROPATHY PERIPHERAL,1087
pertuzumab,RASH,938
pertuzumab,NEUTROPENIA,932
pertuzumab,ANAEMIA,824
pertuzumab,ASTHENIA,819
pertuzumab,PAIN,754
pertuzumab,HEADACHE,752
pertuzumab,FEBRILE NEUTROPENIA,723
pertuzumab,EJECTION FRACTION DECREASED,677
pertuzumab,DECREASED APPETITE,656
pertuzumab,PRURITUS,618
pertuzumab,DRUG INEFFECTIVE,601
pertuzumab,PNEUMONIA,597
pertuzumab,MALAISE,537
pertuzumab,METASTASES TO CENTRAL NERVOUS SYSTEM,537
pertuzumab,WEIGHT DECREASED,530
pertuzumab,CONSTIPATION,529
pertuzumab,CHILLS,526
pertuzumab,COUGH,519
pertuzumab,MUCOSAL INFLAMMATION,504
pertuzumab,THROMBOCYTOPENIA,487
pertuzumab,ABDOMINAL PAIN,486
pertuzumab,DIZZINESS,472
pertuzumab,URINARY TRACT INFECTION,468
pertuzumab,PLATELET COUNT DECREASED,460
pertuzumab,ARTHRALGIA,453
pertuzumab,BACK PAIN,447
pertuzumab,INFUSION RELATED REACTION,438
pertuzumab,STOMATITIS,436
pertuzumab,WHITE BLOOD CELL COUNT DECREASED,427
pertuzumab,DEHYDRATION,415
pertuzumab,MYALGIA,398
pertuzumab,HAIR COLOUR CHANGES,397
pertuzumab,HAIR TEXTURE ABNORMAL,397
pertuzumab,EPISTAXIS,392
pertuzumab,MADAROSIS,390
pertuzumab,HYPOKALAEMIA,383
pertuzumab,PARAESTHESIA,381
pertuzumab,ERYTHEMA,371
pertuzumab,CARDIAC FAILURE,369
pertuzumab,POLYNEUROPATHY,365
pertuzumab,HYPOTENSION,362
pertuzumab,PAIN IN EXTREMITY,355
pertuzumab,HYPOAESTHESIA,352
pertuzumab,HAIR DISORDER,336
pertuzumab,GENERAL PHYSICAL HEALTH DETERIORATION,335
pertuzumab,HYPERTENSION,332
pertuzumab,PLEURAL EFFUSION,327
pertuzumab,INTERSTITIAL LUNG DISEASE,324
pertuzumab,NEUTROPHIL COUNT DECREASED,312
pertuzumab,BREAST CANCER METASTATIC,308
pertuzumab,CARDIOTOXICITY,308
pertuzumab,HYPERSENSITIVITY,308
pertuzumab,NASOPHARYNGITIS,294
pertuzumab,ACUTE KIDNEY INJURY,292
pertuzumab,MALIGNANT NEOPLASM PROGRESSION,288
pertuzumab,SEPSIS,284
pertuzumab,BONE PAIN,283
pertuzumab,CELLULITIS,278
pertuzumab,LEUKOPENIA,277
pertuzumab,ANXIETY,272
pertuzumab,CHEST DISCOMFORT,271
pertuzumab,CHEST PAIN,264
pertuzumab,INSOMNIA,258
pertuzumab,SEIZURE,258
pertuzumab,DYSPEPSIA,256
pertuzumab,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,253
pertuzumab,COVID-19,251
pertuzumab,DYSGEUSIA,249
pertuzumab,OEDEMA PERIPHERAL,249
pertuzumab,TACHYCARDIA,249
pertuzumab,METASTASES TO BONE,246
pertuzumab,PNEUMONITIS,241
pertuzumab,ABDOMINAL PAIN UPPER,240
pertuzumab,BREAST CANCER,237
pertuzumab,METASTASES TO LIVER,237
pertuzumab,NEOPLASM PROGRESSION,235
pertuzumab,INTENTIONAL PRODUCT USE ISSUE,231
pertuzumab,LEFT VENTRICULAR DYSFUNCTION,221
pertuzumab,MUSCLE SPASMS,221
pertuzumab,PULMONARY EMBOLISM,218
pertuzumab,TREMOR,218
pertuzumab,INFECTION,217
pertuzumab,DRY SKIN,214
pertuzumab,METASTASES TO LUNG,212
pertuzumab,LOWER RESPIRATORY TRACT INFECTION,209
pertuzumab,ALANINE AMINOTRANSFERASE INCREASED,207
pertuzumab,LACRIMATION INCREASED,204
panitumumab,RASH,1586
panitumumab,DIARRHOEA,1437
panitumumab,DERMATITIS ACNEIFORM,965
panitumumab,DEATH,868
panitumumab,NEUTROPENIA,853
panitumumab,SKIN TOXICITY,766
panitumumab,NAUSEA,743
panitumumab,HYPOMAGNESAEMIA,741
panitumumab,DISEASE PROGRESSION,678
panitumumab,NEUROPATHY PERIPHERAL,643
panitumumab,FATIGUE,590
panitumumab,VOMITING,558
panitumumab,OFF LABEL USE,553
panitumumab,PARONYCHIA,549
panitumumab,STOMATITIS,543
panitumumab,THROMBOCYTOPENIA,538
panitumumab,COLORECTAL CANCER METASTATIC,522
panitumumab,DECREASED APPETITE,499
panitumumab,DRY SKIN,486
panitumumab,ANAEMIA,460
panitumumab,PYREXIA,460
panitumumab,ASTHENIA,458
panitumumab,ERYTHEMA,349
panitumumab,PRURITUS,349
panitumumab,METASTASES TO LIVER,347
panitumumab,INTERSTITIAL LUNG DISEASE,346
panitumumab,DYSPNOEA,339
panitumumab,THERAPY PARTIAL RESPONDER,330
panitumumab,DEHYDRATION,307
panitumumab,MUCOSAL INFLAMMATION,300
panitumumab,FEBRILE NEUTROPENIA,298
panitumumab,SKIN DISORDER,293
panitumumab,RASH PUSTULAR,286
panitumumab,ABDOMINAL PAIN,267
panitumumab,MALAISE,259
panitumumab,SKIN REACTION,259
panitumumab,PULMONARY EMBOLISM,257
panitumumab,COLON CANCER,248
panitumumab,ACNE,238
panitumumab,NEUTROPHIL COUNT DECREASED,225
panitumumab,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,224
panitumumab,SKIN FISSURES,221
panitumumab,HYPERSENSITIVITY,220
panitumumab,MALIGNANT NEOPLASM PROGRESSION,218
panitumumab,HYPERTENSION,212
panitumumab,HYPOKALAEMIA,212
panitumumab,GENERAL PHYSICAL HEALTH DETERIORATION,207
panitumumab,LEUKOPENIA,205
panitumumab,COLORECTAL CANCER,201
panitumumab,POLYNEUROPATHY,199
panitumumab,PRODUCT STORAGE ERROR,199
panitumumab,WEIGHT DECREASED,194
panitumumab,CONSTIPATION,191
panitumumab,PNEUMONIA,183
panitumumab,DRUG INEFFECTIVE,177
panitumumab,CONJUNCTIVITIS,172
panitumumab,PAIN,172
panitumumab,HYPOCALCAEMIA,171
panitumumab,NEUROTOXICITY,169
panitumumab,SEPSIS,165
panitumumab,ALOPECIA,164
panitumumab,HYPOTENSION,160
panitumumab,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,159
panitumumab,INFECTION,157
panitumumab,METASTASES TO LUNG,156
panitumumab,URINARY TRACT INFECTION,155
panitumumab,ACUTE KIDNEY INJURY,147
panitumumab,PLATELET COUNT DECREASED,144
panitumumab,INFUSION RELATED REACTION,142
panitumumab,BLOOD MAGNESIUM DECREASED,139
panitumumab,WHITE BLOOD CELL COUNT DECREASED,139
panitumumab,SKIN EXFOLIATION,132
panitumumab,SKIN LESION,129
panitumumab,DEEP VEIN THROMBOSIS,125
panitumumab,FOLLICULITIS,125
panitumumab,DERMATITIS,123
panitumumab,BACK PAIN,121
panitumumab,PERIPHERAL SENSORY NEUROPATHY,121
panitumumab,CHILLS,114
panitumumab,CONDITION AGGRAVATED,112
panitumumab,INTESTINAL OBSTRUCTION,112
panitumumab,RASH MACULO-PAPULAR,112
panitumumab,DIZZINESS,110
panitumumab,NEOPLASM PROGRESSION,109
panitumumab,TOXICITY TO VARIOUS AGENTS,107
panitumumab,HEADACHE,106
panitumumab,RENAL FAILURE,103
panitumumab,HAEMOGLOBIN DECREASED,102
panitumumab,EPISTAXIS,101
panitumumab,ASCITES,99
panitumumab,PARAESTHESIA,99
panitumumab,COVID-19,96
panitumumab,ILEUS,92
panitumumab,CHEST PAIN,85
panitumumab,ATRIAL FIBRILLATION,82
panitumumab,DYSGEUSIA,82
panitumumab,HEPATIC FAILURE,82
panitumumab,OEDEMA PERIPHERAL,81
panitumumab,THERAPEUTIC PRODUCT EFFECT INCOMPLETE,80
panitumumab,ADENOCARCINOMA OF COLON,79
alectinib,DEATH,656
alectinib,FATIGUE,585
alectinib,CONSTIPATION,513
alectinib,OFF LABEL USE,486
alectinib,NO ADVERSE EVENT,452
alectinib,DISEASE PROGRESSION,361
alectinib,RASH,307
alectinib,DYSPNOEA,284
alectinib,DRUG INEFFECTIVE,275
alectinib,ANAEMIA,259
alectinib,MYALGIA,259
alectinib,ASTHENIA,247
alectinib,NAUSEA,241
alectinib,WEIGHT INCREASED,223
alectinib,DIARRHOEA,210
alectinib,BLOOD BILIRUBIN INCREASED,188
alectinib,PNEUMONIA,187
alectinib,PERIPHERAL SWELLING,173
alectinib,OEDEMA PERIPHERAL,172
alectinib,COUGH,168
alectinib,PAIN,162
alectinib,HEADACHE,161
alectinib,METASTASES TO CENTRAL NERVOUS SYSTEM,160
alectinib,OEDEMA,155
alectinib,COVID-19,144
alectinib,PYREXIA,140
alectinib,BLOOD CREATINE PHOSPHOKINASE INCREASED,139
alectinib,ARTHRALGIA,137
alectinib,NEOPLASM PROGRESSION,136
alectinib,DIZZINESS,132
alectinib,BLOOD CREATININE INCREASED,129
alectinib,ASPARTATE AMINOTRANSFERASE INCREASED,125
alectinib,VOMITING,124
alectinib,DECREASED APPETITE,118
alectinib,PLEURAL EFFUSION,116
alectinib,BRADYCARDIA,109
alectinib,HEPATIC FUNCTION ABNORMAL,109
alectinib,PNEUMONITIS,105
alectinib,BACK PAIN,101
alectinib,MALIGNANT NEOPLASM PROGRESSION,98
alectinib,PRURITUS,96
alectinib,ALANINE AMINOTRANSFERASE INCREASED,95
alectinib,INTERSTITIAL LUNG DISEASE,94
alectinib,DRUG RESISTANCE,86
alectinib,PAIN IN EXTREMITY,83
alectinib,INTENTIONAL PRODUCT USE ISSUE,80
alectinib,DYSPHAGIA,78
alectinib,NEUROPATHY PERIPHERAL,77
alectinib,MALAISE,76
alectinib,HAEMOGLOBIN DECREASED,74
alectinib,ALOPECIA,72
alectinib,MEMORY IMPAIRMENT,72
alectinib,MUSCULAR WEAKNESS,72
alectinib,PHOTOSENSITIVITY REACTION,72
alectinib,SWELLING,71
alectinib,HEPATIC ENZYME INCREASED,69
alectinib,FALL,68
alectinib,TRANSAMINASES INCREASED,68
alectinib,JOINT SWELLING,67
alectinib,NEOPLASM MALIGNANT,67
alectinib,LIVER DISORDER,66
alectinib,PULMONARY OEDEMA,65
alectinib,RENAL IMPAIRMENT,64
alectinib,CHEST PAIN,63
alectinib,GENERAL PHYSICAL HEALTH DETERIORATION,63
alectinib,PERICARDIAL EFFUSION,63
alectinib,INSOMNIA,61
alectinib,HAEMOLYTIC ANAEMIA,60
alectinib,BLOOD ALKALINE PHOSPHATASE INCREASED,59
alectinib,FLUID RETENTION,59
alectinib,MUSCLE SPASMS,57
alectinib,LUNG NEOPLASM MALIGNANT,56
alectinib,RENAL FAILURE,56
alectinib,URINARY TRACT INFECTION,56
alectinib,PRODUCT STORAGE ERROR,54
alectinib,SEIZURE,54
alectinib,ABDOMINAL DISTENSION,53
alectinib,DRUG INTERACTION,53
alectinib,HEART RATE DECREASED,53
alectinib,WEIGHT DECREASED,53
alectinib,ACUTE KIDNEY INJURY,52
alectinib,HYPOAESTHESIA,52
alectinib,RHABDOMYOLYSIS,52
alectinib,HYPOTENSION,51
alectinib,PULMONARY EMBOLISM,50
alectinib,ABDOMINAL PAIN UPPER,49
alectinib,HAEMOLYSIS,49
alectinib,NASOPHARYNGITIS,48
alectinib,HYPERBILIRUBINAEMIA,47
alectinib,THROMBOSIS,47
alectinib,CARDIAC FAILURE,46
alectinib,DYSGEUSIA,46
alectinib,LUNG DISORDER,46
alectinib,VISUAL IMPAIRMENT,46
alectinib,ABDOMINAL PAIN,45
alectinib,METASTASES TO BONE,45
alectinib,ATRIAL FIBRILLATION,44
alectinib,DRUG INTOLERANCE,44
alectinib,NON-SMALL CELL LUNG CANCER,44
alectinib,TASTE DISORDER,43
dabrafenib,PYREXIA,3927
dabrafenib,DEATH,2766
dabrafenib,MALIGNANT NEOPLASM PROGRESSION,1650
dabrafenib,FATIGUE,1323
dabrafenib,NAUSEA,1310
dabrafenib,CHILLS,1266
dabrafenib,RASH,1099
dabrafenib,VOMITING,936
dabrafenib,DIARRHOEA,914
dabrafenib,HEADACHE,709
dabrafenib,ASTHENIA,662
dabrafenib,MALAISE,593
dabrafenib,DECREASED APPETITE,556
dabrafenib,ARTHRALGIA,547
dabrafenib,PRODUCT USE IN UNAPPROVED INDICATION,529
dabrafenib,DRUG INEFFECTIVE,477
dabrafenib,PAIN,457
dabrafenib,METASTASES TO CENTRAL NERVOUS SYSTEM,455
dabrafenib,METASTATIC MALIGNANT MELANOMA,453
dabrafenib,VISUAL IMPAIRMENT,452
dabrafenib,MALIGNANT MELANOMA,422
dabrafenib,DISEASE PROGRESSION,421
dabrafenib,DYSPNOEA,399
dabrafenib,DIZZINESS,362
dabrafenib,DEHYDRATION,351
dabrafenib,PNEUMONIA,343
dabrafenib,COUGH,340
dabrafenib,GENERAL PHYSICAL HEALTH DETERIORATION,313
dabrafenib,VISION BLURRED,312
dabrafenib,HYPOTENSION,303
dabrafenib,WEIGHT DECREASED,298
dabrafenib,CONSTIPATION,296
dabrafenib,DYSPHAGIA,281
dabrafenib,OFF LABEL USE,274
dabrafenib,PRURITUS,273
dabrafenib,PAIN IN EXTREMITY,272
dabrafenib,ANAEMIA,264
dabrafenib,MYALGIA,264
dabrafenib,ABDOMINAL PAIN,257
dabrafenib,PERIPHERAL SWELLING,253
dabrafenib,UVEITIS,253
dabrafenib,BLOOD CREATINE PHOSPHOKINASE INCREASED,238
dabrafenib,EJECTION FRACTION DECREASED,230
dabrafenib,CONFUSIONAL STATE,224
dabrafenib,SEIZURE,222
dabrafenib,NEUTROPENIA,218
dabrafenib,ACUTE KIDNEY INJURY,216
dabrafenib,FALL,209
dabrafenib,INFECTION,209
dabrafenib,TREMOR,203
dabrafenib,URINARY TRACT INFECTION,201
dabrafenib,ASPARTATE AMINOTRANSFERASE INCREASED,196
dabrafenib,NEOPLASM MALIGNANT,195
dabrafenib,SEPSIS,190
dabrafenib,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,189
dabrafenib,THROMBOCYTOPENIA,188
dabrafenib,ALOPECIA,187
dabrafenib,ERYTHEMA,182
dabrafenib,C-REACTIVE PROTEIN INCREASED,181
dabrafenib,ALANINE AMINOTRANSFERASE INCREASED,179
dabrafenib,OEDEMA PERIPHERAL,179
dabrafenib,DRY SKIN,177
dabrafenib,DRUG INTOLERANCE,175
dabrafenib,BACK PAIN,167
dabrafenib,RENAL FAILURE,166
dabrafenib,ABDOMINAL PAIN UPPER,162
dabrafenib,INCORRECT DOSE ADMINISTERED,155
dabrafenib,PULMONARY EMBOLISM,155
dabrafenib,ABDOMINAL DISCOMFORT,153
dabrafenib,HYPERHIDROSIS,152
dabrafenib,HEPATIC ENZYME INCREASED,149
dabrafenib,GAIT DISTURBANCE,148
dabrafenib,METASTASES TO LUNG,147
dabrafenib,RHABDOMYOLYSIS,143
dabrafenib,SYNCOPE,141
dabrafenib,ILLNESS,140
dabrafenib,HYPERTENSION,137
dabrafenib,METASTASES TO LIVER,136
dabrafenib,FEELING ABNORMAL,130
dabrafenib,INFLUENZA LIKE ILLNESS,128
dabrafenib,PNEUMONITIS,127
dabrafenib,PRODUCT USE ISSUE,127
dabrafenib,ATRIAL FIBRILLATION,124
dabrafenib,SOMNOLENCE,123
dabrafenib,HYPONATRAEMIA,122
dabrafenib,BLOOD LACTATE DEHYDROGENASE INCREASED,120
dabrafenib,PANNICULITIS,120
dabrafenib,SECOND PRIMARY MALIGNANCY,119
dabrafenib,NASOPHARYNGITIS,117
dabrafenib,HOSPITALISATION,116
dabrafenib,ELECTROCARDIOGRAM QT PROLONGED,115
dabrafenib,BASAL CELL CARCINOMA,114
dabrafenib,CARDIAC FAILURE,113
dabrafenib,JOINT SWELLING,113
dabrafenib,LYMPHADENOPATHY,113
dabrafenib,CONDITION AGGRAVATED,112
dabrafenib,HYPERSENSITIVITY,111
dabrafenib,HEPATITIS,110
dabrafenib,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,109
dabrafenib,BLOOD ALKALINE PHOSPHATASE INCREASED,107
niraparib,NAUSEA,5754
niraparib,FATIGUE,5196
niraparib,CONSTIPATION,4093
niraparib,PLATELET COUNT DECREASED,4038
niraparib,INSOMNIA,2847
niraparib,BLOOD PRESSURE INCREASED,2458
niraparib,HEADACHE,2361
niraparib,OFF LABEL USE,2189
niraparib,VOMITING,2011
niraparib,CARBOHYDRATE ANTIGEN 125 INCREASED,1865
niraparib,DECREASED APPETITE,1862
niraparib,ASTHENIA,1850
niraparib,PRODUCT DOSE OMISSION ISSUE,1836
niraparib,HAEMOGLOBIN DECREASED,1745
niraparib,DIZZINESS,1597
niraparib,DYSPNOEA,1423
niraparib,ANAEMIA,1414
niraparib,WHITE BLOOD CELL COUNT DECREASED,1395
niraparib,RED BLOOD CELL COUNT DECREASED,1341
niraparib,MALIGNANT NEOPLASM PROGRESSION,1314
niraparib,HYPERTENSION,1301
niraparib,HEART RATE INCREASED,1236
niraparib,ARTHRALGIA,1214
niraparib,DIARRHOEA,1143
niraparib,DRUG INEFFECTIVE,1081
niraparib,MALAISE,1079
niraparib,NEUROPATHY PERIPHERAL,1077
niraparib,PAIN,1056
niraparib,THROMBOCYTOPENIA,1018
niraparib,WEIGHT DECREASED,927
niraparib,DEATH,890
niraparib,ANXIETY,880
niraparib,DISEASE PROGRESSION,866
niraparib,DRY MOUTH,866
niraparib,ABDOMINAL DISCOMFORT,858
niraparib,ABDOMINAL PAIN UPPER,851
niraparib,BACK PAIN,839
niraparib,FEELING ABNORMAL,817
niraparib,ADVERSE DRUG REACTION,811
niraparib,COUGH,769
niraparib,RECURRENT CANCER,767
niraparib,PAIN IN EXTREMITY,693
niraparib,ABDOMINAL PAIN,683
niraparib,CONDITION AGGRAVATED,681
niraparib,INTENTIONAL UNDERDOSE,677
niraparib,PRURITUS,671
niraparib,PALPITATIONS,650
niraparib,RENAL IMPAIRMENT,648
niraparib,HOSPITALISATION,636
niraparib,DYSPEPSIA,610
niraparib,SLEEP DISORDER,604
niraparib,RASH,596
niraparib,DECREASED ACTIVITY,586
niraparib,DEHYDRATION,579
niraparib,URINARY TRACT INFECTION,573
niraparib,MYALGIA,568
niraparib,OVARIAN CANCER,552
niraparib,LABORATORY TEST ABNORMAL,534
niraparib,BLOOD CREATININE INCREASED,529
niraparib,CONTUSION,529
niraparib,STOMATITIS,519
niraparib,PRODUCT USE IN UNAPPROVED INDICATION,509
niraparib,ABDOMINAL DISTENSION,488
niraparib,MUSCLE SPASMS,476
niraparib,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,473
niraparib,ILLNESS,465
niraparib,NASOPHARYNGITIS,463
niraparib,OVARIAN CANCER RECURRENT,460
niraparib,EMOTIONAL DISTRESS,445
niraparib,BLOOD COUNT ABNORMAL,439
niraparib,PRODUCT DOSE OMISSION IN ERROR,427
niraparib,FALL,412
niraparib,HAEMATOCRIT DECREASED,403
niraparib,PERIPHERAL SWELLING,395
niraparib,HOT FLUSH,380
niraparib,NEUTROPHIL COUNT DECREASED,379
niraparib,BLOOD GLUCOSE INCREASED,376
niraparib,HYPOAESTHESIA,376
niraparib,BALANCE DISORDER,366
niraparib,PHOTOSENSITIVITY REACTION,359
niraparib,UNDERDOSE,358
niraparib,TUMOUR MARKER INCREASED,356
niraparib,FULL BLOOD COUNT DECREASED,352
niraparib,GAIT DISTURBANCE,351
niraparib,INTESTINAL OBSTRUCTION,351
niraparib,MEMORY IMPAIRMENT,351
niraparib,PYREXIA,347
niraparib,ALOPECIA,346
niraparib,DRUG INTOLERANCE,346
niraparib,FULL BLOOD COUNT ABNORMAL,336
niraparib,FLATULENCE,332
niraparib,OROPHARYNGEAL PAIN,332
niraparib,PRODUCT DOSE OMISSION,332
niraparib,TREMOR,331
niraparib,TASTE DISORDER,296
niraparib,DYSGEUSIA,289
niraparib,WEIGHT INCREASED,286
niraparib,BLOOD PRESSURE FLUCTUATION,285
niraparib,COVID-19,285
niraparib,GASTROOESOPHAGEAL REFLUX DISEASE,281
trastuzumab,DIARRHOEA,7212
trastuzumab,NAUSEA,5602
trastuzumab,OFF LABEL USE,5487
trastuzumab,ALOPECIA,5254
trastuzumab,FATIGUE,5148
trastuzumab,DEATH,4837
trastuzumab,DISEASE PROGRESSION,4318
trastuzumab,VOMITING,3486
trastuzumab,DYSPNOEA,3215
trastuzumab,PYREXIA,2932
trastuzumab,ASTHENIA,2594
trastuzumab,MYELOSUPPRESSION,2435
trastuzumab,PAIN,2406
trastuzumab,NEUTROPENIA,2399
trastuzumab,NEUROPATHY PERIPHERAL,2279
trastuzumab,NO ADVERSE EVENT,2191
trastuzumab,ANAEMIA,2146
trastuzumab,EJECTION FRACTION DECREASED,2121
trastuzumab,RASH,2076
trastuzumab,HEADACHE,1998
trastuzumab,DECREASED APPETITE,1904
trastuzumab,MALAISE,1680
trastuzumab,FEBRILE NEUTROPENIA,1678
trastuzumab,METASTASES TO CENTRAL NERVOUS SYSTEM,1631
trastuzumab,INTERSTITIAL LUNG DISEASE,1610
trastuzumab,COUGH,1580
trastuzumab,THROMBOCYTOPENIA,1564
trastuzumab,PNEUMONIA,1542
trastuzumab,DRUG INEFFECTIVE,1525
trastuzumab,HAIR COLOUR CHANGES,1511
trastuzumab,HAIR TEXTURE ABNORMAL,1509
trastuzumab,MALIGNANT NEOPLASM PROGRESSION,1502
trastuzumab,CHILLS,1495
trastuzumab,MADAROSIS,1433
trastuzumab,ARTHRALGIA,1417
trastuzumab,CONSTIPATION,1373
trastuzumab,HAIR DISORDER,1369
trastuzumab,WEIGHT DECREASED,1351
trastuzumab,DIZZINESS,1301
trastuzumab,PLATELET COUNT DECREASED,1266
trastuzumab,PSYCHOLOGICAL TRAUMA,1262
trastuzumab,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1237
trastuzumab,ANXIETY,1225
trastuzumab,ABDOMINAL PAIN,1178
trastuzumab,WHITE BLOOD CELL COUNT DECREASED,1146
trastuzumab,CARDIOTOXICITY,1143
trastuzumab,PRURITUS,1122
trastuzumab,BACK PAIN,1089
trastuzumab,PAIN IN EXTREMITY,1087
trastuzumab,CARDIAC FAILURE,1084
trastuzumab,DEHYDRATION,1059
trastuzumab,STOMATITIS,1047
trastuzumab,MYALGIA,1026
trastuzumab,PLEURAL EFFUSION,1004
trastuzumab,INFUSION RELATED REACTION,993
trastuzumab,MUCOSAL INFLAMMATION,971
trastuzumab,ERYTHEMA,964
trastuzumab,EPISTAXIS,947
trastuzumab,HYPERTENSION,917
trastuzumab,URINARY TRACT INFECTION,900
trastuzumab,PNEUMONITIS,898
trastuzumab,PARAESTHESIA,893
trastuzumab,GENERAL PHYSICAL HEALTH DETERIORATION,880
trastuzumab,HYPOKALAEMIA,880
trastuzumab,HYPOTENSION,840
trastuzumab,METASTASES TO LIVER,837
trastuzumab,BREAST CANCER METASTATIC,812
trastuzumab,HYPOAESTHESIA,812
trastuzumab,NEUTROPHIL COUNT DECREASED,808
trastuzumab,LEUKOPENIA,802
trastuzumab,HYPERSENSITIVITY,801
trastuzumab,SEPSIS,797
trastuzumab,METASTASES TO BONE,790
trastuzumab,ALANINE AMINOTRANSFERASE INCREASED,774
trastuzumab,CHEST PAIN,759
trastuzumab,INTENTIONAL PRODUCT USE ISSUE,731
trastuzumab,EMOTIONAL DISTRESS,729
trastuzumab,BREAST CANCER,719
trastuzumab,OEDEMA PERIPHERAL,718
trastuzumab,ASPARTATE AMINOTRANSFERASE INCREASED,714
trastuzumab,INSOMNIA,707
trastuzumab,NEOPLASM PROGRESSION,706
trastuzumab,INFECTION,680
trastuzumab,BONE PAIN,666
trastuzumab,PULMONARY EMBOLISM,666
trastuzumab,CHEST DISCOMFORT,642
trastuzumab,ABDOMINAL PAIN UPPER,629
trastuzumab,METASTASES TO LUNG,629
trastuzumab,TACHYCARDIA,628
trastuzumab,NASOPHARYNGITIS,626
trastuzumab,TREMOR,626
trastuzumab,ACUTE KIDNEY INJURY,603
trastuzumab,HAEMOGLOBIN DECREASED,589
trastuzumab,DEPRESSION,587
trastuzumab,CELLULITIS,581
trastuzumab,TOXICITY TO VARIOUS AGENTS,570
trastuzumab,BONE MARROW FAILURE,567
trastuzumab,CARDIAC DISORDER,564
trastuzumab,HEPATIC FUNCTION ABNORMAL,561
trastuzumab,MUSCLE SPASMS,553
cabozantinib,DIARRHOEA,8016
cabozantinib,FATIGUE,6513
cabozantinib,NAUSEA,4270
cabozantinib,OFF LABEL USE,4193
cabozantinib,DECREASED APPETITE,3965
cabozantinib,DEATH,2656
cabozantinib,BLOOD PRESSURE INCREASED,2627
cabozantinib,MALIGNANT NEOPLASM PROGRESSION,2623
cabozantinib,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,2565
cabozantinib,WEIGHT DECREASED,2555
cabozantinib,STOMATITIS,2488
cabozantinib,CONSTIPATION,1995
cabozantinib,VOMITING,1896
cabozantinib,ASTHENIA,1806
cabozantinib,BLISTER,1798
cabozantinib,TASTE DISORDER,1595
cabozantinib,HYPERTENSION,1588
cabozantinib,MALAISE,1550
cabozantinib,PAIN IN EXTREMITY,1522
cabozantinib,RASH,1518
cabozantinib,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,1398
cabozantinib,DYSPHONIA,1210
cabozantinib,DRY SKIN,1109
cabozantinib,ORAL PAIN,1078
cabozantinib,ADVERSE DRUG REACTION,1074
cabozantinib,SKIN ULCER,1001
cabozantinib,PRURITUS,996
cabozantinib,PAIN,974
cabozantinib,HEADACHE,920
cabozantinib,DIZZINESS,889
cabozantinib,DRY MOUTH,866
cabozantinib,DEHYDRATION,844
cabozantinib,DYSPNOEA,822
cabozantinib,HEPATIC FUNCTION ABNORMAL,806
cabozantinib,DYSGEUSIA,803
cabozantinib,ABDOMINAL DISCOMFORT,801
cabozantinib,ARTHRALGIA,767
cabozantinib,ABDOMINAL PAIN UPPER,746
cabozantinib,PRODUCT DOSE OMISSION ISSUE,734
cabozantinib,HYPOTHYROIDISM,687
cabozantinib,SKIN EXFOLIATION,677
cabozantinib,ALOPECIA,672
cabozantinib,DRUG INEFFECTIVE,666
cabozantinib,PERIPHERAL SWELLING,630
cabozantinib,ERYTHEMA,615
cabozantinib,ABDOMINAL PAIN,595
cabozantinib,BACK PAIN,585
cabozantinib,DRUG INTOLERANCE,584
cabozantinib,MUSCLE SPASMS,582
cabozantinib,AGEUSIA,581
cabozantinib,OROPHARYNGEAL PAIN,577
cabozantinib,PYREXIA,572
cabozantinib,HAIR COLOUR CHANGES,540
cabozantinib,DISEASE PROGRESSION,525
cabozantinib,GLOSSODYNIA,520
cabozantinib,COUGH,498
cabozantinib,PNEUMONIA,493
cabozantinib,HEPATIC ENZYME INCREASED,485
cabozantinib,DYSPEPSIA,436
cabozantinib,PULMONARY EMBOLISM,433
cabozantinib,URINARY TRACT INFECTION,421
cabozantinib,PLATELET COUNT DECREASED,419
cabozantinib,FLATULENCE,412
cabozantinib,ANAEMIA,398
cabozantinib,DYSPHAGIA,396
cabozantinib,PROTEINURIA,396
cabozantinib,HYPERKERATOSIS,377
cabozantinib,FALL,375
cabozantinib,RENAL CELL CARCINOMA,370
cabozantinib,INSOMNIA,366
cabozantinib,NEUROPATHY PERIPHERAL,359
cabozantinib,CONFUSIONAL STATE,354
cabozantinib,PLEURAL EFFUSION,353
cabozantinib,LIVER DISORDER,349
cabozantinib,IMPAIRED HEALING,345
cabozantinib,GASTROOESOPHAGEAL REFLUX DISEASE,343
cabozantinib,EPISTAXIS,340
cabozantinib,GENERAL PHYSICAL HEALTH DETERIORATION,339
cabozantinib,SOMNOLENCE,338
cabozantinib,ALANINE AMINOTRANSFERASE INCREASED,321
cabozantinib,ILLNESS,314
cabozantinib,MUCOSAL INFLAMMATION,313
cabozantinib,MYALGIA,310
cabozantinib,ASPARTATE AMINOTRANSFERASE INCREASED,309
cabozantinib,GAIT DISTURBANCE,304
cabozantinib,CHEST PAIN,298
cabozantinib,THROMBOSIS,291
cabozantinib,TOOTH DISORDER,286
cabozantinib,FEELING ABNORMAL,278
cabozantinib,HYPOAESTHESIA,278
cabozantinib,ORAL DISCOMFORT,277
cabozantinib,PARAESTHESIA,274
cabozantinib,SEPSIS,274
cabozantinib,ACNE,272
cabozantinib,LIVER FUNCTION TEST INCREASED,272
cabozantinib,MEMORY IMPAIRMENT,269
cabozantinib,COVID-19,260
cabozantinib,OEDEMA PERIPHERAL,254
cabozantinib,CONTUSION,252
cabozantinib,ADVERSE EVENT,251
ramucirumab,MALIGNANT NEOPLASM PROGRESSION,764
ramucirumab,DEATH,517
ramucirumab,INTERSTITIAL LUNG DISEASE,285
ramucirumab,FEBRILE NEUTROPENIA,258
ramucirumab,NEUTROPENIA,256
ramucirumab,DECREASED APPETITE,208
ramucirumab,DIARRHOEA,206
ramucirumab,DISEASE PROGRESSION,189
ramucirumab,OFF LABEL USE,187
ramucirumab,HYPERTENSION,177
ramucirumab,FATIGUE,174
ramucirumab,NAUSEA,173
ramucirumab,NEUTROPHIL COUNT DECREASED,166
ramucirumab,PYREXIA,165
ramucirumab,ASCITES,161
ramucirumab,NEUROPATHY PERIPHERAL,161
ramucirumab,DRUG INEFFECTIVE,154
ramucirumab,ANAEMIA,153
ramucirumab,PNEUMONIA,151
ramucirumab,PROTEINURIA,132
ramucirumab,VOMITING,121
ramucirumab,DYSPNOEA,118
ramucirumab,ABDOMINAL PAIN,116
ramucirumab,PLATELET COUNT DECREASED,109
ramucirumab,MALAISE,107
ramucirumab,EPISTAXIS,92
ramucirumab,THROMBOCYTOPENIA,91
ramucirumab,PERITONITIS,90
ramucirumab,WHITE BLOOD CELL COUNT DECREASED,90
ramucirumab,STOMATITIS,87
ramucirumab,PLEURAL EFFUSION,86
ramucirumab,ASTHENIA,85
ramucirumab,PNEUMONITIS,84
ramucirumab,NEPHROTIC SYNDROME,83
ramucirumab,GENERAL PHYSICAL HEALTH DETERIORATION,82
ramucirumab,SEPSIS,82
ramucirumab,PULMONARY EMBOLISM,81
ramucirumab,TUMOUR HAEMORRHAGE,76
ramucirumab,GASTROINTESTINAL PERFORATION,75
ramucirumab,HAEMOPTYSIS,72
ramucirumab,WEIGHT DECREASED,72
ramucirumab,RASH,71
ramucirumab,DISSEMINATED INTRAVASCULAR COAGULATION,69
ramucirumab,GASTROINTESTINAL HAEMORRHAGE,69
ramucirumab,HAEMOGLOBIN DECREASED,65
ramucirumab,PRODUCT USE IN UNAPPROVED INDICATION,62
ramucirumab,OEDEMA PERIPHERAL,60
ramucirumab,INFUSION RELATED REACTION,59
ramucirumab,CARDIAC FAILURE,58
ramucirumab,SEPTIC SHOCK,58
ramucirumab,ACUTE KIDNEY INJURY,56
ramucirumab,MUCOSAL INFLAMMATION,54
ramucirumab,OEDEMA,54
ramucirumab,ALOPECIA,51
ramucirumab,CONSTIPATION,51
ramucirumab,DEHYDRATION,51
ramucirumab,GASTRIC PERFORATION,51
ramucirumab,PRURITUS,51
ramucirumab,ALANINE AMINOTRANSFERASE INCREASED,50
ramucirumab,INFECTION,50
ramucirumab,COUGH,49
ramucirumab,HAEMORRHAGE,49
ramucirumab,RESPIRATORY FAILURE,49
ramucirumab,THERAPY PARTIAL RESPONDER,49
ramucirumab,ABDOMINAL PAIN UPPER,48
ramucirumab,ERYTHEMA,48
ramucirumab,METASTASES TO LIVER,48
ramucirumab,PAIN,48
ramucirumab,DEEP VEIN THROMBOSIS,47
ramucirumab,HYPERSENSITIVITY,46
ramucirumab,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,45
ramucirumab,MYELOSUPPRESSION,44
ramucirumab,DYSPHAGIA,43
ramucirumab,CHEST PAIN,41
ramucirumab,HEADACHE,41
ramucirumab,LEUKOPENIA,41
ramucirumab,C-REACTIVE PROTEIN INCREASED,40
ramucirumab,CEREBRAL HAEMORRHAGE,40
ramucirumab,FALL,40
ramucirumab,HEPATIC FUNCTION ABNORMAL,40
ramucirumab,HAEMATEMESIS,38
ramucirumab,POLYNEUROPATHY,38
ramucirumab,BACK PAIN,37
ramucirumab,CONDITION AGGRAVATED,37
ramucirumab,NEOPLASM PROGRESSION,37
ramucirumab,PNEUMOTHORAX,37
ramucirumab,HYPOAESTHESIA,36
ramucirumab,ANAPHYLACTIC REACTION,35
ramucirumab,BLOOD PRESSURE INCREASED,35
ramucirumab,RENAL IMPAIRMENT,35
ramucirumab,BONE MARROW FAILURE,34
ramucirumab,HEPATIC FAILURE,34
ramucirumab,HYPONATRAEMIA,34
ramucirumab,HYPOTENSION,34
ramucirumab,ASPARTATE AMINOTRANSFERASE INCREASED,33
ramucirumab,HYPOTHYROIDISM,33
ramucirumab,PNEUMONIA ASPIRATION,33
ramucirumab,THROMBOSIS,33
ramucirumab,THROMBOTIC MICROANGIOPATHY,31
ramucirumab,INTESTINAL PERFORATION,30
atezolizumab,DEATH,3343
atezolizumab,OFF LABEL USE,2442
atezolizumab,DISEASE PROGRESSION,1636
atezolizumab,PYREXIA,1538
atezolizumab,DIARRHOEA,1422
atezolizumab,FATIGUE,1231
atezolizumab,ANAEMIA,1164
atezolizumab,PNEUMONIA,985
atezolizumab,NAUSEA,924
atezolizumab,DYSPNOEA,911
atezolizumab,DECREASED APPETITE,875
atezolizumab,FEBRILE NEUTROPENIA,848
atezolizumab,HYPOTHYROIDISM,820
atezolizumab,PNEUMONITIS,785
atezolizumab,RASH,742
atezolizumab,ASTHENIA,741
atezolizumab,HYPERTENSION,735
atezolizumab,VOMITING,689
atezolizumab,NEUTROPENIA,681
atezolizumab,ACUTE KIDNEY INJURY,675
atezolizumab,INTERSTITIAL LUNG DISEASE,672
atezolizumab,THROMBOCYTOPENIA,657
atezolizumab,PLATELET COUNT DECREASED,629
atezolizumab,COLITIS,621
atezolizumab,INTENTIONAL PRODUCT USE ISSUE,610
atezolizumab,DRUG INEFFECTIVE,602
atezolizumab,NEUTROPHIL COUNT DECREASED,576
atezolizumab,CONSTIPATION,558
atezolizumab,PROTEINURIA,532
atezolizumab,SEPSIS,514
atezolizumab,ALANINE AMINOTRANSFERASE INCREASED,479
atezolizumab,HEPATIC FUNCTION ABNORMAL,447
atezolizumab,ABDOMINAL PAIN,445
atezolizumab,ASCITES,443
atezolizumab,ASPARTATE AMINOTRANSFERASE INCREASED,441
atezolizumab,WHITE BLOOD CELL COUNT DECREASED,432
atezolizumab,ADRENAL INSUFFICIENCY,431
atezolizumab,GENERAL PHYSICAL HEALTH DETERIORATION,415
atezolizumab,HEPATOCELLULAR CARCINOMA,409
atezolizumab,PRURITUS,408
atezolizumab,HYPONATRAEMIA,390
atezolizumab,NEUROPATHY PERIPHERAL,383
atezolizumab,HYPERTHYROIDISM,373
atezolizumab,COUGH,357
atezolizumab,MALAISE,353
atezolizumab,HEPATITIS,349
atezolizumab,ARTHRALGIA,348
atezolizumab,HEPATIC FAILURE,343
atezolizumab,MYOCARDITIS,333
atezolizumab,URINARY TRACT INFECTION,330
atezolizumab,NO ADVERSE EVENT,324
atezolizumab,HYPOKALAEMIA,323
atezolizumab,HEADACHE,319
atezolizumab,PLEURAL EFFUSION,315
atezolizumab,COVID-19,312
atezolizumab,ALOPECIA,307
atezolizumab,PAIN,306
atezolizumab,WEIGHT DECREASED,306
atezolizumab,LIVER DISORDER,302
atezolizumab,INFUSION RELATED REACTION,298
atezolizumab,DEHYDRATION,289
atezolizumab,PULMONARY EMBOLISM,286
atezolizumab,BLOOD BILIRUBIN INCREASED,278
atezolizumab,STOMATITIS,278
atezolizumab,MALIGNANT NEOPLASM PROGRESSION,277
atezolizumab,RESPIRATORY FAILURE,275
atezolizumab,HYPOTENSION,274
atezolizumab,BLOOD CREATININE INCREASED,272
atezolizumab,RENAL IMPAIRMENT,262
atezolizumab,BACK PAIN,261
atezolizumab,CARDIAC FAILURE,261
atezolizumab,MYELOSUPPRESSION,259
atezolizumab,PANCYTOPENIA,256
atezolizumab,OEDEMA PERIPHERAL,240
atezolizumab,DIZZINESS,236
atezolizumab,MUSCULAR WEAKNESS,232
atezolizumab,MYOSITIS,232
atezolizumab,INFECTION,230
atezolizumab,THERAPY PARTIAL RESPONDER,221
atezolizumab,ENCEPHALITIS,219
atezolizumab,METASTASES TO CENTRAL NERVOUS SYSTEM,218
atezolizumab,RENAL FAILURE,214
atezolizumab,CHEST PAIN,213
atezolizumab,EPISTAXIS,206
atezolizumab,LYMPHOCYTE COUNT DECREASED,203
atezolizumab,MUCOSAL INFLAMMATION,203
atezolizumab,MYALGIA,197
atezolizumab,NEOPLASM PROGRESSION,196
atezolizumab,ATRIAL FIBRILLATION,195
atezolizumab,NEOPLASM MALIGNANT,187
atezolizumab,SEPTIC SHOCK,187
atezolizumab,CONFUSIONAL STATE,186
atezolizumab,HAEMORRHAGE,183
atezolizumab,LEUKOPENIA,183
atezolizumab,FALL,180
atezolizumab,PANCREATITIS,180
atezolizumab,DRUG-INDUCED LIVER INJURY,179
atezolizumab,GASTROINTESTINAL HAEMORRHAGE,177
atezolizumab,DYSPHAGIA,176
atezolizumab,HYPERGLYCAEMIA,173
bevacizumab,DEATH,12568
bevacizumab,OFF LABEL USE,12211
bevacizumab,DIARRHOEA,7066
bevacizumab,DISEASE PROGRESSION,7009
bevacizumab,NAUSEA,6450
bevacizumab,FATIGUE,6054
bevacizumab,HYPERTENSION,5572
bevacizumab,VOMITING,4912
bevacizumab,ANAEMIA,4100
bevacizumab,PYREXIA,3929
bevacizumab,NEUTROPENIA,3767
bevacizumab,ASTHENIA,3473
bevacizumab,DYSPNOEA,3406
bevacizumab,DECREASED APPETITE,3210
bevacizumab,THROMBOCYTOPENIA,3009
bevacizumab,DRUG INEFFECTIVE,2930
bevacizumab,ABDOMINAL PAIN,2885
bevacizumab,PROTEINURIA,2825
bevacizumab,NEUROPATHY PERIPHERAL,2592
bevacizumab,MALIGNANT NEOPLASM PROGRESSION,2492
bevacizumab,HEADACHE,2379
bevacizumab,CONSTIPATION,2259
bevacizumab,PAIN,2226
bevacizumab,PLATELET COUNT DECREASED,2222
bevacizumab,DEHYDRATION,2217
bevacizumab,FEBRILE NEUTROPENIA,2167
bevacizumab,RASH,2161
bevacizumab,EPISTAXIS,2088
bevacizumab,PULMONARY EMBOLISM,2081
bevacizumab,INTENTIONAL PRODUCT USE ISSUE,1976
bevacizumab,NO ADVERSE EVENT,1975
bevacizumab,PNEUMONIA,1966
bevacizumab,WEIGHT DECREASED,1908
bevacizumab,GENERAL PHYSICAL HEALTH DETERIORATION,1824
bevacizumab,MALAISE,1800
bevacizumab,WHITE BLOOD CELL COUNT DECREASED,1716
bevacizumab,NEUTROPHIL COUNT DECREASED,1620
bevacizumab,MYELOSUPPRESSION,1591
bevacizumab,BLOOD PRESSURE INCREASED,1555
bevacizumab,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1492
bevacizumab,SEPSIS,1488
bevacizumab,STOMATITIS,1447
bevacizumab,COUGH,1388
bevacizumab,MUCOSAL INFLAMMATION,1383
bevacizumab,DIZZINESS,1369
bevacizumab,ASCITES,1368
bevacizumab,LEUKOPENIA,1361
bevacizumab,ARTHRALGIA,1322
bevacizumab,PLEURAL EFFUSION,1302
bevacizumab,DEEP VEIN THROMBOSIS,1295
bevacizumab,HAEMORRHAGE,1294
bevacizumab,HAEMOGLOBIN DECREASED,1262
bevacizumab,INFECTION,1253
bevacizumab,NEOPLASM PROGRESSION,1240
bevacizumab,INTERSTITIAL LUNG DISEASE,1231
bevacizumab,BACK PAIN,1223
bevacizumab,HYPOTENSION,1196
bevacizumab,ALOPECIA,1195
bevacizumab,ENDOPHTHALMITIS,1190
bevacizumab,URINARY TRACT INFECTION,1120
bevacizumab,FALL,1094
bevacizumab,GASTROINTESTINAL PERFORATION,1085
bevacizumab,VISUAL IMPAIRMENT,1083
bevacizumab,CONFUSIONAL STATE,1061
bevacizumab,CHEST PAIN,1058
bevacizumab,BLINDNESS,1046
bevacizumab,INTESTINAL OBSTRUCTION,1034
bevacizumab,ACUTE KIDNEY INJURY,1023
bevacizumab,METASTASES TO LIVER,1017
bevacizumab,BONE MARROW FAILURE,1009
bevacizumab,CEREBROVASCULAR ACCIDENT,1000
bevacizumab,RENAL FAILURE,951
bevacizumab,HYPOKALAEMIA,941
bevacizumab,INTESTINAL PERFORATION,933
bevacizumab,PAIN IN EXTREMITY,923
bevacizumab,HYPERSENSITIVITY,919
bevacizumab,OEDEMA PERIPHERAL,910
bevacizumab,ALANINE AMINOTRANSFERASE INCREASED,899
bevacizumab,ASPARTATE AMINOTRANSFERASE INCREASED,882
bevacizumab,RENAL IMPAIRMENT,881
bevacizumab,ABDOMINAL PAIN UPPER,875
bevacizumab,BLOOD CREATININE INCREASED,875
bevacizumab,ERYTHEMA,868
bevacizumab,PRURITUS,866
bevacizumab,HYPONATRAEMIA,865
bevacizumab,PARAESTHESIA,860
bevacizumab,HEPATIC FUNCTION ABNORMAL,834
bevacizumab,THROMBOSIS,834
bevacizumab,HYPOAESTHESIA,814
bevacizumab,GASTROINTESTINAL HAEMORRHAGE,794
bevacizumab,CARDIAC FAILURE,788
bevacizumab,CONDITION AGGRAVATED,779
bevacizumab,CHILLS,767
bevacizumab,VISUAL ACUITY REDUCED,758
bevacizumab,TOXICITY TO VARIOUS AGENTS,750
bevacizumab,METASTASES TO LUNG,744
bevacizumab,MUSCULAR WEAKNESS,731
bevacizumab,MYOCARDIAL INFARCTION,726
bevacizumab,VISION BLURRED,721
bevacizumab,RESPIRATORY FAILURE,716
olaparib,DEATH,4097
olaparib,MALIGNANT NEOPLASM PROGRESSION,1814
olaparib,NAUSEA,1469
olaparib,ANAEMIA,1389
olaparib,FATIGUE,1321
olaparib,OFF LABEL USE,797
olaparib,VOMITING,626
olaparib,DRUG INEFFECTIVE,571
olaparib,DIARRHOEA,501
olaparib,ASTHENIA,450
olaparib,DISEASE PROGRESSION,445
olaparib,MYELODYSPLASTIC SYNDROME,441
olaparib,DECREASED APPETITE,422
olaparib,PLATELET COUNT DECREASED,353
olaparib,HAEMOGLOBIN DECREASED,350
olaparib,INTERSTITIAL LUNG DISEASE,344
olaparib,MALAISE,325
olaparib,MYELOSUPPRESSION,324
olaparib,HEADACHE,320
olaparib,DYSPNOEA,318
olaparib,CONSTIPATION,317
olaparib,THROMBOCYTOPENIA,315
olaparib,ACUTE MYELOID LEUKAEMIA,305
olaparib,NEUROPATHY PERIPHERAL,292
olaparib,PAIN,292
olaparib,DIZZINESS,283
olaparib,OVARIAN CANCER RECURRENT,280
olaparib,PRODUCT USE ISSUE,279
olaparib,CARBOHYDRATE ANTIGEN 125 INCREASED,277
olaparib,PRODUCT USE IN UNAPPROVED INDICATION,275
olaparib,PRODUCT DOSE OMISSION ISSUE,261
olaparib,ARTHRALGIA,258
olaparib,PANCYTOPENIA,255
olaparib,WHITE BLOOD CELL COUNT DECREASED,249
olaparib,RENAL IMPAIRMENT,228
olaparib,PYREXIA,224
olaparib,TOXICITY TO VARIOUS AGENTS,203
olaparib,NEUTROPHIL COUNT DECREASED,202
olaparib,RASH,201
olaparib,WEIGHT DECREASED,194
olaparib,NEUTROPENIA,188
olaparib,ABDOMINAL PAIN,182
olaparib,METASTASES TO LIVER,180
olaparib,PROSTATIC SPECIFIC ANTIGEN INCREASED,171
olaparib,FALL,163
olaparib,PNEUMONIA,161
olaparib,ABDOMINAL PAIN UPPER,159
olaparib,TUMOUR MARKER INCREASED,154
olaparib,METASTASES TO BONE,149
olaparib,BLOOD CREATININE INCREASED,148
olaparib,COUGH,148
olaparib,BACK PAIN,147
olaparib,HYPERTENSION,146
olaparib,MYALGIA,145
olaparib,PAIN IN EXTREMITY,144
olaparib,RENAL FAILURE,142
olaparib,HAEMATOTOXICITY,141
olaparib,DEHYDRATION,140
olaparib,ABDOMINAL DISCOMFORT,139
olaparib,DRUG INTERACTION,137
olaparib,RED BLOOD CELL COUNT DECREASED,137
olaparib,DYSPHAGIA,134
olaparib,FULL BLOOD COUNT DECREASED,133
olaparib,PERIPHERAL SWELLING,131
olaparib,THROMBOSIS,130
olaparib,DYSPEPSIA,125
olaparib,INSOMNIA,125
olaparib,DRUG INTOLERANCE,123
olaparib,PRURITUS,123
olaparib,INTESTINAL OBSTRUCTION,122
olaparib,PLEURAL EFFUSION,122
olaparib,PNEUMONITIS,122
olaparib,GENERAL PHYSICAL HEALTH DETERIORATION,118
olaparib,NEOPLASM MALIGNANT,118
olaparib,FEELING ABNORMAL,115
olaparib,COVID-19,112
olaparib,METASTASES TO CENTRAL NERVOUS SYSTEM,112
olaparib,ASCITES,108
olaparib,URINARY TRACT INFECTION,105
olaparib,ABDOMINAL DISTENSION,104
olaparib,ILLNESS,104
olaparib,DYSGEUSIA,103
olaparib,TASTE DISORDER,100
olaparib,SOMNOLENCE,99
olaparib,ALOPECIA,97
olaparib,METASTASES TO LYMPH NODES,96
olaparib,UNDERDOSE,95
olaparib,DRUG RESISTANCE,94
olaparib,BONE PAIN,92
olaparib,FULL BLOOD COUNT ABNORMAL,92
olaparib,MUSCLE SPASMS,92
olaparib,CEREBROVASCULAR ACCIDENT,88
olaparib,HYPOTENSION,88
olaparib,BLOOD PRESSURE INCREASED,87
olaparib,GAIT DISTURBANCE,87
olaparib,FEBRILE NEUTROPENIA,86
olaparib,INTENTIONAL PRODUCT MISUSE,85
olaparib,OVARIAN CANCER,85
olaparib,INFECTION,83
olaparib,STOMATITIS,83
trametinib,PYREXIA,3883
trametinib,DEATH,3256
trametinib,MALIGNANT NEOPLASM PROGRESSION,1901
trametinib,RASH,1574
trametinib,FATIGUE,1405
trametinib,NAUSEA,1390
trametinib,CHILLS,1222
trametinib,DIARRHOEA,1192
trametinib,PRODUCT USE IN UNAPPROVED INDICATION,1071
trametinib,VOMITING,1018
trametinib,HEADACHE,708
trametinib,ASTHENIA,675
trametinib,MALAISE,624
trametinib,DRUG INEFFECTIVE,593
trametinib,OFF LABEL USE,571
trametinib,DECREASED APPETITE,566
trametinib,VISUAL IMPAIRMENT,516
trametinib,ARTHRALGIA,514
trametinib,DISEASE PROGRESSION,494
trametinib,DYSPNOEA,469
trametinib,METASTATIC MALIGNANT MELANOMA,459
trametinib,PAIN,458
trametinib,METASTASES TO CENTRAL NERVOUS SYSTEM,447
trametinib,MALIGNANT MELANOMA,421
trametinib,PNEUMONIA,420
trametinib,DEHYDRATION,406
trametinib,DIZZINESS,363
trametinib,COUGH,354
trametinib,CONSTIPATION,341
trametinib,VISION BLURRED,336
trametinib,GENERAL PHYSICAL HEALTH DETERIORATION,332
trametinib,ANAEMIA,324
trametinib,PRURITUS,321
trametinib,ABDOMINAL PAIN,312
trametinib,HYPOTENSION,312
trametinib,WEIGHT DECREASED,309
trametinib,PERIPHERAL SWELLING,300
trametinib,BLOOD CREATINE PHOSPHOKINASE INCREASED,297
trametinib,PAIN IN EXTREMITY,265
trametinib,DRY SKIN,256
trametinib,EJECTION FRACTION DECREASED,256
trametinib,MYALGIA,253
trametinib,DYSPHAGIA,245
trametinib,URINARY TRACT INFECTION,240
trametinib,SEIZURE,236
trametinib,CONFUSIONAL STATE,235
trametinib,SEPSIS,235
trametinib,UVEITIS,233
trametinib,ASPARTATE AMINOTRANSFERASE INCREASED,230
trametinib,INFECTION,230
trametinib,NEUTROPENIA,224
trametinib,ACUTE KIDNEY INJURY,222
trametinib,ACNE,219
trametinib,ALOPECIA,218
trametinib,PRODUCT STORAGE ERROR,217
trametinib,PRODUCT USE ISSUE,217
trametinib,ERYTHEMA,214
trametinib,NEOPLASM MALIGNANT,214
trametinib,FALL,213
trametinib,ALANINE AMINOTRANSFERASE INCREASED,211
trametinib,THROMBOCYTOPENIA,206
trametinib,OEDEMA PERIPHERAL,204
trametinib,C-REACTIVE PROTEIN INCREASED,203
trametinib,TREMOR,203
trametinib,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,195
trametinib,ABDOMINAL PAIN UPPER,189
trametinib,DRUG INTOLERANCE,185
trametinib,HYPERTENSION,178
trametinib,PULMONARY EMBOLISM,172
trametinib,ABDOMINAL DISCOMFORT,169
trametinib,BACK PAIN,167
trametinib,INCORRECT DOSE ADMINISTERED,165
trametinib,DERMATITIS ACNEIFORM,162
trametinib,GAIT DISTURBANCE,159
trametinib,HEPATIC ENZYME INCREASED,159
trametinib,RENAL FAILURE,158
trametinib,ILLNESS,156
trametinib,METASTASES TO LUNG,152
trametinib,METASTASES TO LIVER,151
trametinib,STOMATITIS,151
trametinib,SYNCOPE,149
trametinib,PNEUMONITIS,146
trametinib,RHABDOMYOLYSIS,146
trametinib,HYPERHIDROSIS,140
trametinib,HYPONATRAEMIA,137
trametinib,PLEURAL EFFUSION,137
trametinib,NEOPLASM PROGRESSION,136
trametinib,EPISTAXIS,134
trametinib,FEELING ABNORMAL,134
trametinib,ATRIAL FIBRILLATION,133
trametinib,INFLUENZA LIKE ILLNESS,133
trametinib,HYPERSENSITIVITY,132
trametinib,BLOOD LACTATE DEHYDROGENASE INCREASED,128
trametinib,PLATELET COUNT DECREASED,128
trametinib,OEDEMA,127
trametinib,SOMNOLENCE,127
trametinib,TOXICITY TO VARIOUS AGENTS,126
trametinib,CARDIAC FAILURE,125
trametinib,DRY MOUTH,124
trametinib,JOINT SWELLING,122
ribociclib,NEUTROPENIA,3193
ribociclib,NAUSEA,3143
ribociclib,FATIGUE,3032
ribociclib,DEATH,2347
ribociclib,MALIGNANT NEOPLASM PROGRESSION,2146
ribociclib,VOMITING,1784
ribociclib,DIARRHOEA,1703
ribociclib,WHITE BLOOD CELL COUNT DECREASED,1533
ribociclib,PAIN,1476
ribociclib,METASTASES TO BONE,1353
ribociclib,DYSPNOEA,1342
ribociclib,BREAST CANCER METASTATIC,1296
ribociclib,MALAISE,1291
ribociclib,ASTHENIA,1228
ribociclib,ANAEMIA,1213
ribociclib,ALOPECIA,1187
ribociclib,DECREASED APPETITE,1163
ribociclib,LEUKOPENIA,1141
ribociclib,RASH,1096
ribociclib,HEADACHE,1064
ribociclib,PRURITUS,1054
ribociclib,ARTHRALGIA,1043
ribociclib,DIZZINESS,1001
ribociclib,COUGH,994
ribociclib,CONSTIPATION,923
ribociclib,ELECTROCARDIOGRAM QT PROLONGED,909
ribociclib,PYREXIA,897
ribociclib,METASTASES TO LIVER,878
ribociclib,BACK PAIN,873
ribociclib,PAIN IN EXTREMITY,873
ribociclib,DRUG INEFFECTIVE,870
ribociclib,GENERAL PHYSICAL HEALTH DETERIORATION,865
ribociclib,WEIGHT DECREASED,781
ribociclib,DECREASED IMMUNE RESPONSIVENESS,747
ribociclib,BREAST CANCER,714
ribociclib,ALANINE AMINOTRANSFERASE INCREASED,697
ribociclib,ASPARTATE AMINOTRANSFERASE INCREASED,659
ribociclib,THROMBOCYTOPENIA,655
ribociclib,HAEMOGLOBIN DECREASED,652
ribociclib,BONE PAIN,626
ribociclib,NEUTROPHIL COUNT DECREASED,624
ribociclib,PLEURAL EFFUSION,600
ribociclib,DISEASE PROGRESSION,597
ribociclib,METASTASES TO LUNG,591
ribociclib,PNEUMONIA,574
ribociclib,PLATELET COUNT DECREASED,547
ribociclib,ABDOMINAL PAIN UPPER,544
ribociclib,COVID-19,537
ribociclib,DRY SKIN,524
ribociclib,BLOOD CREATININE INCREASED,523
ribociclib,ABDOMINAL DISCOMFORT,518
ribociclib,FEELING ABNORMAL,516
ribociclib,PERIPHERAL SWELLING,488
ribociclib,HEPATOTOXICITY,484
ribociclib,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,483
ribociclib,ABDOMINAL PAIN,480
ribociclib,INSOMNIA,471
ribociclib,ILLNESS,463
ribociclib,HYPERTENSION,459
ribociclib,HYPERSENSITIVITY,449
ribociclib,GAIT DISTURBANCE,448
ribociclib,NASOPHARYNGITIS,441
ribociclib,OFF LABEL USE,426
ribociclib,HEPATIC ENZYME INCREASED,425
ribociclib,URINARY TRACT INFECTION,420
ribociclib,FALL,419
ribociclib,HOT FLUSH,413
ribociclib,DRUG INTOLERANCE,389
ribociclib,ANXIETY,387
ribociclib,LIVER FUNCTION TEST INCREASED,373
ribociclib,METASTASIS,359
ribociclib,ERYTHEMA,350
ribociclib,OEDEMA PERIPHERAL,348
ribociclib,GAMMA-GLUTAMYLTRANSFERASE INCREASED,346
ribociclib,DYSPEPSIA,341
ribociclib,CHEST PAIN,332
ribociclib,DEPRESSION,326
ribociclib,INFLUENZA,326
ribociclib,RENAL IMPAIRMENT,325
ribociclib,DYSPHAGIA,319
ribociclib,MEMORY IMPAIRMENT,318
ribociclib,TUMOUR MARKER INCREASED,317
ribociclib,VISUAL IMPAIRMENT,315
ribociclib,RENAL FAILURE,312
ribociclib,SOMNOLENCE,305
ribociclib,ATRIAL FIBRILLATION,301
ribociclib,PRODUCT DOSE OMISSION ISSUE,301
ribociclib,RED BLOOD CELL COUNT DECREASED,299
ribociclib,DEHYDRATION,289
ribociclib,NEOPLASM MALIGNANT,289
ribociclib,TRANSAMINASES INCREASED,284
ribociclib,METASTASES TO SPINE,275
ribociclib,ASCITES,274
ribociclib,WEIGHT INCREASED,274
ribociclib,BLOOD ALKALINE PHOSPHATASE INCREASED,271
ribociclib,BLOOD BILIRUBIN INCREASED,256
ribociclib,DISCOMFORT,256
ribociclib,LIVER DISORDER,252
ribociclib,INFECTION,250
ribociclib,ACUTE KIDNEY INJURY,248
durvalumab,DEATH,2350
durvalumab,MALIGNANT NEOPLASM PROGRESSION,1147
durvalumab,RADIATION PNEUMONITIS,756
durvalumab,PNEUMONITIS,754
durvalumab,PYREXIA,508
durvalumab,DIARRHOEA,456
durvalumab,DYSPNOEA,440
durvalumab,PNEUMONIA,403
durvalumab,INTERSTITIAL LUNG DISEASE,400
durvalumab,OFF LABEL USE,366
durvalumab,FATIGUE,338
durvalumab,FEBRILE NEUTROPENIA,303
durvalumab,RASH,303
durvalumab,COLITIS,295
durvalumab,ASTHENIA,283
durvalumab,NEUTROPHIL COUNT DECREASED,282
durvalumab,ANAEMIA,261
durvalumab,PLATELET COUNT DECREASED,246
durvalumab,DISEASE PROGRESSION,245
durvalumab,METASTASES TO CENTRAL NERVOUS SYSTEM,243
durvalumab,NAUSEA,233
durvalumab,VOMITING,220
durvalumab,DECREASED APPETITE,219
durvalumab,THROMBOCYTOPENIA,216
durvalumab,MYELOSUPPRESSION,215
durvalumab,HYPOTHYROIDISM,208
durvalumab,PLEURAL EFFUSION,198
durvalumab,DRUG INEFFECTIVE,188
durvalumab,NEUTROPENIA,186
durvalumab,TOXICITY TO VARIOUS AGENTS,184
durvalumab,SEPSIS,182
durvalumab,COUGH,181
durvalumab,HEPATIC FUNCTION ABNORMAL,181
durvalumab,MYOCARDITIS,181
durvalumab,LUNG DISORDER,155
durvalumab,ACUTE KIDNEY INJURY,153
durvalumab,DRUG-INDUCED LIVER INJURY,151
durvalumab,PRURITUS,145
durvalumab,MALAISE,141
durvalumab,RESPIRATORY FAILURE,140
durvalumab,HEPATITIS,131
durvalumab,LIVER DISORDER,129
durvalumab,WHITE BLOOD CELL COUNT DECREASED,129
durvalumab,ARTHRALGIA,128
durvalumab,ABDOMINAL PAIN,124
durvalumab,ADRENAL INSUFFICIENCY,122
durvalumab,GENERAL PHYSICAL HEALTH DETERIORATION,121
durvalumab,DEHYDRATION,119
durvalumab,HYPERTHYROIDISM,113
durvalumab,CYTOKINE RELEASE SYNDROME,108
durvalumab,IMMUNE-MEDIATED ENTEROCOLITIS,107
durvalumab,MYOSITIS,102
durvalumab,PULMONARY TOXICITY,102
durvalumab,CHOLANGITIS,101
durvalumab,NEUROPATHY PERIPHERAL,100
durvalumab,MUSCULAR WEAKNESS,98
durvalumab,COVID-19,97
durvalumab,HYPOTENSION,97
durvalumab,METASTASES TO LIVER,97
durvalumab,PULMONARY EMBOLISM,97
durvalumab,WEIGHT DECREASED,96
durvalumab,HYPERTENSION,95
durvalumab,CONSTIPATION,94
durvalumab,PANCYTOPENIA,93
durvalumab,CEREBROVASCULAR ACCIDENT,90
durvalumab,CONDITION AGGRAVATED,88
durvalumab,METASTASES TO BONE,88
durvalumab,ALANINE AMINOTRANSFERASE INCREASED,86
durvalumab,INFECTION,86
durvalumab,OESOPHAGITIS,86
durvalumab,DIZZINESS,85
durvalumab,PANCREATITIS,85
durvalumab,CHILLS,84
durvalumab,IMMUNE-MEDIATED HEPATITIS,84
durvalumab,DIABETES MELLITUS,83
durvalumab,NEOPLASM PROGRESSION,83
durvalumab,BILIARY TRACT INFECTION,79
durvalumab,DYSPHAGIA,79
durvalumab,MYALGIA,79
durvalumab,PAIN,79
durvalumab,URINARY TRACT INFECTION,79
durvalumab,HAEMOPTYSIS,78
durvalumab,ASPARTATE AMINOTRANSFERASE INCREASED,77
durvalumab,ATRIAL FIBRILLATION,77
durvalumab,CARDIAC FAILURE,77
durvalumab,IMMUNE-MEDIATED LUNG DISEASE,76
durvalumab,MYASTHENIA GRAVIS,74
durvalumab,FALL,72
durvalumab,HAEMATOTOXICITY,72
durvalumab,IMMUNE-MEDIATED HEPATIC DISORDER,72
durvalumab,RENAL FAILURE,71
durvalumab,CONFUSIONAL STATE,70
durvalumab,HEADACHE,70
durvalumab,PNEUMOTHORAX,69
durvalumab,BACK PAIN,68
durvalumab,ARTHRITIS,66
durvalumab,PERICARDIAL EFFUSION,65
durvalumab,RENAL IMPAIRMENT,65
durvalumab,ALOPECIA,63
durvalumab,INFUSION RELATED REACTION,63
lenvatinib,DIARRHOEA,4080
lenvatinib,HYPERTENSION,3864
lenvatinib,FATIGUE,3520
lenvatinib,DECREASED APPETITE,3118
lenvatinib,MALIGNANT NEOPLASM PROGRESSION,2739
lenvatinib,NAUSEA,2437
lenvatinib,BLOOD PRESSURE INCREASED,2183
lenvatinib,VOMITING,1925
lenvatinib,ASTHENIA,1575
lenvatinib,WEIGHT DECREASED,1495
lenvatinib,MALAISE,1488
lenvatinib,DEHYDRATION,1480
lenvatinib,PYREXIA,1371
lenvatinib,HYPOTHYROIDISM,1250
lenvatinib,HEADACHE,1232
lenvatinib,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1126
lenvatinib,PLATELET COUNT DECREASED,1126
lenvatinib,PROTEINURIA,1099
lenvatinib,RASH,1088
lenvatinib,STOMATITIS,1035
lenvatinib,ARTHRALGIA,973
lenvatinib,DYSPHONIA,966
lenvatinib,DEATH,933
lenvatinib,ABDOMINAL PAIN,905
lenvatinib,CONSTIPATION,893
lenvatinib,DYSPNOEA,829
lenvatinib,PAIN,725
lenvatinib,PNEUMONIA,673
lenvatinib,RENAL IMPAIRMENT,673
lenvatinib,DIZZINESS,598
lenvatinib,ABDOMINAL PAIN UPPER,596
lenvatinib,INTERSTITIAL LUNG DISEASE,563
lenvatinib,PRODUCT USE ISSUE,532
lenvatinib,PAIN IN EXTREMITY,514
lenvatinib,HYPOTENSION,510
lenvatinib,HEPATIC ENCEPHALOPATHY,509
lenvatinib,OFF LABEL USE,505
lenvatinib,ACUTE KIDNEY INJURY,500
lenvatinib,BACK PAIN,497
lenvatinib,MYALGIA,488
lenvatinib,COUGH,487
lenvatinib,EPISTAXIS,487
lenvatinib,ANAEMIA,484
lenvatinib,DRUG INEFFECTIVE,478
lenvatinib,HEPATIC FUNCTION ABNORMAL,476
lenvatinib,CARDIAC FAILURE,455
lenvatinib,URINARY TRACT INFECTION,455
lenvatinib,ADRENAL INSUFFICIENCY,404
lenvatinib,ASCITES,395
lenvatinib,CONFUSIONAL STATE,390
lenvatinib,THROMBOCYTOPENIA,381
lenvatinib,PRURITUS,379
lenvatinib,ORAL PAIN,377
lenvatinib,PULMONARY EMBOLISM,370
lenvatinib,DRY MOUTH,357
lenvatinib,ABDOMINAL DISCOMFORT,348
lenvatinib,PERIPHERAL SWELLING,346
lenvatinib,HYPONATRAEMIA,345
lenvatinib,RENAL FAILURE,336
lenvatinib,CEREBROVASCULAR ACCIDENT,335
lenvatinib,COLITIS,319
lenvatinib,PLEURAL EFFUSION,308
lenvatinib,INSOMNIA,307
lenvatinib,PRODUCT USE IN UNAPPROVED INDICATION,306
lenvatinib,FALL,303
lenvatinib,CHEST PAIN,294
lenvatinib,PANCREATITIS,294
lenvatinib,CHOLECYSTITIS,292
lenvatinib,SEPSIS,284
lenvatinib,BLOOD CREATININE INCREASED,283
lenvatinib,SOMNOLENCE,271
lenvatinib,OEDEMA PERIPHERAL,268
lenvatinib,MYOCARDIAL INFARCTION,261
lenvatinib,TASTE DISORDER,255
lenvatinib,DYSPHAGIA,254
lenvatinib,MUSCLE SPASMS,246
lenvatinib,GASTROINTESTINAL HAEMORRHAGE,239
lenvatinib,BLOOD PRESSURE FLUCTUATION,234
lenvatinib,LIVER DISORDER,234
lenvatinib,OROPHARYNGEAL PAIN,231
lenvatinib,GENERAL PHYSICAL HEALTH DETERIORATION,229
lenvatinib,HEPATIC ENZYME INCREASED,228
lenvatinib,INFECTION,228
lenvatinib,GAIT DISTURBANCE,226
lenvatinib,BLOOD BILIRUBIN INCREASED,224
lenvatinib,ASPARTATE AMINOTRANSFERASE INCREASED,223
lenvatinib,HEPATIC FAILURE,223
lenvatinib,PNEUMONITIS,222
lenvatinib,BLOOD THYROID STIMULATING HORMONE INCREASED,219
lenvatinib,FEELING ABNORMAL,219
lenvatinib,HYPERTHYROIDISM,214
lenvatinib,ALANINE AMINOTRANSFERASE INCREASED,213
lenvatinib,AMMONIA INCREASED,211
lenvatinib,PNEUMOTHORAX,210
lenvatinib,CEREBRAL HAEMORRHAGE,208
lenvatinib,ABDOMINAL DISTENSION,207
lenvatinib,INTESTINAL PERFORATION,205
lenvatinib,BLISTER,203
lenvatinib,DRY SKIN,196
lenvatinib,NEUROPATHY PERIPHERAL,196
palbociclib,FATIGUE,14910
palbociclib,WHITE BLOOD CELL COUNT DECREASED,10971
palbociclib,NEOPLASM PROGRESSION,10943
palbociclib,NAUSEA,8133
palbociclib,DEATH,8055
palbociclib,NEUTROPENIA,6338
palbociclib,ALOPECIA,6099
palbociclib,DIARRHOEA,5565
palbociclib,ASTHENIA,3647
palbociclib,PAIN,3380
palbociclib,DECREASED APPETITE,3359
palbociclib,OFF LABEL USE,3339
palbociclib,MALAISE,3276
palbociclib,DYSPNOEA,3169
palbociclib,VOMITING,3060
palbociclib,ARTHRALGIA,2939
palbociclib,CONSTIPATION,2670
palbociclib,STOMATITIS,2659
palbociclib,HEADACHE,2639
palbociclib,DIZZINESS,2404
palbociclib,COUGH,2241
palbociclib,DISEASE PROGRESSION,2241
palbociclib,RASH,2237
palbociclib,PLATELET COUNT DECREASED,2232
palbociclib,NEUTROPHIL COUNT DECREASED,2173
palbociclib,ANAEMIA,2144
palbociclib,PRODUCT DOSE OMISSION ISSUE,2122
palbociclib,WEIGHT DECREASED,1874
palbociclib,FULL BLOOD COUNT DECREASED,1873
palbociclib,HOT FLUSH,1835
palbociclib,MALIGNANT NEOPLASM PROGRESSION,1820
palbociclib,BACK PAIN,1804
palbociclib,RED BLOOD CELL COUNT DECREASED,1751
palbociclib,PYREXIA,1723
palbociclib,HAEMOGLOBIN DECREASED,1675
palbociclib,PRURITUS,1648
palbociclib,PAIN IN EXTREMITY,1644
palbociclib,PRODUCT USE ISSUE,1559
palbociclib,COVID-19,1478
palbociclib,PNEUMONIA,1439
palbociclib,LEUKOPENIA,1404
palbociclib,INSOMNIA,1394
palbociclib,DRY SKIN,1371
palbociclib,THROMBOCYTOPENIA,1365
palbociclib,NASOPHARYNGITIS,1313
palbociclib,NEUROPATHY PERIPHERAL,1305
palbociclib,MEMORY IMPAIRMENT,1298
palbociclib,ABDOMINAL DISCOMFORT,1293
palbociclib,EPISTAXIS,1262
palbociclib,ILLNESS,1235
palbociclib,BONE PAIN,1224
palbociclib,FALL,1213
palbociclib,FEELING ABNORMAL,1207
palbociclib,URINARY TRACT INFECTION,1185
palbociclib,BLOOD COUNT ABNORMAL,1171
palbociclib,DRUG INEFFECTIVE,1118
palbociclib,FULL BLOOD COUNT ABNORMAL,1118
palbociclib,PERIPHERAL SWELLING,1073
palbociclib,CONDITION AGGRAVATED,1028
palbociclib,ABDOMINAL PAIN UPPER,1000
palbociclib,ANXIETY,974
palbociclib,BONE MARROW FAILURE,957
palbociclib,WEIGHT INCREASED,947
palbociclib,HYPOAESTHESIA,945
palbociclib,PRODUCT USE IN UNAPPROVED INDICATION,929
palbociclib,BREAST CANCER METASTATIC,896
palbociclib,HYPOACUSIS,890
palbociclib,DEHYDRATION,866
palbociclib,GAIT DISTURBANCE,859
palbociclib,METASTASES TO BONE,858
palbociclib,MYALGIA,857
palbociclib,PLEURAL EFFUSION,851
palbociclib,TUMOUR MARKER INCREASED,847
palbociclib,SOMNOLENCE,838
palbociclib,MUSCLE SPASMS,812
palbociclib,DEPRESSION,809
palbociclib,INFECTION,800
palbociclib,DYSPEPSIA,781
palbociclib,PARAESTHESIA,774
palbociclib,ABDOMINAL PAIN,771
palbociclib,DYSPHAGIA,758
palbociclib,ORAL PAIN,752
palbociclib,CONFUSIONAL STATE,688
palbociclib,OROPHARYNGEAL PAIN,688
palbociclib,CHILLS,657
palbociclib,BREAST CANCER,650
palbociclib,SECOND PRIMARY MALIGNANCY,641
palbociclib,METASTASES TO LIVER,621
palbociclib,PULMONARY EMBOLISM,620
palbociclib,DYSGEUSIA,615
palbociclib,THROMBOSIS,611
palbociclib,PANCYTOPENIA,606
palbociclib,CHEST PAIN,596
palbociclib,CEREBROVASCULAR ACCIDENT,594
palbociclib,CONTUSION,593
palbociclib,THERAPY CESSATION,590
palbociclib,DRY MOUTH,583
palbociclib,HYPERTENSION,580
palbociclib,INFLUENZA,576
palbociclib,GENERAL PHYSICAL HEALTH DETERIORATION,553
trifluridine tipiracil,NEUTROPENIA,73
trifluridine tipiracil,DIARRHOEA,62
trifluridine tipiracil,ANAEMIA,38
trifluridine tipiracil,THROMBOCYTOPENIA,30
trifluridine tipiracil,FATIGUE,29
trifluridine tipiracil,DISEASE PROGRESSION,28
trifluridine tipiracil,NAUSEA,27
trifluridine tipiracil,NEUROTOXICITY,25
trifluridine tipiracil,ASTHENIA,22
trifluridine tipiracil,VOMITING,21
trifluridine tipiracil,HAEMATOTOXICITY,18
trifluridine tipiracil,NEUROPATHY PERIPHERAL,18
trifluridine tipiracil,STOMATITIS,18
trifluridine tipiracil,COLORECTAL CANCER METASTATIC,17
trifluridine tipiracil,HYPERTENSION,17
trifluridine tipiracil,FEBRILE NEUTROPENIA,16
trifluridine tipiracil,DECREASED APPETITE,15
trifluridine tipiracil,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,14
trifluridine tipiracil,DEATH,13
trifluridine tipiracil,DRUG INEFFECTIVE,11
trifluridine tipiracil,LEUKOPENIA,11
trifluridine tipiracil,DRUG INTOLERANCE,10
trifluridine tipiracil,PROTEINURIA,10
trifluridine tipiracil,THERAPEUTIC PRODUCT EFFECT INCOMPLETE,9
trifluridine tipiracil,ANAL INFLAMMATION,8
trifluridine tipiracil,GASTROINTESTINAL TOXICITY,8
trifluridine tipiracil,INFECTION,8
trifluridine tipiracil,MALIGNANT NEOPLASM PROGRESSION,8
trifluridine tipiracil,SKIN TOXICITY,8
trifluridine tipiracil,TOXICITY TO VARIOUS AGENTS,8
trifluridine tipiracil,ALOPECIA,7
trifluridine tipiracil,MUSCLE SPASMS,7
trifluridine tipiracil,PNEUMONIA,7
trifluridine tipiracil,ABDOMINAL PAIN,6
trifluridine tipiracil,CLOSTRIDIUM DIFFICILE INFECTION,6
trifluridine tipiracil,HEPATOTOXICITY,6
trifluridine tipiracil,METASTASES TO LIVER,6
trifluridine tipiracil,METASTASES TO LUNG,6
trifluridine tipiracil,MUCOSAL INFLAMMATION,6
trifluridine tipiracil,PYREXIA,6
trifluridine tipiracil,THERAPY PARTIAL RESPONDER,6
trifluridine tipiracil,TRANSIENT ISCHAEMIC ATTACK,6
trifluridine tipiracil,WEIGHT DECREASED,6
trifluridine tipiracil,CONDITION AGGRAVATED,5
trifluridine tipiracil,CONJUNCTIVITIS,5
trifluridine tipiracil,DIABETES MELLITUS,5
trifluridine tipiracil,NEUTROPHIL COUNT DECREASED,5
trifluridine tipiracil,OFF LABEL USE,5
trifluridine tipiracil,TOXIC CARDIOMYOPATHY,5
trifluridine tipiracil,ACUTE KIDNEY INJURY,4
trifluridine tipiracil,ALANINE AMINOTRANSFERASE INCREASED,4
trifluridine tipiracil,BLOOD BILIRUBIN INCREASED,4
trifluridine tipiracil,CIRCULATORY COLLAPSE,4
trifluridine tipiracil,IGA NEPHROPATHY,4
trifluridine tipiracil,METABOLIC ACIDOSIS,4
trifluridine tipiracil,MUCOSAL TOXICITY,4
trifluridine tipiracil,MYELOSUPPRESSION,4
trifluridine tipiracil,PLATELET COUNT DECREASED,4
trifluridine tipiracil,PULMONARY EMBOLISM,4
trifluridine tipiracil,ADVERSE EVENT,3
trifluridine tipiracil,ASCITES,3
trifluridine tipiracil,BLOOD LACTATE DEHYDROGENASE INCREASED,3
trifluridine tipiracil,CHOLESTASIS,3
trifluridine tipiracil,CONSTIPATION,3
trifluridine tipiracil,DEVICE RELATED INFECTION,3
trifluridine tipiracil,DISEASE RECURRENCE,3
trifluridine tipiracil,DYSAESTHESIA,3
trifluridine tipiracil,HAEMORRHAGE,3
trifluridine tipiracil,HEADACHE,3
trifluridine tipiracil,HYPOKALAEMIA,3
trifluridine tipiracil,METABOLIC DISORDER,3
trifluridine tipiracil,METASTASES TO PERITONEUM,3
trifluridine tipiracil,PALPITATIONS,3
trifluridine tipiracil,PERIPHERAL SENSORY NEUROPATHY,3
trifluridine tipiracil,PHOTOPHOBIA,3
trifluridine tipiracil,PNEUMONITIS,3
trifluridine tipiracil,WHITE BLOOD CELL COUNT DECREASED,3
trifluridine tipiracil,ADENOCARCINOMA OF COLON,2
trifluridine tipiracil,ANAPHYLACTIC REACTION,2
trifluridine tipiracil,BACK PAIN,2
trifluridine tipiracil,BLOOD PRESSURE INCREASED,2
trifluridine tipiracil,CARDIAC DISORDER,2
trifluridine tipiracil,CATHETER SITE INFECTION,2
trifluridine tipiracil,DRY SKIN,2
trifluridine tipiracil,DYSGEUSIA,2
trifluridine tipiracil,DYSPNOEA,2
trifluridine tipiracil,EMBOLISM,2
trifluridine tipiracil,EPISTAXIS,2
trifluridine tipiracil,FACIAL BONES FRACTURE,2
trifluridine tipiracil,FALL,2
trifluridine tipiracil,FUNCTIONAL GASTROINTESTINAL DISORDER,2
trifluridine tipiracil,GASTRIC CANCER,2
trifluridine tipiracil,GASTROINTESTINAL DISORDER,2
trifluridine tipiracil,GASTROINTESTINAL PERFORATION,2
trifluridine tipiracil,IMPAIRED QUALITY OF LIFE,2
trifluridine tipiracil,LOSS OF CONSCIOUSNESS,2
trifluridine tipiracil,LYMPHOPENIA,2
trifluridine tipiracil,OBSTRUCTIVE PANCREATITIS,2
trifluridine tipiracil,PAIN,2
trifluridine tipiracil,PANCYTOPENIA,2
ipilimumab,DEATH,3886
ipilimumab,MALIGNANT NEOPLASM PROGRESSION,3558
ipilimumab,DIARRHOEA,2991
ipilimumab,COLITIS,2236
ipilimumab,OFF LABEL USE,2185
ipilimumab,PYREXIA,1959
ipilimumab,RASH,1706
ipilimumab,FATIGUE,1610
ipilimumab,INTENTIONAL PRODUCT USE ISSUE,1349
ipilimumab,NAUSEA,1309
ipilimumab,HYPOPHYSITIS,1048
ipilimumab,DECREASED APPETITE,1037
ipilimumab,VOMITING,1019
ipilimumab,DYSPNOEA,975
ipilimumab,PNEUMONIA,928
ipilimumab,PNEUMONITIS,916
ipilimumab,IMMUNE-MEDIATED ENTEROCOLITIS,898
ipilimumab,ADVERSE EVENT,893
ipilimumab,ADRENAL INSUFFICIENCY,870
ipilimumab,PRURITUS,864
ipilimumab,ACUTE KIDNEY INJURY,835
ipilimumab,HEADACHE,799
ipilimumab,HYPOTHYROIDISM,765
ipilimumab,DEHYDRATION,688
ipilimumab,ASTHENIA,685
ipilimumab,ANAEMIA,681
ipilimumab,MALAISE,647
ipilimumab,DRUG INEFFECTIVE,638
ipilimumab,SEPSIS,629
ipilimumab,WEIGHT DECREASED,629
ipilimumab,HEPATITIS,576
ipilimumab,GENERAL PHYSICAL HEALTH DETERIORATION,561
ipilimumab,ARTHRALGIA,535
ipilimumab,HYPERTHYROIDISM,526
ipilimumab,HYPONATRAEMIA,526
ipilimumab,ABDOMINAL PAIN,500
ipilimumab,LIVER DISORDER,498
ipilimumab,HEPATIC FUNCTION ABNORMAL,489
ipilimumab,HYPOTENSION,480
ipilimumab,INTERSTITIAL LUNG DISEASE,471
ipilimumab,MYOCARDITIS,461
ipilimumab,PRESCRIBED OVERDOSE,455
ipilimumab,PRODUCT USE IN UNAPPROVED INDICATION,441
ipilimumab,CONSTIPATION,436
ipilimumab,ALANINE AMINOTRANSFERASE INCREASED,431
ipilimumab,ASPARTATE AMINOTRANSFERASE INCREASED,429
ipilimumab,HYPOPITUITARISM,423
ipilimumab,PLEURAL EFFUSION,423
ipilimumab,PAIN,408
ipilimumab,IMMUNE-MEDIATED HEPATITIS,401
ipilimumab,COUGH,394
ipilimumab,THROMBOCYTOPENIA,387
ipilimumab,AUTOIMMUNE HEPATITIS,384
ipilimumab,BACK PAIN,380
ipilimumab,PULMONARY EMBOLISM,370
ipilimumab,ENTEROCOLITIS,356
ipilimumab,DIABETIC KETOACIDOSIS,346
ipilimumab,MUSCULAR WEAKNESS,330
ipilimumab,RENAL FAILURE,329
ipilimumab,DIZZINESS,323
ipilimumab,THYROIDITIS,319
ipilimumab,RESPIRATORY FAILURE,317
ipilimumab,NEUTROPENIA,309
ipilimumab,CHILLS,308
ipilimumab,CYTOKINE RELEASE SYNDROME,308
ipilimumab,ATRIAL FIBRILLATION,305
ipilimumab,METASTASES TO CENTRAL NERVOUS SYSTEM,305
ipilimumab,IMMUNE-MEDIATED HEPATIC DISORDER,303
ipilimumab,TYPE 1 DIABETES MELLITUS,302
ipilimumab,RASH MACULO-PAPULAR,289
ipilimumab,MYOSITIS,284
ipilimumab,HYPERGLYCAEMIA,281
ipilimumab,URINARY TRACT INFECTION,279
ipilimumab,AUTOIMMUNE COLITIS,277
ipilimumab,DIABETES MELLITUS,275
ipilimumab,FEBRILE NEUTROPENIA,273
ipilimumab,ARTHRITIS,271
ipilimumab,CONFUSIONAL STATE,271
ipilimumab,MYALGIA,269
ipilimumab,HYPOKALAEMIA,268
ipilimumab,NON-SMALL CELL LUNG CANCER,262
ipilimumab,AUTOIMMUNE DISORDER,251
ipilimumab,FALL,246
ipilimumab,HEPATOTOXICITY,241
ipilimumab,NEUROPATHY PERIPHERAL,237
ipilimumab,IMMUNE-MEDIATED LUNG DISEASE,236
ipilimumab,INFUSION RELATED REACTION,234
ipilimumab,DISEASE PROGRESSION,230
ipilimumab,PANCREATITIS,229
ipilimumab,SEPTIC SHOCK,227
ipilimumab,HYPERTENSION,224
ipilimumab,CARDIAC FAILURE,220
ipilimumab,BLOOD CREATININE INCREASED,219
ipilimumab,PLATELET COUNT DECREASED,219
ipilimumab,RASH PRURITIC,218
ipilimumab,IMMUNE-MEDIATED MYOCARDITIS,215
ipilimumab,LIPASE INCREASED,214
ipilimumab,PAIN IN EXTREMITY,213
ipilimumab,THYROID DISORDER,213
ipilimumab,HOSPITALISATION,211
pazopanib,DEATH,4546
pazopanib,DIARRHOEA,3579
pazopanib,FATIGUE,2483
pazopanib,NAUSEA,2424
pazopanib,MALIGNANT NEOPLASM PROGRESSION,1629
pazopanib,DRUG INEFFECTIVE,1442
pazopanib,DECREASED APPETITE,1433
pazopanib,VOMITING,1405
pazopanib,HYPERTENSION,1258
pazopanib,DISEASE PROGRESSION,993
pazopanib,ASTHENIA,930
pazopanib,MALAISE,901
pazopanib,WEIGHT DECREASED,883
pazopanib,DYSPNOEA,849
pazopanib,HAIR COLOUR CHANGES,822
pazopanib,BLOOD PRESSURE INCREASED,781
pazopanib,PRODUCT USE IN UNAPPROVED INDICATION,765
pazopanib,HEADACHE,714
pazopanib,PAIN,676
pazopanib,ABDOMINAL PAIN,522
pazopanib,DYSGEUSIA,504
pazopanib,PYREXIA,499
pazopanib,RASH,496
pazopanib,ABDOMINAL PAIN UPPER,489
pazopanib,OFF LABEL USE,432
pazopanib,PAIN IN EXTREMITY,419
pazopanib,ABDOMINAL DISCOMFORT,416
pazopanib,DEHYDRATION,413
pazopanib,DIZZINESS,404
pazopanib,CONSTIPATION,390
pazopanib,HEPATIC ENZYME INCREASED,388
pazopanib,COUGH,379
pazopanib,ANAEMIA,378
pazopanib,ALANINE AMINOTRANSFERASE INCREASED,376
pazopanib,METASTASES TO LUNG,361
pazopanib,PNEUMONIA,344
pazopanib,PLATELET COUNT DECREASED,336
pazopanib,BACK PAIN,335
pazopanib,ARTHRALGIA,323
pazopanib,STOMATITIS,323
pazopanib,GENERAL PHYSICAL HEALTH DETERIORATION,318
pazopanib,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,311
pazopanib,ALOPECIA,302
pazopanib,ASPARTATE AMINOTRANSFERASE INCREASED,294
pazopanib,THROMBOCYTOPENIA,288
pazopanib,HEPATIC FUNCTION ABNORMAL,279
pazopanib,PLEURAL EFFUSION,277
pazopanib,RENAL CELL CARCINOMA,274
pazopanib,BLOOD BILIRUBIN INCREASED,262
pazopanib,NEOPLASM MALIGNANT,262
pazopanib,HYPOTHYROIDISM,249
pazopanib,CHEST PAIN,232
pazopanib,NEOPLASM PROGRESSION,230
pazopanib,RENAL IMPAIRMENT,228
pazopanib,MUSCLE SPASMS,226
pazopanib,AGEUSIA,225
pazopanib,HOSPITALISATION,220
pazopanib,DRUG INTOLERANCE,216
pazopanib,RENAL CANCER,214
pazopanib,EPISTAXIS,213
pazopanib,HEPATOTOXICITY,210
pazopanib,ADVERSE DRUG REACTION,207
pazopanib,LIVER DISORDER,207
pazopanib,GAIT DISTURBANCE,206
pazopanib,PROTEINURIA,201
pazopanib,PRURITUS,201
pazopanib,DRUG INTERACTION,199
pazopanib,DYSPEPSIA,199
pazopanib,JAUNDICE,197
pazopanib,BLOOD CREATININE INCREASED,194
pazopanib,FALL,194
pazopanib,CONFUSIONAL STATE,191
pazopanib,FEELING ABNORMAL,190
pazopanib,MYALGIA,187
pazopanib,SKIN DISCOLOURATION,186
pazopanib,OEDEMA PERIPHERAL,184
pazopanib,DRUG DOSE OMISSION,183
pazopanib,CEREBROVASCULAR ACCIDENT,181
pazopanib,PNEUMOTHORAX,181
pazopanib,RENAL FAILURE,180
pazopanib,CARDIAC FAILURE,178
pazopanib,LIVER FUNCTION TEST ABNORMAL,177
pazopanib,HOSPICE CARE,175
pazopanib,METASTATIC RENAL CELL CARCINOMA,175
pazopanib,ACUTE KIDNEY INJURY,173
pazopanib,METASTASES TO LIVER,172
pazopanib,METASTASES TO CENTRAL NERVOUS SYSTEM,167
pazopanib,PRODUCT USE ISSUE,165
pazopanib,NEUTROPENIA,164
pazopanib,MYOCARDIAL INFARCTION,162
pazopanib,INSOMNIA,161
pazopanib,PULMONARY EMBOLISM,160
pazopanib,URINARY TRACT INFECTION,158
pazopanib,ABDOMINAL DISTENSION,157
pazopanib,ERYTHEMA,157
pazopanib,METASTASES TO BONE,156
pazopanib,PERIPHERAL SWELLING,155
pazopanib,ASCITES,153
pazopanib,BLISTER,153
pazopanib,TOXICITY TO VARIOUS AGENTS,153
crizotinib,DEATH,2329
crizotinib,DISEASE PROGRESSION,1248
crizotinib,NEOPLASM PROGRESSION,1195
crizotinib,NAUSEA,1109
crizotinib,DIARRHOEA,823
crizotinib,VOMITING,772
crizotinib,FATIGUE,543
crizotinib,OFF LABEL USE,437
crizotinib,DYSPNOEA,435
crizotinib,CONSTIPATION,433
crizotinib,OEDEMA PERIPHERAL,425
crizotinib,LUNG NEOPLASM MALIGNANT,407
crizotinib,VISUAL IMPAIRMENT,405
crizotinib,DECREASED APPETITE,374
crizotinib,ASTHENIA,336
crizotinib,PNEUMONIA,330
crizotinib,DIZZINESS,313
crizotinib,PLEURAL EFFUSION,308
crizotinib,MALAISE,307
crizotinib,PERIPHERAL SWELLING,284
crizotinib,NON-SMALL CELL LUNG CANCER,276
crizotinib,PYREXIA,257
crizotinib,COUGH,254
crizotinib,MALIGNANT NEOPLASM PROGRESSION,246
crizotinib,NEOPLASM MALIGNANT,223
crizotinib,DRUG INEFFECTIVE,219
crizotinib,RASH,204
crizotinib,OEDEMA,198
crizotinib,DYSGEUSIA,197
crizotinib,WEIGHT DECREASED,192
crizotinib,PAIN,185
crizotinib,RENAL IMPAIRMENT,182
crizotinib,DYSPHAGIA,180
crizotinib,HEADACHE,172
crizotinib,ALANINE AMINOTRANSFERASE INCREASED,171
crizotinib,PULMONARY EMBOLISM,170
crizotinib,INTERSTITIAL LUNG DISEASE,167
crizotinib,VISION BLURRED,165
crizotinib,PRODUCT USE IN UNAPPROVED INDICATION,163
crizotinib,PRODUCT USE ISSUE,163
crizotinib,ANAEMIA,161
crizotinib,DEHYDRATION,160
crizotinib,NEUTROPENIA,156
crizotinib,HYPOTENSION,148
crizotinib,PNEUMONITIS,146
crizotinib,ASPARTATE AMINOTRANSFERASE INCREASED,142
crizotinib,BLOOD CREATININE INCREASED,138
crizotinib,DRUG INTERACTION,137
crizotinib,PHOTOPSIA,135
crizotinib,RENAL FAILURE,134
crizotinib,HEPATIC FUNCTION ABNORMAL,130
crizotinib,BRADYCARDIA,129
crizotinib,DRUG RESISTANCE,129
crizotinib,GENERAL PHYSICAL HEALTH DETERIORATION,127
crizotinib,DYSPEPSIA,120
crizotinib,HEPATIC ENZYME INCREASED,116
crizotinib,RESPIRATORY FAILURE,115
crizotinib,ABDOMINAL PAIN,114
crizotinib,FALL,114
crizotinib,DEEP VEIN THROMBOSIS,112
crizotinib,CARDIAC FAILURE,111
crizotinib,METASTASES TO CENTRAL NERVOUS SYSTEM,109
crizotinib,WEIGHT INCREASED,109
crizotinib,PERICARDIAL EFFUSION,108
crizotinib,ABDOMINAL DISCOMFORT,107
crizotinib,CONDITION AGGRAVATED,106
crizotinib,ELECTROCARDIOGRAM QT PROLONGED,105
crizotinib,ABDOMINAL PAIN UPPER,103
crizotinib,BACK PAIN,102
crizotinib,CHEST PAIN,99
crizotinib,OESOPHAGITIS,99
crizotinib,WHITE BLOOD CELL COUNT DECREASED,99
crizotinib,HEPATOTOXICITY,94
crizotinib,PAIN IN EXTREMITY,93
crizotinib,THROMBOCYTOPENIA,92
crizotinib,SEPSIS,91
crizotinib,THROMBOSIS,91
crizotinib,HAEMOGLOBIN DECREASED,90
crizotinib,PULMONARY OEDEMA,89
crizotinib,ACUTE KIDNEY INJURY,88
crizotinib,TRANSAMINASES INCREASED,87
crizotinib,SEIZURE,86
crizotinib,ARTHRALGIA,85
crizotinib,HEART RATE DECREASED,85
crizotinib,FEBRILE NEUTROPENIA,84
crizotinib,HYPOAESTHESIA,84
crizotinib,STOMATITIS,81
crizotinib,LIVER DISORDER,79
crizotinib,JOINT SWELLING,77
crizotinib,NEUROPATHY PERIPHERAL,76
crizotinib,CONFUSIONAL STATE,75
crizotinib,VITREOUS FLOATERS,75
crizotinib,GAIT DISTURBANCE,74
crizotinib,SECOND PRIMARY MALIGNANCY,73
crizotinib,CEREBROVASCULAR ACCIDENT,72
crizotinib,GASTROOESOPHAGEAL REFLUX DISEASE,72
crizotinib,HYPONATRAEMIA,72
crizotinib,NEUTROPHIL COUNT DECREASED,72
crizotinib,HYPOXIA,71
crizotinib,INSOMNIA,71
trabectedin,NEUTROPENIA,229
trabectedin,ANAEMIA,201
trabectedin,NAUSEA,185
trabectedin,THROMBOCYTOPENIA,184
trabectedin,FEBRILE NEUTROPENIA,164
trabectedin,PANCYTOPENIA,145
trabectedin,VOMITING,144
trabectedin,RHABDOMYOLYSIS,121
trabectedin,DISEASE PROGRESSION,117
trabectedin,ALANINE AMINOTRANSFERASE INCREASED,116
trabectedin,OFF LABEL USE,111
trabectedin,ASTHENIA,105
trabectedin,PYREXIA,102
trabectedin,ASPARTATE AMINOTRANSFERASE INCREASED,98
trabectedin,FATIGUE,93
trabectedin,ACUTE KIDNEY INJURY,90
trabectedin,DRUG INEFFECTIVE,88
trabectedin,DIARRHOEA,80
trabectedin,PLATELET COUNT DECREASED,79
trabectedin,LEUKOPENIA,76
trabectedin,BLOOD CREATINE PHOSPHOKINASE INCREASED,68
trabectedin,NEUTROPHIL COUNT DECREASED,68
trabectedin,HAEMATOTOXICITY,67
trabectedin,HEPATOTOXICITY,66
trabectedin,DEATH,64
trabectedin,DYSPNOEA,64
trabectedin,PNEUMONIA,63
trabectedin,SEPSIS,62
trabectedin,TRANSAMINASES INCREASED,59
trabectedin,WHITE BLOOD CELL COUNT DECREASED,58
trabectedin,DECREASED APPETITE,57
trabectedin,GAMMA-GLUTAMYLTRANSFERASE INCREASED,50
trabectedin,MALIGNANT NEOPLASM PROGRESSION,50
trabectedin,HEPATIC FUNCTION ABNORMAL,46
trabectedin,RENAL FAILURE,46
trabectedin,BONE MARROW FAILURE,43
trabectedin,ABDOMINAL PAIN,40
trabectedin,BLOOD ALKALINE PHOSPHATASE INCREASED,40
trabectedin,MUCOSAL INFLAMMATION,40
trabectedin,ACUTE MYELOID LEUKAEMIA,39
trabectedin,CARDIAC FAILURE,37
trabectedin,BLOOD BILIRUBIN INCREASED,35
trabectedin,CONSTIPATION,35
trabectedin,PRODUCT USE IN UNAPPROVED INDICATION,35
trabectedin,HAEMOGLOBIN DECREASED,33
trabectedin,MALAISE,32
trabectedin,HEPATIC ENZYME INCREASED,31
trabectedin,MYALGIA,31
trabectedin,TOXICITY TO VARIOUS AGENTS,31
trabectedin,DRUG INTERACTION,30
trabectedin,DEHYDRATION,29
trabectedin,HEPATIC FAILURE,29
trabectedin,DEVICE RELATED INFECTION,28
trabectedin,PLEURAL EFFUSION,28
trabectedin,ASCITES,27
trabectedin,HYPERTRANSAMINASAEMIA,26
trabectedin,PRODUCT USE ISSUE,26
trabectedin,THERAPEUTIC PRODUCT EFFECT INCOMPLETE,26
trabectedin,PNEUMONITIS,25
trabectedin,ATRIAL FIBRILLATION,24
trabectedin,DISEASE RECURRENCE,24
trabectedin,INTERSTITIAL LUNG DISEASE,24
trabectedin,OEDEMA PERIPHERAL,24
trabectedin,RENAL IMPAIRMENT,24
trabectedin,SEPTIC SHOCK,24
trabectedin,CAPILLARY LEAK SYNDROME,23
trabectedin,EXTRAVASATION,23
trabectedin,HEPATOCELLULAR INJURY,23
trabectedin,HYPOTENSION,23
trabectedin,NEUROPATHY PERIPHERAL,23
trabectedin,BLOOD CREATININE INCREASED,22
trabectedin,UNDERDOSE,22
trabectedin,CHOLESTASIS,21
trabectedin,HYPERSENSITIVITY,21
trabectedin,HYPOALBUMINAEMIA,21
trabectedin,HYPONATRAEMIA,21
trabectedin,INFECTION,21
trabectedin,RESPIRATORY FAILURE,21
trabectedin,GENERAL PHYSICAL HEALTH DETERIORATION,20
trabectedin,HYPOKALAEMIA,20
trabectedin,NEOPLASM PROGRESSION,20
trabectedin,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,20
trabectedin,URINARY TRACT INFECTION,20
trabectedin,ADVERSE EVENT,19
trabectedin,EJECTION FRACTION DECREASED,19
trabectedin,PULMONARY EMBOLISM,18
trabectedin,CARDIOTOXICITY,17
trabectedin,CEREBROVASCULAR ACCIDENT,17
trabectedin,HEPATIC CYTOLYSIS,17
trabectedin,HYPERTENSION,17
trabectedin,INTESTINAL OBSTRUCTION,17
trabectedin,ENCEPHALOPATHY,16
trabectedin,LEFT VENTRICULAR DYSFUNCTION,16
trabectedin,LIVER DISORDER,16
trabectedin,MULTIPLE ORGAN DYSFUNCTION SYNDROME,16
trabectedin,MYELOSUPPRESSION,16
trabectedin,NEUTROPENIC SEPSIS,16
trabectedin,PAIN,16
trabectedin,STOMATITIS,16
trabectedin,DRUG HYPERSENSITIVITY,15
avelumab,DEATH,362
avelumab,DISEASE PROGRESSION,337
avelumab,OFF LABEL USE,217
avelumab,DIARRHOEA,164
avelumab,INFUSION RELATED REACTION,138
avelumab,PYREXIA,136
avelumab,NEOPLASM PROGRESSION,122
avelumab,FATIGUE,119
avelumab,NAUSEA,105
avelumab,DYSPNOEA,98
avelumab,HYPERTENSION,93
avelumab,CHILLS,92
avelumab,RASH,90
avelumab,INTERSTITIAL LUNG DISEASE,88
avelumab,ACUTE KIDNEY INJURY,83
avelumab,GENERAL PHYSICAL HEALTH DETERIORATION,83
avelumab,HYPOTHYROIDISM,83
avelumab,DECREASED APPETITE,80
avelumab,PNEUMONIA,73
avelumab,MALAISE,72
avelumab,VOMITING,69
avelumab,COLITIS,68
avelumab,THROMBOCYTOPENIA,68
avelumab,ANAEMIA,65
avelumab,PNEUMONITIS,65
avelumab,NEUROPATHY PERIPHERAL,63
avelumab,SEPSIS,61
avelumab,ADRENAL INSUFFICIENCY,58
avelumab,FEBRILE NEUTROPENIA,58
avelumab,MALIGNANT NEOPLASM PROGRESSION,57
avelumab,MYOCARDITIS,54
avelumab,DRUG INEFFECTIVE,49
avelumab,ASTHENIA,48
avelumab,BACK PAIN,48
avelumab,NEUTROPENIA,47
avelumab,HYPOTENSION,46
avelumab,HEPATITIS,45
avelumab,PRURITUS,45
avelumab,MYOSITIS,44
avelumab,PULMONARY EMBOLISM,44
avelumab,DEHYDRATION,41
avelumab,HEPATIC FUNCTION ABNORMAL,41
avelumab,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,40
avelumab,CONSTIPATION,39
avelumab,DIZZINESS,39
avelumab,RENAL IMPAIRMENT,38
avelumab,SKIN TOXICITY,36
avelumab,CONDITION AGGRAVATED,35
avelumab,HYPERTHYROIDISM,35
avelumab,HYPONATRAEMIA,35
avelumab,ABDOMINAL PAIN,34
avelumab,DYSPHONIA,33
avelumab,PLATELET COUNT DECREASED,32
avelumab,PRODUCT USE IN UNAPPROVED INDICATION,32
avelumab,BLOOD PRESSURE INCREASED,31
avelumab,HAEMATURIA,31
avelumab,HAEMOGLOBIN DECREASED,31
avelumab,RENAL FAILURE,31
avelumab,ALANINE AMINOTRANSFERASE INCREASED,30
avelumab,PAIN,30
avelumab,RESPIRATORY FAILURE,30
avelumab,TRANSAMINASES INCREASED,30
avelumab,ARTHRITIS,28
avelumab,ATRIAL FIBRILLATION,28
avelumab,COUGH,28
avelumab,HYPERSENSITIVITY,28
avelumab,ASPARTATE AMINOTRANSFERASE INCREASED,27
avelumab,PANCREATITIS,27
avelumab,STOMATITIS,27
avelumab,TREMOR,27
avelumab,URINARY TRACT INFECTION,27
avelumab,MYASTHENIA GRAVIS,26
avelumab,CONFUSIONAL STATE,25
avelumab,FALL,25
avelumab,PLEURAL EFFUSION,25
avelumab,ARTHRALGIA,24
avelumab,DIABETES MELLITUS,24
avelumab,HEADACHE,24
avelumab,MUCOSAL INFLAMMATION,24
avelumab,OXYGEN SATURATION DECREASED,24
avelumab,SYNCOPE,24
avelumab,CHEST PAIN,23
avelumab,HYPERGLYCAEMIA,23
avelumab,THYROIDITIS,23
avelumab,WEIGHT DECREASED,23
avelumab,BLOOD CREATININE INCREASED,22
avelumab,CARDIAC ARREST,22
avelumab,CARDIAC FAILURE,22
avelumab,MYALGIA,22
avelumab,NEUTROPHIL COUNT DECREASED,22
avelumab,METASTASES TO CENTRAL NERVOUS SYSTEM,21
avelumab,MUSCULAR WEAKNESS,21
avelumab,DEVICE RELATED INFECTION,20
avelumab,DYSPHAGIA,20
avelumab,ENCEPHALITIS,20
avelumab,HYPOKALAEMIA,20
avelumab,LIVER DISORDER,20
avelumab,NEPHRITIS,20
avelumab,SEPTIC SHOCK,20
avelumab,HEPATOTOXICITY,18
lorlatinib,DEATH,894
lorlatinib,NEOPLASM PROGRESSION,662
lorlatinib,OFF LABEL USE,319
lorlatinib,BLOOD CHOLESTEROL INCREASED,195
lorlatinib,HALLUCINATION,195
lorlatinib,WEIGHT INCREASED,189
lorlatinib,DYSPNOEA,173
lorlatinib,OEDEMA PERIPHERAL,169
lorlatinib,DISEASE PROGRESSION,149
lorlatinib,OEDEMA,142
lorlatinib,FATIGUE,138
lorlatinib,HYPERCHOLESTEROLAEMIA,130
lorlatinib,PLEURAL EFFUSION,126
lorlatinib,COGNITIVE DISORDER,122
lorlatinib,BLOOD TRIGLYCERIDES INCREASED,108
lorlatinib,PNEUMONIA,106
lorlatinib,NEUROPATHY PERIPHERAL,105
lorlatinib,ASTHENIA,104
lorlatinib,MEMORY IMPAIRMENT,104
lorlatinib,PERIPHERAL SWELLING,104
lorlatinib,DIARRHOEA,102
lorlatinib,HYPERLIPIDAEMIA,101
lorlatinib,PAIN,94
lorlatinib,HEADACHE,89
lorlatinib,DRUG INEFFECTIVE,88
lorlatinib,CONFUSIONAL STATE,84
lorlatinib,HAEMOGLOBIN DECREASED,83
lorlatinib,PYREXIA,82
lorlatinib,NAUSEA,80
lorlatinib,HYPERTRIGLYCERIDAEMIA,78
lorlatinib,MALAISE,78
lorlatinib,DIZZINESS,75
lorlatinib,PULMONARY EMBOLISM,75
lorlatinib,ARTHRALGIA,69
lorlatinib,PAIN IN EXTREMITY,69
lorlatinib,COUGH,67
lorlatinib,ANXIETY,65
lorlatinib,BLOOD PRESSURE INCREASED,64
lorlatinib,"HALLUCINATION, AUDITORY",63
lorlatinib,"HALLUCINATION, VISUAL",63
lorlatinib,ANAEMIA,62
lorlatinib,LOW DENSITY LIPOPROTEIN INCREASED,62
lorlatinib,NERVOUS SYSTEM DISORDER,61
lorlatinib,PERICARDIAL EFFUSION,61
lorlatinib,GAIT DISTURBANCE,59
lorlatinib,CONSTIPATION,57
lorlatinib,MALIGNANT NEOPLASM PROGRESSION,55
lorlatinib,BLOOD GLUCOSE INCREASED,54
lorlatinib,SPEECH DISORDER,54
lorlatinib,INSOMNIA,52
lorlatinib,BACK PAIN,50
lorlatinib,DECREASED APPETITE,50
lorlatinib,FALL,50
lorlatinib,GENERAL PHYSICAL HEALTH DETERIORATION,50
lorlatinib,PSYCHOTIC DISORDER,50
lorlatinib,RASH,50
lorlatinib,VOMITING,50
lorlatinib,DYSLIPIDAEMIA,49
lorlatinib,HEART RATE INCREASED,49
lorlatinib,VISUAL IMPAIRMENT,49
lorlatinib,WEIGHT DECREASED,49
lorlatinib,CARDIAC FAILURE,48
lorlatinib,DEPRESSION,48
lorlatinib,PNEUMONITIS,45
lorlatinib,SEIZURE,45
lorlatinib,THROMBOCYTOPENIA,43
lorlatinib,COVID-19,42
lorlatinib,FEELING ABNORMAL,42
lorlatinib,CONDITION AGGRAVATED,41
lorlatinib,DYSPHAGIA,41
lorlatinib,HYPERTENSION,41
lorlatinib,MENTAL DISORDER,41
lorlatinib,PARAESTHESIA,40
lorlatinib,PRODUCT USE IN UNAPPROVED INDICATION,40
lorlatinib,ABDOMINAL DISTENSION,39
lorlatinib,AMNESIA,39
lorlatinib,DRUG RESISTANCE,39
lorlatinib,DELIRIUM,38
lorlatinib,HYPOAESTHESIA,38
lorlatinib,METASTASES TO CENTRAL NERVOUS SYSTEM,38
lorlatinib,MYALGIA,38
lorlatinib,CHEST PAIN,37
lorlatinib,PLATELET COUNT DECREASED,37
lorlatinib,CEREBROVASCULAR ACCIDENT,36
lorlatinib,PANCYTOPENIA,36
lorlatinib,ASPARTATE AMINOTRANSFERASE INCREASED,35
lorlatinib,LIPIDS INCREASED,35
lorlatinib,MUSCULAR WEAKNESS,35
lorlatinib,PULMONARY OEDEMA,35
lorlatinib,BALANCE DISORDER,34
lorlatinib,FLUID RETENTION,34
lorlatinib,BLOOD CREATININE INCREASED,32
lorlatinib,CARPAL TUNNEL SYNDROME,32
lorlatinib,ELECTROCARDIOGRAM QT PROLONGED,32
lorlatinib,SWELLING,32
lorlatinib,ASCITES,31
lorlatinib,DIABETES MELLITUS,31
lorlatinib,DYSPNOEA EXERTIONAL,31
lorlatinib,IRRITABILITY,31
lorlatinib,METASTASES TO LIVER,31
enzalutamide,FATIGUE,9538
enzalutamide,DEATH,7575
enzalutamide,MALIGNANT NEOPLASM PROGRESSION,5261
enzalutamide,PROSTATIC SPECIFIC ANTIGEN INCREASED,4171
enzalutamide,DRUG INEFFECTIVE,3952
enzalutamide,ASTHENIA,3884
enzalutamide,HOT FLUSH,3296
enzalutamide,DECREASED APPETITE,3278
enzalutamide,NAUSEA,3159
enzalutamide,DIZZINESS,2959
enzalutamide,DIARRHOEA,2672
enzalutamide,BACK PAIN,2182
enzalutamide,UNDERDOSE,2023
enzalutamide,ARTHRALGIA,1996
enzalutamide,CONSTIPATION,1709
enzalutamide,WEIGHT DECREASED,1703
enzalutamide,FALL,1696
enzalutamide,PAIN,1608
enzalutamide,HEADACHE,1599
enzalutamide,MALAISE,1488
enzalutamide,DYSPNOEA,1408
enzalutamide,INSOMNIA,1281
enzalutamide,PERIPHERAL SWELLING,1271
enzalutamide,DYSPHAGIA,1268
enzalutamide,VOMITING,1213
enzalutamide,PAIN IN EXTREMITY,1163
enzalutamide,OFF LABEL USE,970
enzalutamide,SOMNOLENCE,967
enzalutamide,MUSCULAR WEAKNESS,958
enzalutamide,ABDOMINAL DISCOMFORT,953
enzalutamide,DRUG DOSE OMISSION,937
enzalutamide,MYALGIA,913
enzalutamide,CONFUSIONAL STATE,879
enzalutamide,DRUG INTERACTION,815
enzalutamide,GAIT DISTURBANCE,805
enzalutamide,FEELING ABNORMAL,797
enzalutamide,MEMORY IMPAIRMENT,788
enzalutamide,PROSTATE CANCER,783
enzalutamide,RASH,776
enzalutamide,ANAEMIA,774
enzalutamide,BONE PAIN,755
enzalutamide,URINARY TRACT INFECTION,719
enzalutamide,PNEUMONIA,695
enzalutamide,BLOOD PRESSURE INCREASED,680
enzalutamide,HYPERTENSION,668
enzalutamide,BALANCE DISORDER,635
enzalutamide,CEREBROVASCULAR ACCIDENT,616
enzalutamide,TREATMENT NONCOMPLIANCE,607
enzalutamide,PRODUCT SIZE ISSUE,599
enzalutamide,HYPOAESTHESIA,594
enzalutamide,HYPERHIDROSIS,592
enzalutamide,DYSGEUSIA,585
enzalutamide,NEUROPATHY PERIPHERAL,563
enzalutamide,ANXIETY,560
enzalutamide,ABDOMINAL PAIN UPPER,547
enzalutamide,GENERAL PHYSICAL HEALTH DETERIORATION,541
enzalutamide,PRURITUS,541
enzalutamide,DEHYDRATION,529
enzalutamide,DEPRESSION,526
enzalutamide,PARAESTHESIA,525
enzalutamide,METASTASES TO BONE,493
enzalutamide,SEIZURE,492
enzalutamide,OEDEMA PERIPHERAL,485
enzalutamide,HOSPITALISATION,483
enzalutamide,VISION BLURRED,478
enzalutamide,PYREXIA,466
enzalutamide,COUGH,462
enzalutamide,LOSS OF CONSCIOUSNESS,452
enzalutamide,AMNESIA,444
enzalutamide,MUSCLE SPASMS,439
enzalutamide,WEIGHT INCREASED,427
enzalutamide,CHEST PAIN,417
enzalutamide,PRODUCT STORAGE ERROR,395
enzalutamide,JOINT SWELLING,394
enzalutamide,MYOCARDIAL INFARCTION,394
enzalutamide,POLLAKIURIA,392
enzalutamide,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,376
enzalutamide,NASOPHARYNGITIS,376
enzalutamide,TREMOR,376
enzalutamide,CONDITION AGGRAVATED,368
enzalutamide,MUSCULOSKELETAL PAIN,365
enzalutamide,HAEMOGLOBIN DECREASED,364
enzalutamide,CARDIAC FAILURE,347
enzalutamide,ABDOMINAL PAIN,333
enzalutamide,HYPOTENSION,332
enzalutamide,ATRIAL FIBRILLATION,326
enzalutamide,HALLUCINATION,322
enzalutamide,PRODUCT USE COMPLAINT,321
enzalutamide,BLOOD URINE PRESENT,320
enzalutamide,ALOPECIA,319
enzalutamide,DISEASE PROGRESSION,318
enzalutamide,VISUAL IMPAIRMENT,316
enzalutamide,LETHARGY,310
enzalutamide,PRODUCT DOSE OMISSION,303
enzalutamide,HAEMATURIA,302
enzalutamide,PROSTATE CANCER METASTATIC,297
enzalutamide,DYSPEPSIA,290
enzalutamide,DRUG INTOLERANCE,288
enzalutamide,PLATELET COUNT DECREASED,282
enzalutamide,SEPSIS,275
afatinib,DIARRHOEA,2112
afatinib,MALIGNANT NEOPLASM PROGRESSION,1689
afatinib,RASH,871
afatinib,DEATH,541
afatinib,NAUSEA,489
afatinib,STOMATITIS,487
afatinib,DECREASED APPETITE,452
afatinib,VOMITING,419
afatinib,PARONYCHIA,353
afatinib,DEHYDRATION,336
afatinib,FATIGUE,301
afatinib,METASTASES TO CENTRAL NERVOUS SYSTEM,272
afatinib,OFF LABEL USE,264
afatinib,ASTHENIA,247
afatinib,DRUG INEFFECTIVE,225
afatinib,DYSPNOEA,224
afatinib,WEIGHT DECREASED,209
afatinib,PNEUMONIA,201
afatinib,DRY SKIN,200
afatinib,DISEASE PROGRESSION,194
afatinib,PLEURAL EFFUSION,188
afatinib,PYREXIA,171
afatinib,DRUG RESISTANCE,167
afatinib,ACNE,165
afatinib,PRURITUS,161
afatinib,INTERSTITIAL LUNG DISEASE,155
afatinib,DERMATITIS ACNEIFORM,150
afatinib,ALOPECIA,136
afatinib,EPISTAXIS,134
afatinib,ANAEMIA,123
afatinib,COUGH,119
afatinib,CONSTIPATION,117
afatinib,DIZZINESS,117
afatinib,MUCOSAL INFLAMMATION,113
afatinib,MALAISE,111
afatinib,HEADACHE,104
afatinib,ABDOMINAL PAIN,103
afatinib,ACUTE KIDNEY INJURY,99
afatinib,METASTASES TO BONE,90
afatinib,EGFR GENE MUTATION,87
afatinib,RESPIRATORY FAILURE,87
afatinib,DYSPHAGIA,86
afatinib,PAIN,86
afatinib,SKIN DISORDER,86
afatinib,PNEUMONITIS,85
afatinib,SKIN TOXICITY,85
afatinib,NAIL DISORDER,83
afatinib,DRY MOUTH,81
afatinib,PAIN IN EXTREMITY,78
afatinib,BLOOD CREATININE INCREASED,77
afatinib,METASTASES TO MENINGES,77
afatinib,ORAL PAIN,77
afatinib,METASTASES TO LIVER,75
afatinib,URINARY TRACT INFECTION,75
afatinib,FALL,74
afatinib,NEOPLASM PROGRESSION,71
afatinib,DYSGEUSIA,70
afatinib,SKIN FISSURES,70
afatinib,HYPOKALAEMIA,68
afatinib,SKIN EXFOLIATION,68
afatinib,THERAPY PARTIAL RESPONDER,67
afatinib,GENERAL PHYSICAL HEALTH DETERIORATION,65
afatinib,RENAL FAILURE,64
afatinib,PULMONARY EMBOLISM,62
afatinib,HYPOTENSION,61
afatinib,SEPSIS,61
afatinib,BACK PAIN,60
afatinib,ERYTHEMA,60
afatinib,NON-SMALL CELL LUNG CANCER,60
afatinib,ABDOMINAL PAIN UPPER,59
afatinib,ONYCHOCLASIS,59
afatinib,MUSCLE SPASMS,58
afatinib,DRUG INTOLERANCE,57
afatinib,RHINORRHOEA,57
afatinib,LUNG DISORDER,55
afatinib,METASTASES TO LUNG,55
afatinib,TOXICITY TO VARIOUS AGENTS,54
afatinib,PERIPHERAL SWELLING,53
afatinib,ABDOMINAL DISCOMFORT,52
afatinib,ACQUIRED GENE MUTATION,52
afatinib,CHEST PAIN,51
afatinib,DRY EYE,50
afatinib,CARDIAC FAILURE,48
afatinib,HYPONATRAEMIA,47
afatinib,INFECTION,47
afatinib,MOUTH ULCERATION,47
afatinib,OROPHARYNGEAL PAIN,47
afatinib,LUNG NEOPLASM MALIGNANT,46
afatinib,RASH PUSTULAR,46
afatinib,NASOPHARYNGITIS,45
afatinib,TREATMENT FAILURE,45
afatinib,DYSPEPSIA,44
afatinib,CONFUSIONAL STATE,43
afatinib,GENE MUTATION,43
afatinib,SEIZURE,43
afatinib,ALANINE AMINOTRANSFERASE INCREASED,39
afatinib,GLOSSODYNIA,38
afatinib,NEUTROPENIA,38
afatinib,HAEMORRHAGE,37
afatinib,INSOMNIA,37
capecitabine,DIARRHOEA,13963
capecitabine,DEATH,9017
capecitabine,NAUSEA,8641
capecitabine,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,6954
capecitabine,FATIGUE,6677
capecitabine,VOMITING,6314
capecitabine,DISEASE PROGRESSION,6010
capecitabine,MALIGNANT NEOPLASM PROGRESSION,3626
capecitabine,OFF LABEL USE,3624
capecitabine,ASTHENIA,3393
capecitabine,DECREASED APPETITE,3188
capecitabine,DEHYDRATION,2978
capecitabine,NEUTROPENIA,2937
capecitabine,NEUROPATHY PERIPHERAL,2784
capecitabine,DYSPNOEA,2687
capecitabine,PYREXIA,2476
capecitabine,DRUG INEFFECTIVE,2455
capecitabine,THROMBOCYTOPENIA,2336
capecitabine,RASH,2307
capecitabine,ABDOMINAL PAIN,2288
capecitabine,ANAEMIA,2276
capecitabine,PAIN,2242
capecitabine,STOMATITIS,2177
capecitabine,WEIGHT DECREASED,2034
capecitabine,MUCOSAL INFLAMMATION,1955
capecitabine,CONSTIPATION,1938
capecitabine,PAIN IN EXTREMITY,1887
capecitabine,MALAISE,1770
capecitabine,METASTASES TO LIVER,1707
capecitabine,DIZZINESS,1675
capecitabine,PARAESTHESIA,1627
capecitabine,HEADACHE,1596
capecitabine,ERYTHEMA,1568
capecitabine,SKIN EXFOLIATION,1352
capecitabine,PNEUMONIA,1322
capecitabine,HYPOAESTHESIA,1307
capecitabine,DRY SKIN,1277
capecitabine,PLATELET COUNT DECREASED,1248
capecitabine,NEOPLASM PROGRESSION,1224
capecitabine,METASTASES TO BONE,1213
capecitabine,SEPSIS,1181
capecitabine,ABDOMINAL PAIN UPPER,1179
capecitabine,CHEST PAIN,1161
capecitabine,WHITE BLOOD CELL COUNT DECREASED,1151
capecitabine,FEBRILE NEUTROPENIA,1147
capecitabine,GENERAL PHYSICAL HEALTH DETERIORATION,1142
capecitabine,HYPERTENSION,1122
capecitabine,PULMONARY EMBOLISM,1115
capecitabine,BREAST CANCER METASTATIC,1089
capecitabine,LEUKOPENIA,1078
capecitabine,SKIN DISCOLOURATION,1046
capecitabine,BACK PAIN,1026
capecitabine,COUGH,1024
capecitabine,HYPOKALAEMIA,987
capecitabine,TOXICITY TO VARIOUS AGENTS,979
capecitabine,INFECTION,964
capecitabine,ALOPECIA,961
capecitabine,FALL,960
capecitabine,METASTASES TO CENTRAL NERVOUS SYSTEM,943
capecitabine,BREAST CANCER,941
capecitabine,HYPOTENSION,939
capecitabine,METASTASES TO LUNG,933
capecitabine,ARTHRALGIA,921
capecitabine,PRURITUS,918
capecitabine,DYSPHAGIA,909
capecitabine,PLEURAL EFFUSION,896
capecitabine,THERAPY INTERRUPTED,889
capecitabine,MYELOSUPPRESSION,886
capecitabine,HOSPITALISATION,852
capecitabine,PERIPHERAL SWELLING,850
capecitabine,URINARY TRACT INFECTION,769
capecitabine,NEUROTOXICITY,768
capecitabine,OEDEMA PERIPHERAL,766
capecitabine,MUSCLE SPASMS,756
capecitabine,ASCITES,751
capecitabine,THERAPY CESSATION,742
capecitabine,RENAL FAILURE,738
capecitabine,BLISTER,733
capecitabine,BONE MARROW FAILURE,731
capecitabine,THROMBOSIS,729
capecitabine,GAIT DISTURBANCE,723
capecitabine,HAEMOGLOBIN DECREASED,685
capecitabine,NO ADVERSE EVENT,681
capecitabine,HYPERSENSITIVITY,679
capecitabine,GASTROINTESTINAL DISORDER,675
capecitabine,ABDOMINAL DISTENSION,674
capecitabine,INSOMNIA,669
capecitabine,DRUG INTOLERANCE,668
capecitabine,INTENTIONAL PRODUCT USE ISSUE,668
capecitabine,INTESTINAL OBSTRUCTION,663
capecitabine,ACUTE KIDNEY INJURY,659
capecitabine,BLOOD BILIRUBIN INCREASED,655
capecitabine,EPISTAXIS,653
capecitabine,ABDOMINAL DISCOMFORT,647
capecitabine,CONFUSIONAL STATE,637
capecitabine,CHILLS,632
capecitabine,SKIN FISSURES,617
capecitabine,COLITIS,615
capecitabine,PANCYTOPENIA,607
capecitabine,DEEP VEIN THROMBOSIS,605
cetuximab,RASH,2222
cetuximab,DIARRHOEA,2019
cetuximab,NAUSEA,1669
cetuximab,OFF LABEL USE,1594
cetuximab,VOMITING,1413
cetuximab,DYSPNOEA,1381
cetuximab,NEUTROPENIA,1188
cetuximab,DEHYDRATION,1169
cetuximab,PYREXIA,1124
cetuximab,INFUSION RELATED REACTION,1113
cetuximab,FATIGUE,1050
cetuximab,DEATH,1043
cetuximab,MALIGNANT NEOPLASM PROGRESSION,1009
cetuximab,HYPOTENSION,932
cetuximab,ANAEMIA,907
cetuximab,DERMATITIS ACNEIFORM,848
cetuximab,ASTHENIA,832
cetuximab,DECREASED APPETITE,829
cetuximab,MUCOSAL INFLAMMATION,829
cetuximab,THROMBOCYTOPENIA,708
cetuximab,PNEUMONIA,676
cetuximab,PRURITUS,662
cetuximab,STOMATITIS,660
cetuximab,WEIGHT DECREASED,659
cetuximab,WHITE BLOOD CELL COUNT DECREASED,628
cetuximab,DISEASE PROGRESSION,626
cetuximab,HYPERSENSITIVITY,604
cetuximab,HYPOMAGNESAEMIA,603
cetuximab,DYSPHAGIA,594
cetuximab,FEBRILE NEUTROPENIA,585
cetuximab,PULMONARY EMBOLISM,583
cetuximab,ABDOMINAL PAIN,574
cetuximab,CHILLS,552
cetuximab,ERYTHEMA,550
cetuximab,SEPSIS,532
cetuximab,MALAISE,516
cetuximab,ANAPHYLACTIC REACTION,508
cetuximab,NEUTROPHIL COUNT DECREASED,478
cetuximab,LEUKOPENIA,469
cetuximab,NEUROPATHY PERIPHERAL,441
cetuximab,PAIN,440
cetuximab,PLATELET COUNT DECREASED,425
cetuximab,HYPOKALAEMIA,413
cetuximab,DRY SKIN,411
cetuximab,DIZZINESS,384
cetuximab,GENERAL PHYSICAL HEALTH DETERIORATION,384
cetuximab,INTERSTITIAL LUNG DISEASE,379
cetuximab,MYELOSUPPRESSION,366
cetuximab,RESPIRATORY FAILURE,333
cetuximab,SKIN TOXICITY,326
cetuximab,HAEMOGLOBIN DECREASED,325
cetuximab,DEEP VEIN THROMBOSIS,323
cetuximab,CONSTIPATION,321
cetuximab,ACNE,314
cetuximab,OXYGEN SATURATION DECREASED,311
cetuximab,HEADACHE,310
cetuximab,LOSS OF CONSCIOUSNESS,309
cetuximab,DRUG INEFFECTIVE,302
cetuximab,FLUSHING,301
cetuximab,BLOOD PRESSURE DECREASED,300
cetuximab,CHEST PAIN,300
cetuximab,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,298
cetuximab,TACHYCARDIA,298
cetuximab,URTICARIA,295
cetuximab,INFECTION,281
cetuximab,HYPONATRAEMIA,277
cetuximab,PARONYCHIA,263
cetuximab,COUGH,256
cetuximab,HYPERTENSION,253
cetuximab,RENAL FAILURE,253
cetuximab,ALOPECIA,243
cetuximab,ACUTE KIDNEY INJURY,240
cetuximab,NEOPLASM PROGRESSION,240
cetuximab,SYNCOPE,236
cetuximab,SKIN REACTION,232
cetuximab,SEPTIC SHOCK,223
cetuximab,HYPOCALCAEMIA,222
cetuximab,PNEUMONITIS,222
cetuximab,HYPERHIDROSIS,221
cetuximab,CARDIO-RESPIRATORY ARREST,220
cetuximab,BACK PAIN,219
cetuximab,RADIATION SKIN INJURY,216
cetuximab,ASPARTATE AMINOTRANSFERASE INCREASED,212
cetuximab,PLEURAL EFFUSION,212
cetuximab,ATRIAL FIBRILLATION,211
cetuximab,SKIN FISSURES,210
cetuximab,DERMATITIS,207
cetuximab,ALANINE AMINOTRANSFERASE INCREASED,205
cetuximab,PNEUMONIA ASPIRATION,205
cetuximab,BONE MARROW FAILURE,204
cetuximab,CHEST DISCOMFORT,204
cetuximab,CONFUSIONAL STATE,203
cetuximab,SKIN DISORDER,200
cetuximab,PARAESTHESIA,199
cetuximab,URINARY TRACT INFECTION,199
cetuximab,BLOOD CREATININE INCREASED,194
cetuximab,CARDIAC ARREST,189
cetuximab,INTESTINAL OBSTRUCTION,188
cetuximab,EPISTAXIS,184
cetuximab,MYOCARDIAL INFARCTION,177
paclitaxel albumin,MALIGNANT NEOPLASM PROGRESSION,60
paclitaxel albumin,MYELOSUPPRESSION,59
paclitaxel albumin,PYREXIA,46
paclitaxel albumin,DEATH,39
paclitaxel albumin,NAUSEA,39
paclitaxel albumin,OFF LABEL USE,39
paclitaxel albumin,DIARRHOEA,34
paclitaxel albumin,PLATELET COUNT DECREASED,33
paclitaxel albumin,NEUTROPHIL COUNT DECREASED,31
paclitaxel albumin,DECREASED APPETITE,30
paclitaxel albumin,INTERSTITIAL LUNG DISEASE,29
paclitaxel albumin,NEUTROPENIA,29
paclitaxel albumin,FEBRILE NEUTROPENIA,28
paclitaxel albumin,PNEUMONIA,26
paclitaxel albumin,WHITE BLOOD CELL COUNT DECREASED,25
paclitaxel albumin,ANAEMIA,24
paclitaxel albumin,VOMITING,23
paclitaxel albumin,THROMBOCYTOPENIA,22
paclitaxel albumin,GASTROINTESTINAL DISORDER,21
paclitaxel albumin,NEUROPATHY PERIPHERAL,20
paclitaxel albumin,ASTHENIA,19
paclitaxel albumin,DEHYDRATION,19
paclitaxel albumin,FATIGUE,19
paclitaxel albumin,INTENTIONAL PRODUCT USE ISSUE,19
paclitaxel albumin,RASH,19
paclitaxel albumin,BONE MARROW FAILURE,18
paclitaxel albumin,DISEASE PROGRESSION,17
paclitaxel albumin,DYSPNOEA,16
paclitaxel albumin,HEPATIC FUNCTION ABNORMAL,16
paclitaxel albumin,PAIN,15
paclitaxel albumin,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,15
paclitaxel albumin,GENERAL PHYSICAL HEALTH DETERIORATION,14
paclitaxel albumin,LUNG DISORDER,13
paclitaxel albumin,RESPIRATORY FAILURE,13
paclitaxel albumin,ALANINE AMINOTRANSFERASE INCREASED,12
paclitaxel albumin,INFECTION,12
paclitaxel albumin,MUCOSAL INFLAMMATION,12
paclitaxel albumin,PANCYTOPENIA,12
paclitaxel albumin,SEPSIS,12
paclitaxel albumin,ABDOMINAL PAIN,11
paclitaxel albumin,HYPOAESTHESIA,11
paclitaxel albumin,HYPOKALAEMIA,11
paclitaxel albumin,PNEUMONITIS,11
paclitaxel albumin,ACUTE KIDNEY INJURY,10
paclitaxel albumin,IMMUNE-MEDIATED HEPATIC DISORDER,10
paclitaxel albumin,MALAISE,10
paclitaxel albumin,PLEURAL EFFUSION,10
paclitaxel albumin,URINARY TRACT INFECTION,10
paclitaxel albumin,ALOPECIA,9
paclitaxel albumin,ARTHRALGIA,9
paclitaxel albumin,HYPOTHYROIDISM,9
paclitaxel albumin,LEUKOPENIA,9
paclitaxel albumin,PRODUCT USE IN UNAPPROVED INDICATION,9
paclitaxel albumin,ASPARTATE AMINOTRANSFERASE INCREASED,8
paclitaxel albumin,CHOLANGITIS,8
paclitaxel albumin,MUSCULAR WEAKNESS,8
paclitaxel albumin,NEUROTOXICITY,8
paclitaxel albumin,TOXICITY TO VARIOUS AGENTS,8
paclitaxel albumin,BLOOD CREATININE INCREASED,7
paclitaxel albumin,CHEST DISCOMFORT,7
paclitaxel albumin,GASTROINTESTINAL HAEMORRHAGE,7
paclitaxel albumin,HYPERTENSION,7
paclitaxel albumin,HYPONATRAEMIA,7
paclitaxel albumin,METASTASES TO LIVER,7
paclitaxel albumin,NEOPLASM PROGRESSION,7
paclitaxel albumin,PNEUMOCYSTIS JIROVECII PNEUMONIA,7
paclitaxel albumin,PRURITUS,7
paclitaxel albumin,RENAL IMPAIRMENT,7
paclitaxel albumin,SEPTIC SHOCK,7
paclitaxel albumin,STOMATITIS,7
paclitaxel albumin,ABDOMINAL PAIN UPPER,6
paclitaxel albumin,CARDIAC FAILURE,6
paclitaxel albumin,CEREBROVASCULAR ACCIDENT,6
paclitaxel albumin,CHILLS,6
paclitaxel albumin,CHOLANGITIS SCLEROSING,6
paclitaxel albumin,COLITIS,6
paclitaxel albumin,CONSTIPATION,6
paclitaxel albumin,COUGH,6
paclitaxel albumin,DRUG-INDUCED LIVER INJURY,6
paclitaxel albumin,DYSPHAGIA,6
paclitaxel albumin,HEADACHE,6
paclitaxel albumin,HYPERSENSITIVITY,6
paclitaxel albumin,HYPOXIA,6
paclitaxel albumin,LIVER DISORDER,6
paclitaxel albumin,LYMPHANGIOSIS CARCINOMATOSA,6
paclitaxel albumin,PERICARDIAL EFFUSION,6
paclitaxel albumin,PNEUMONIA ASPIRATION,6
paclitaxel albumin,PROTEINURIA,6
paclitaxel albumin,ABDOMINAL DISTENSION,5
paclitaxel albumin,ADRENAL INSUFFICIENCY,5
paclitaxel albumin,ASCITES,5
paclitaxel albumin,BLOOD GLUCOSE INCREASED,5
paclitaxel albumin,BREAST CANCER,5
paclitaxel albumin,CELLULITIS,5
paclitaxel albumin,CYTOPENIA,5
paclitaxel albumin,DEEP VEIN THROMBOSIS,5
paclitaxel albumin,DIZZINESS,5
paclitaxel albumin,EJECTION FRACTION DECREASED,5
paclitaxel albumin,EPISTAXIS,5
paclitaxel albumin,FAILURE TO THRIVE,5
aflibercept,DEATH,8144
aflibercept,VISUAL IMPAIRMENT,1892
aflibercept,OFF LABEL USE,1425
aflibercept,BLINDNESS,1372
aflibercept,ENDOPHTHALMITIS,1333
aflibercept,VISUAL ACUITY REDUCED,1228
aflibercept,EYE PAIN,1116
aflibercept,DRUG INEFFECTIVE,1097
aflibercept,VISION BLURRED,1083
aflibercept,PRODUCT DOSE OMISSION ISSUE,1050
aflibercept,BLINDNESS UNILATERAL,1001
aflibercept,BLINDNESS TRANSIENT,977
aflibercept,EYE INFLAMMATION,896
aflibercept,EYE HAEMORRHAGE,798
aflibercept,VITREOUS FLOATERS,730
aflibercept,INTRAOCULAR PRESSURE INCREASED,696
aflibercept,DIARRHOEA,630
aflibercept,RETINAL HAEMORRHAGE,576
aflibercept,CATARACT,530
aflibercept,HYPERTENSION,525
aflibercept,NON-INFECTIOUS ENDOPHTHALMITIS,440
aflibercept,HEADACHE,419
aflibercept,VITRITIS,394
aflibercept,UVEITIS,388
aflibercept,OCULAR HYPERAEMIA,385
aflibercept,CEREBROVASCULAR ACCIDENT,357
aflibercept,DISEASE PROGRESSION,325
aflibercept,PRODUCT USE ISSUE,323
aflibercept,NEUTROPENIA,322
aflibercept,EYE DISORDER,319
aflibercept,FATIGUE,316
aflibercept,ASTHENIA,313
aflibercept,INJECTION SITE PAIN,307
aflibercept,FALL,291
aflibercept,MALAISE,287
aflibercept,EYE IRRITATION,283
aflibercept,NAUSEA,282
aflibercept,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,279
aflibercept,VITRECTOMY,264
aflibercept,LACRIMATION INCREASED,257
aflibercept,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,252
aflibercept,VITREOUS HAEMORRHAGE,252
aflibercept,EYE INFECTION,244
aflibercept,MYOCARDIAL INFARCTION,240
aflibercept,VOMITING,232
aflibercept,HOSPITALISATION,230
aflibercept,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,230
aflibercept,DYSPNOEA,229
aflibercept,RETINAL OEDEMA,223
aflibercept,MACULAR OEDEMA,221
aflibercept,RETINAL DETACHMENT,220
aflibercept,PAIN,217
aflibercept,DRUG DOSE OMISSION,215
aflibercept,CATARACT OPERATION,213
aflibercept,PRODUCT DOSE OMISSION,204
aflibercept,SUBRETINAL FLUID,204
aflibercept,PNEUMONIA,202
aflibercept,PYREXIA,201
aflibercept,CONDITION AGGRAVATED,194
aflibercept,DIZZINESS,192
aflibercept,GENERAL PHYSICAL HEALTH DETERIORATION,184
aflibercept,PHOTOPHOBIA,184
aflibercept,OCULAR DISCOMFORT,182
aflibercept,DEVICE USE ISSUE,179
aflibercept,GLAUCOMA,176
aflibercept,EYE SWELLING,174
aflibercept,ABDOMINAL PAIN,171
aflibercept,DECREASED APPETITE,169
aflibercept,ANAEMIA,166
aflibercept,PROTEINURIA,165
aflibercept,VITREOUS OPACITIES,161
aflibercept,BLOOD PRESSURE INCREASED,160
aflibercept,ANTERIOR CHAMBER CELL,159
aflibercept,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,155
aflibercept,RETINAL ARTERY OCCLUSION,155
aflibercept,REFUSAL OF TREATMENT BY PATIENT,152
aflibercept,DETACHMENT OF RETINAL PIGMENT EPITHELIUM,150
aflibercept,MACULAR DEGENERATION,150
aflibercept,THROMBOCYTOPENIA,149
aflibercept,PULMONARY EMBOLISM,145
aflibercept,NO ADVERSE EVENT,142
aflibercept,METAMORPHOPSIA,140
aflibercept,MACULAR HOLE,138
aflibercept,AGE-RELATED MACULAR DEGENERATION,136
aflibercept,STOMATITIS,136
aflibercept,UNEVALUABLE EVENT,133
aflibercept,FOREIGN BODY SENSATION IN EYES,130
aflibercept,RENAL FAILURE,128
aflibercept,WEIGHT DECREASED,126
aflibercept,IRITIS,125
aflibercept,DRY EYE,124
aflibercept,IRIDOCYCLITIS,123
aflibercept,VISUAL FIELD DEFECT,121
aflibercept,NEUROPATHY PERIPHERAL,120
aflibercept,HYPOACUSIS,117
aflibercept,ALOPECIA,116
aflibercept,CARDIAC FAILURE,116
aflibercept,URINARY TRACT INFECTION,116
aflibercept,ACUTE KIDNEY INJURY,115
aflibercept,INJURY ASSOCIATED WITH DEVICE,114
sacituzumab govitecan,DISEASE PROGRESSION,1230
sacituzumab govitecan,DEATH,586
sacituzumab govitecan,DIARRHOEA,515
sacituzumab govitecan,NEUTROPENIA,453
sacituzumab govitecan,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,354
sacituzumab govitecan,FATIGUE,291
sacituzumab govitecan,OFF LABEL USE,287
sacituzumab govitecan,NAUSEA,240
sacituzumab govitecan,ASTHENIA,221
sacituzumab govitecan,FEBRILE NEUTROPENIA,208
sacituzumab govitecan,WEIGHT FLUCTUATION,192
sacituzumab govitecan,ALOPECIA,164
sacituzumab govitecan,WEIGHT DECREASED,160
sacituzumab govitecan,VOMITING,135
sacituzumab govitecan,NEUTROPHIL COUNT DECREASED,124
sacituzumab govitecan,CONSTIPATION,118
sacituzumab govitecan,WEIGHT INCREASED,116
sacituzumab govitecan,ANAEMIA,115
sacituzumab govitecan,MALAISE,112
sacituzumab govitecan,DYSPNOEA,111
sacituzumab govitecan,PYREXIA,107
sacituzumab govitecan,DRUG INEFFECTIVE,105
sacituzumab govitecan,THROMBOCYTOPENIA,99
sacituzumab govitecan,HEART RATE INCREASED,93
sacituzumab govitecan,ABDOMINAL PAIN,91
sacituzumab govitecan,SEPSIS,90
sacituzumab govitecan,HYPOTENSION,87
sacituzumab govitecan,PAIN,84
sacituzumab govitecan,COLITIS,83
sacituzumab govitecan,WHITE BLOOD CELL COUNT DECREASED,82
sacituzumab govitecan,COVID-19,79
sacituzumab govitecan,RASH,76
sacituzumab govitecan,DECREASED APPETITE,75
sacituzumab govitecan,HYPERTENSION,70
sacituzumab govitecan,MYELOSUPPRESSION,67
sacituzumab govitecan,GENERAL PHYSICAL HEALTH DETERIORATION,66
sacituzumab govitecan,METASTASES TO CENTRAL NERVOUS SYSTEM,65
sacituzumab govitecan,PNEUMONIA,65
sacituzumab govitecan,DIZZINESS,64
sacituzumab govitecan,COUGH,63
sacituzumab govitecan,NEUTROPENIC COLITIS,63
sacituzumab govitecan,HEADACHE,60
sacituzumab govitecan,PNEUMONITIS,57
sacituzumab govitecan,SEPTIC SHOCK,57
sacituzumab govitecan,PANCYTOPENIA,53
sacituzumab govitecan,ABDOMINAL PAIN UPPER,49
sacituzumab govitecan,DEHYDRATION,46
sacituzumab govitecan,ILL-DEFINED DISORDER,42
sacituzumab govitecan,MALIGNANT NEOPLASM PROGRESSION,42
sacituzumab govitecan,NEUTROPENIC SEPSIS,42
sacituzumab govitecan,PLEURAL EFFUSION,42
sacituzumab govitecan,METASTASES TO LIVER,40
sacituzumab govitecan,SOMNOLENCE,40
sacituzumab govitecan,MUCOSAL INFLAMMATION,38
sacituzumab govitecan,NASOPHARYNGITIS,38
sacituzumab govitecan,PLATELET COUNT DECREASED,38
sacituzumab govitecan,BACK PAIN,37
sacituzumab govitecan,URINARY TRACT INFECTION,37
sacituzumab govitecan,INFECTION,36
sacituzumab govitecan,ACUTE KIDNEY INJURY,34
sacituzumab govitecan,DYSPHAGIA,34
sacituzumab govitecan,FEBRILE BONE MARROW APLASIA,32
sacituzumab govitecan,LEUKOPENIA,32
sacituzumab govitecan,NEUTROPHIL COUNT ABNORMAL,32
sacituzumab govitecan,PRODUCT DOSE OMISSION ISSUE,32
sacituzumab govitecan,METASTASES TO BONE,31
sacituzumab govitecan,NEUROPATHY PERIPHERAL,31
sacituzumab govitecan,PAIN IN EXTREMITY,31
sacituzumab govitecan,BREAST CANCER METASTATIC,30
sacituzumab govitecan,GENERAL PHYSICAL CONDITION ABNORMAL,30
sacituzumab govitecan,HAEMOGLOBIN DECREASED,30
sacituzumab govitecan,HYPERSENSITIVITY,30
sacituzumab govitecan,PRURITUS,30
sacituzumab govitecan,ARTHRALGIA,29
sacituzumab govitecan,HYPOKALAEMIA,29
sacituzumab govitecan,HYPONATRAEMIA,29
sacituzumab govitecan,INFUSION RELATED REACTION,29
sacituzumab govitecan,NEOPLASM PROGRESSION,28
sacituzumab govitecan,INTENTIONAL DOSE OMISSION,26
sacituzumab govitecan,OROPHARYNGEAL PAIN,26
sacituzumab govitecan,OXYGEN SATURATION DECREASED,26
sacituzumab govitecan,HAEMATOTOXICITY,25
sacituzumab govitecan,PULMONARY EMBOLISM,25
sacituzumab govitecan,BONE PAIN,24
sacituzumab govitecan,ANXIETY,23
sacituzumab govitecan,ASCITES,23
sacituzumab govitecan,CONDITION AGGRAVATED,23
sacituzumab govitecan,GAIT DISTURBANCE,22
sacituzumab govitecan,PRODUCT PREPARATION ISSUE,22
sacituzumab govitecan,RENAL FAILURE,22
sacituzumab govitecan,SARS-COV-2 TEST POSITIVE,22
sacituzumab govitecan,ILLNESS,21
sacituzumab govitecan,METASTASES TO LUNG,21
sacituzumab govitecan,SEIZURE,21
sacituzumab govitecan,TRIPLE NEGATIVE BREAST CANCER,21
sacituzumab govitecan,INCORRECT DOSE ADMINISTERED,20
sacituzumab govitecan,LIVER DISORDER,20
sacituzumab govitecan,LIVER FUNCTION TEST INCREASED,20
sacituzumab govitecan,PRODUCT USE ISSUE,20
sacituzumab govitecan,RED BLOOD CELL COUNT DECREASED,20
eribulin,NEUTROPENIA,850
eribulin,MALIGNANT NEOPLASM PROGRESSION,746
eribulin,FEBRILE NEUTROPENIA,531
eribulin,MYELOSUPPRESSION,418
eribulin,NEUROPATHY PERIPHERAL,378
eribulin,DISEASE PROGRESSION,339
eribulin,PYREXIA,325
eribulin,FATIGUE,304
eribulin,NEUTROPHIL COUNT DECREASED,264
eribulin,NAUSEA,262
eribulin,LEUKOPENIA,257
eribulin,ANAEMIA,246
eribulin,WHITE BLOOD CELL COUNT DECREASED,246
eribulin,METASTASES TO LIVER,236
eribulin,ASTHENIA,218
eribulin,INTERSTITIAL LUNG DISEASE,217
eribulin,DIARRHOEA,210
eribulin,METASTASES TO BONE,209
eribulin,THROMBOCYTOPENIA,209
eribulin,DECREASED APPETITE,208
eribulin,BREAST CANCER METASTATIC,197
eribulin,DYSPNOEA,186
eribulin,PNEUMONIA,184
eribulin,BREAST CANCER,173
eribulin,VOMITING,170
eribulin,STOMATITIS,162
eribulin,ALOPECIA,159
eribulin,OFF LABEL USE,144
eribulin,DEATH,141
eribulin,MUCOSAL INFLAMMATION,136
eribulin,NEOPLASM PROGRESSION,132
eribulin,DRUG INEFFECTIVE,129
eribulin,PLEURAL EFFUSION,127
eribulin,MALAISE,124
eribulin,HEADACHE,119
eribulin,SEPSIS,115
eribulin,PLATELET COUNT DECREASED,111
eribulin,COUGH,109
eribulin,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,108
eribulin,METASTASES TO LUNG,102
eribulin,RASH,94
eribulin,ABDOMINAL PAIN,92
eribulin,CONSTIPATION,89
eribulin,OSTEONECROSIS OF JAW,89
eribulin,METASTASES TO CENTRAL NERVOUS SYSTEM,88
eribulin,PULMONARY EMBOLISM,83
eribulin,DRUG INTOLERANCE,78
eribulin,PAIN,78
eribulin,PANCYTOPENIA,76
eribulin,ASPARTATE AMINOTRANSFERASE INCREASED,75
eribulin,GENERAL PHYSICAL HEALTH DETERIORATION,75
eribulin,URINARY TRACT INFECTION,74
eribulin,ALANINE AMINOTRANSFERASE INCREASED,72
eribulin,WEIGHT DECREASED,72
eribulin,BACK PAIN,70
eribulin,METASTASES TO LYMPH NODES,70
eribulin,CARDIAC FAILURE,67
eribulin,HYPOAESTHESIA,67
eribulin,ASCITES,65
eribulin,HAEMATOTOXICITY,65
eribulin,PNEUMONITIS,64
eribulin,HEPATIC FUNCTION ABNORMAL,60
eribulin,PAIN IN EXTREMITY,59
eribulin,DIZZINESS,55
eribulin,BONE PAIN,54
eribulin,ARTHRALGIA,53
eribulin,HYPERGLYCAEMIA,53
eribulin,PSEUDOCIRRHOSIS,52
eribulin,ELECTROCARDIOGRAM QT PROLONGED,51
eribulin,ACUTE KIDNEY INJURY,49
eribulin,HYPOKALAEMIA,49
eribulin,PNEUMOTHORAX,49
eribulin,LYMPHOPENIA,48
eribulin,DEHYDRATION,46
eribulin,HEPATIC FAILURE,46
eribulin,TREMOR,46
eribulin,COLITIS,45
eribulin,POLYNEUROPATHY,44
eribulin,OEDEMA PERIPHERAL,43
eribulin,CHILLS,41
eribulin,PALPITATIONS,40
eribulin,DYSPHONIA,39
eribulin,CONDITION AGGRAVATED,38
eribulin,DYSPEPSIA,38
eribulin,EPISTAXIS,38
eribulin,RESPIRATORY FAILURE,38
eribulin,BLOOD CREATININE INCREASED,37
eribulin,HAEMOGLOBIN DECREASED,37
eribulin,JAUNDICE,37
eribulin,PROTEIN TOTAL INCREASED,37
eribulin,RASH PRURITIC,37
eribulin,BREAST CANCER RECURRENT,36
eribulin,INFECTION,36
eribulin,BLOOD BILIRUBIN INCREASED,35
eribulin,CELLULITIS,35
eribulin,FALL,35
eribulin,HYPERTENSION,35
eribulin,HYPONATRAEMIA,34
eribulin,IMMUNOSUPPRESSION,34
eribulin,METASTASES TO SKIN,32
paclitaxel,NAUSEA,6239
paclitaxel,DYSPNOEA,6208
paclitaxel,DIARRHOEA,5687
paclitaxel,NEUTROPENIA,5545
paclitaxel,DEATH,5195
paclitaxel,OFF LABEL USE,5099
paclitaxel,FATIGUE,4875
paclitaxel,ANAEMIA,4870
paclitaxel,MALIGNANT NEOPLASM PROGRESSION,4430
paclitaxel,VOMITING,4352
paclitaxel,PYREXIA,4134
paclitaxel,NEUROPATHY PERIPHERAL,4083
paclitaxel,DISEASE PROGRESSION,4049
paclitaxel,FEBRILE NEUTROPENIA,3803
paclitaxel,ASTHENIA,3224
paclitaxel,THROMBOCYTOPENIA,3110
paclitaxel,ALOPECIA,2800
paclitaxel,ERYTHEMA,2674
paclitaxel,DRUG INEFFECTIVE,2628
paclitaxel,RASH,2538
paclitaxel,DECREASED APPETITE,2466
paclitaxel,PNEUMONIA,2431
paclitaxel,ABDOMINAL PAIN,2348
paclitaxel,HYPERTENSION,2231
paclitaxel,BACK PAIN,2143
paclitaxel,MYELOSUPPRESSION,2104
paclitaxel,NEUTROPHIL COUNT DECREASED,2094
paclitaxel,HYPOTENSION,1977
paclitaxel,WHITE BLOOD CELL COUNT DECREASED,1965
paclitaxel,LEUKOPENIA,1940
paclitaxel,PAIN,1933
paclitaxel,MALAISE,1923
paclitaxel,GENERAL PHYSICAL HEALTH DETERIORATION,1921
paclitaxel,HYPERSENSITIVITY,1831
paclitaxel,FLUSHING,1819
paclitaxel,DEHYDRATION,1777
paclitaxel,COUGH,1766
paclitaxel,CONSTIPATION,1752
paclitaxel,PLATELET COUNT DECREASED,1717
paclitaxel,SEPSIS,1650
paclitaxel,INTERSTITIAL LUNG DISEASE,1647
paclitaxel,INFUSION RELATED REACTION,1504
paclitaxel,DIZZINESS,1482
paclitaxel,CHEST DISCOMFORT,1458
paclitaxel,ARTHRALGIA,1422
paclitaxel,PLEURAL EFFUSION,1361
paclitaxel,CHEST PAIN,1355
paclitaxel,PULMONARY EMBOLISM,1339
paclitaxel,PNEUMONITIS,1335
paclitaxel,ACUTE KIDNEY INJURY,1327
paclitaxel,NEOPLASM PROGRESSION,1320
paclitaxel,HEADACHE,1319
paclitaxel,METASTASES TO LIVER,1289
paclitaxel,PRURITUS,1265
paclitaxel,MUCOSAL INFLAMMATION,1254
paclitaxel,PANCYTOPENIA,1252
paclitaxel,PARAESTHESIA,1234
paclitaxel,TACHYCARDIA,1227
paclitaxel,PRODUCT USE IN UNAPPROVED INDICATION,1218
paclitaxel,WEIGHT DECREASED,1202
paclitaxel,METASTASES TO BONE,1141
paclitaxel,EPISTAXIS,1130
paclitaxel,HAEMOGLOBIN DECREASED,1070
paclitaxel,URINARY TRACT INFECTION,1062
paclitaxel,STOMATITIS,1061
paclitaxel,HYPOKALAEMIA,1056
paclitaxel,INFECTION,1036
paclitaxel,OXYGEN SATURATION DECREASED,1015
paclitaxel,MYALGIA,996
paclitaxel,OEDEMA PERIPHERAL,982
paclitaxel,ALANINE AMINOTRANSFERASE INCREASED,954
paclitaxel,RESPIRATORY FAILURE,953
paclitaxel,PAIN IN EXTREMITY,952
paclitaxel,CHILLS,897
paclitaxel,HYPOAESTHESIA,896
paclitaxel,ASCITES,888
paclitaxel,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,882
paclitaxel,HYPOXIA,879
paclitaxel,BREAST CANCER METASTATIC,875
paclitaxel,HYPONATRAEMIA,871
paclitaxel,CARDIAC FAILURE,837
paclitaxel,NEUROTOXICITY,831
paclitaxel,LOSS OF CONSCIOUSNESS,830
paclitaxel,ASPARTATE AMINOTRANSFERASE INCREASED,822
paclitaxel,CONDITION AGGRAVATED,811
paclitaxel,METASTASES TO LUNG,803
paclitaxel,HYPERHIDROSIS,800
paclitaxel,BREAST CANCER,799
paclitaxel,POLYNEUROPATHY,797
paclitaxel,ABDOMINAL PAIN UPPER,795
paclitaxel,BONE MARROW FAILURE,793
paclitaxel,ANAPHYLACTIC REACTION,790
paclitaxel,SEPTIC SHOCK,789
paclitaxel,BONE PAIN,784
paclitaxel,METASTASES TO CENTRAL NERVOUS SYSTEM,767
paclitaxel,FEELING HOT,760
paclitaxel,DYSPHAGIA,752
paclitaxel,DEEP VEIN THROMBOSIS,736
paclitaxel,TOXICITY TO VARIOUS AGENTS,734
paclitaxel,HEPATIC FUNCTION ABNORMAL,733
sodium chloride,DEATH,23695
sodium chloride,DRUG INEFFECTIVE,21343
sodium chloride,OFF LABEL USE,18794
sodium chloride,NAUSEA,16809
sodium chloride,DYSPNOEA,16196
sodium chloride,FATIGUE,15848
sodium chloride,VOMITING,14286
sodium chloride,DIARRHOEA,14031
sodium chloride,PYREXIA,13312
sodium chloride,PNEUMONIA,12894
sodium chloride,HYPOTENSION,12711
sodium chloride,PAIN,12596
sodium chloride,HEADACHE,12327
sodium chloride,SEIZURE,10446
sodium chloride,ASTHENIA,10233
sodium chloride,MALAISE,9900
sodium chloride,DIZZINESS,9816
sodium chloride,FALL,9536
sodium chloride,RASH,9312
sodium chloride,CONDITION AGGRAVATED,8814
sodium chloride,ABDOMINAL PAIN,8557
sodium chloride,HYPERTENSION,7887
sodium chloride,INFECTION,7687
sodium chloride,ARTHRALGIA,7556
sodium chloride,PERITONITIS,7515
sodium chloride,PRURITUS,7363
sodium chloride,WEIGHT DECREASED,7244
sodium chloride,DEHYDRATION,7170
sodium chloride,COUGH,6794
sodium chloride,WEIGHT INCREASED,6553
sodium chloride,CONSTIPATION,6461
sodium chloride,ANAEMIA,6448
sodium chloride,ACUTE KIDNEY INJURY,6425
sodium chloride,PERIPHERAL SWELLING,6375
sodium chloride,CONFUSIONAL STATE,6371
sodium chloride,DECREASED APPETITE,6344
sodium chloride,GENERAL PHYSICAL HEALTH DETERIORATION,6170
sodium chloride,SEPSIS,6100
sodium chloride,NASOPHARYNGITIS,5777
sodium chloride,DRUG INTERACTION,5649
sodium chloride,CHEST PAIN,5558
sodium chloride,ANXIETY,5494
sodium chloride,SWELLING,5365
sodium chloride,MUSCLE SPASMS,5359
sodium chloride,PAIN IN EXTREMITY,5347
sodium chloride,URINARY TRACT INFECTION,5314
sodium chloride,PERITONITIS BACTERIAL,5297
sodium chloride,BACK PAIN,5205
sodium chloride,MATERNAL EXPOSURE DURING PREGNANCY,5191
sodium chloride,ABDOMINAL DISTENSION,5122
sodium chloride,SINUSITIS,5100
sodium chloride,HYPERSENSITIVITY,5054
sodium chloride,DRUG HYPERSENSITIVITY,4927
sodium chloride,ABDOMINAL DISCOMFORT,4847
sodium chloride,SOMNOLENCE,4841
sodium chloride,ABDOMINAL PAIN UPPER,4786
sodium chloride,CARDIAC ARREST,4712
sodium chloride,PERITONEAL DIALYSIS COMPLICATION,4683
sodium chloride,MYOCARDIAL INFARCTION,4659
sodium chloride,INSOMNIA,4642
sodium chloride,PRODUCT USE IN UNAPPROVED INDICATION,4599
sodium chloride,FLUID OVERLOAD,4532
sodium chloride,THROMBOCYTOPENIA,4523
sodium chloride,INFUSION RELATED REACTION,4440
sodium chloride,BLOOD PRESSURE INCREASED,4147
sodium chloride,COVID-19,4122
sodium chloride,RENAL FAILURE,4038
sodium chloride,PRODUCT USE ISSUE,4010
sodium chloride,JOINT SWELLING,3940
sodium chloride,OEDEMA PERIPHERAL,3937
sodium chloride,WHITE BLOOD CELL COUNT DECREASED,3868
sodium chloride,CEREBROVASCULAR ACCIDENT,3839
sodium chloride,ALOPECIA,3819
sodium chloride,DEPRESSION,3797
sodium chloride,GAIT DISTURBANCE,3688
sodium chloride,ERYTHEMA,3675
sodium chloride,URTICARIA,3665
sodium chloride,MYELOSUPPRESSION,3635
sodium chloride,CHILLS,3624
sodium chloride,TOXICITY TO VARIOUS AGENTS,3560
sodium chloride,FLUID RETENTION,3551
sodium chloride,HYPONATRAEMIA,3502
sodium chloride,PRODUCT DOSE OMISSION ISSUE,3492
sodium chloride,TREMOR,3477
sodium chloride,HAEMOGLOBIN DECREASED,3447
sodium chloride,DRUG INTOLERANCE,3439
sodium chloride,EPILEPSY,3416
sodium chloride,DISCOMFORT,3370
sodium chloride,LOSS OF CONSCIOUSNESS,3349
sodium chloride,ASTHMA,3315
sodium chloride,RESPIRATORY FAILURE,3267
sodium chloride,GASTROINTESTINAL DISORDER,3262
sodium chloride,RHEUMATOID ARTHRITIS,3239
sodium chloride,CONTUSION,3236
sodium chloride,HYPOAESTHESIA,3197
sodium chloride,FOETAL EXPOSURE DURING PREGNANCY,3192
sodium chloride,TACHYCARDIA,3189
sodium chloride,CARDIAC FAILURE,3175
sodium chloride,CHEST DISCOMFORT,3152
sodium chloride,PLATELET COUNT DECREASED,3130
encorafenib,DEATH,931
encorafenib,OFF LABEL USE,915
encorafenib,NAUSEA,715
encorafenib,FATIGUE,637
encorafenib,NEOPLASM PROGRESSION,553
encorafenib,DIARRHOEA,539
encorafenib,PRODUCT USE IN UNAPPROVED INDICATION,517
encorafenib,PYREXIA,513
encorafenib,VOMITING,408
encorafenib,RASH,405
encorafenib,SEROUS RETINAL DETACHMENT,256
encorafenib,ARTHRALGIA,254
encorafenib,DECREASED APPETITE,242
encorafenib,MALAISE,242
encorafenib,DISEASE PROGRESSION,237
encorafenib,ASTHENIA,205
encorafenib,VISION BLURRED,200
encorafenib,PAIN,193
encorafenib,CONSTIPATION,180
encorafenib,ACUTE KIDNEY INJURY,176
encorafenib,HEADACHE,173
encorafenib,VISUAL IMPAIRMENT,157
encorafenib,ABDOMINAL PAIN,155
encorafenib,ANAEMIA,155
encorafenib,PRURITUS,144
encorafenib,MALIGNANT NEOPLASM PROGRESSION,135
encorafenib,MYALGIA,135
encorafenib,DYSPNOEA,129
encorafenib,CHILLS,117
encorafenib,DEHYDRATION,113
encorafenib,COLITIS,112
encorafenib,DIZZINESS,111
encorafenib,WEIGHT DECREASED,111
encorafenib,DRUG INEFFECTIVE,107
encorafenib,SECOND PRIMARY MALIGNANCY,102
encorafenib,ABDOMINAL PAIN UPPER,100
encorafenib,DYSPHAGIA,94
encorafenib,ILLNESS,94
encorafenib,HYPOTENSION,93
encorafenib,RENAL IMPAIRMENT,88
encorafenib,PAIN IN EXTREMITY,86
encorafenib,ALOPECIA,85
encorafenib,BACK PAIN,84
encorafenib,BLOOD CREATINE PHOSPHOKINASE INCREASED,84
encorafenib,PRODUCT USE ISSUE,83
encorafenib,SEIZURE,83
encorafenib,RETINAL DETACHMENT,78
encorafenib,ALANINE AMINOTRANSFERASE INCREASED,77
encorafenib,ABDOMINAL DISCOMFORT,75
encorafenib,BLOOD CREATININE INCREASED,75
encorafenib,PERIPHERAL SWELLING,73
encorafenib,RENAL FAILURE,73
encorafenib,ASPARTATE AMINOTRANSFERASE INCREASED,72
encorafenib,LIVER DISORDER,72
encorafenib,NEUROPATHY PERIPHERAL,72
encorafenib,URINARY TRACT INFECTION,70
encorafenib,PNEUMONIA,69
encorafenib,UVEITIS,69
encorafenib,GENERAL PHYSICAL HEALTH DETERIORATION,67
encorafenib,HEPATIC FUNCTION ABNORMAL,66
encorafenib,COVID-19,65
encorafenib,FALL,65
encorafenib,HOSPICE CARE,64
encorafenib,DRY SKIN,63
encorafenib,PRODUCT DOSE OMISSION,63
encorafenib,MUSCLE SPASMS,61
encorafenib,THERAPY INTERRUPTED,61
encorafenib,HYPOACUSIS,60
encorafenib,SEPSIS,60
encorafenib,PRODUCT DOSE OMISSION ISSUE,59
encorafenib,DERMATITIS ACNEIFORM,58
encorafenib,DRUG INTOLERANCE,58
encorafenib,CONFUSIONAL STATE,57
encorafenib,HEPATIC ENZYME INCREASED,57
encorafenib,INSOMNIA,57
encorafenib,HYPERTENSION,55
encorafenib,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,53
encorafenib,ERYTHEMA,52
encorafenib,COUGH,51
encorafenib,HYPERSENSITIVITY,51
encorafenib,SEROUS RETINOPATHY,51
encorafenib,RASH MACULO-PAPULAR,50
encorafenib,INFECTION,49
encorafenib,MEMORY IMPAIRMENT,48
encorafenib,SOMNOLENCE,48
encorafenib,ACNE,47
encorafenib,INTERSTITIAL LUNG DISEASE,47
encorafenib,CONDITION AGGRAVATED,46
encorafenib,HEPATITIS,46
encorafenib,RENAL DISORDER,46
encorafenib,INTESTINAL OBSTRUCTION,44
encorafenib,MELANOCYTIC NAEVUS,44
encorafenib,MUSCULAR WEAKNESS,44
encorafenib,PANCREATITIS,44
encorafenib,GAMMA-GLUTAMYLTRANSFERASE INCREASED,42
encorafenib,THERAPY CESSATION,41
encorafenib,EYE DISORDER,40
encorafenib,UNDERDOSE,40
encorafenib,C-REACTIVE PROTEIN INCREASED,39
encorafenib,CEREBROVASCULAR ACCIDENT,39
everolimus,DEATH,6417
everolimus,MALIGNANT NEOPLASM PROGRESSION,4474
everolimus,DIARRHOEA,4059
everolimus,FATIGUE,3738
everolimus,STOMATITIS,3176
everolimus,NAUSEA,2771
everolimus,DYSPNOEA,2660
everolimus,DRUG INEFFECTIVE,2429
everolimus,PYREXIA,2264
everolimus,VOMITING,2115
everolimus,DECREASED APPETITE,2072
everolimus,RASH,1939
everolimus,COUGH,1923
everolimus,WEIGHT DECREASED,1904
everolimus,MALAISE,1903
everolimus,ASTHENIA,1901
everolimus,PNEUMONIA,1731
everolimus,OFF LABEL USE,1604
everolimus,PAIN,1575
everolimus,DISEASE PROGRESSION,1504
everolimus,ANAEMIA,1499
everolimus,HEADACHE,1372
everolimus,ABDOMINAL PAIN,1207
everolimus,PRODUCT USE IN UNAPPROVED INDICATION,1169
everolimus,METASTASES TO LIVER,1162
everolimus,PNEUMONITIS,1161
everolimus,DEHYDRATION,1103
everolimus,GENERAL PHYSICAL HEALTH DETERIORATION,1055
everolimus,OEDEMA PERIPHERAL,1046
everolimus,NEOPLASM PROGRESSION,1037
everolimus,PLEURAL EFFUSION,1029
everolimus,BLOOD PRESSURE INCREASED,1012
everolimus,HYPERTENSION,1007
everolimus,METASTASES TO BONE,984
everolimus,DIZZINESS,954
everolimus,ARTHRALGIA,921
everolimus,PRURITUS,879
everolimus,PERIPHERAL SWELLING,867
everolimus,BACK PAIN,851
everolimus,HAEMOGLOBIN DECREASED,834
everolimus,ABDOMINAL PAIN UPPER,830
everolimus,CONSTIPATION,822
everolimus,BLOOD GLUCOSE INCREASED,812
everolimus,BLOOD CREATININE INCREASED,805
everolimus,THROMBOCYTOPENIA,794
everolimus,PAIN IN EXTREMITY,790
everolimus,RENAL IMPAIRMENT,788
everolimus,ACUTE KIDNEY INJURY,785
everolimus,NEOPLASM MALIGNANT,764
everolimus,EPISTAXIS,763
everolimus,ORAL PAIN,749
everolimus,INTERSTITIAL LUNG DISEASE,746
everolimus,URINARY TRACT INFECTION,744
everolimus,PLATELET COUNT DECREASED,725
everolimus,RENAL FAILURE,725
everolimus,MUCOSAL INFLAMMATION,724
everolimus,DRUG INTERACTION,722
everolimus,BREAST CANCER METASTATIC,684
everolimus,BREAST CANCER,682
everolimus,SEIZURE,673
everolimus,NEUTROPENIA,655
everolimus,METASTASES TO LUNG,652
everolimus,HYPERGLYCAEMIA,613
everolimus,MOUTH ULCERATION,612
everolimus,CHEST PAIN,596
everolimus,FALL,587
everolimus,TOXICITY TO VARIOUS AGENTS,576
everolimus,LUNG DISORDER,565
everolimus,INFECTION,562
everolimus,DRUG INTOLERANCE,551
everolimus,NASOPHARYNGITIS,539
everolimus,ASCITES,531
everolimus,DIABETES MELLITUS,521
everolimus,SEPSIS,511
everolimus,ABDOMINAL DISCOMFORT,509
everolimus,HYPOTENSION,505
everolimus,INSOMNIA,495
everolimus,ERYTHEMA,491
everolimus,BLOOD CHOLESTEROL INCREASED,477
everolimus,ACNE,469
everolimus,PRODUCT USE ISSUE,469
everolimus,WHITE BLOOD CELL COUNT DECREASED,463
everolimus,DYSGEUSIA,451
everolimus,ABDOMINAL DISTENSION,449
everolimus,FEELING ABNORMAL,446
everolimus,RESPIRATORY FAILURE,441
everolimus,GAIT DISTURBANCE,429
everolimus,DRY SKIN,427
everolimus,COVID-19,418
everolimus,DYSPHAGIA,411
everolimus,OEDEMA,410
everolimus,OSTEONECROSIS OF JAW,409
everolimus,OROPHARYNGEAL PAIN,408
everolimus,CONFUSIONAL STATE,406
everolimus,ALOPECIA,403
everolimus,PULMONARY EMBOLISM,401
everolimus,C-REACTIVE PROTEIN INCREASED,400
everolimus,BONE PAIN,398
everolimus,ANXIETY,396
everolimus,CHILLS,396
vinorelbine,NEUTROPENIA,1032
vinorelbine,DISEASE PROGRESSION,1020
vinorelbine,MALIGNANT NEOPLASM PROGRESSION,1010
vinorelbine,OFF LABEL USE,963
vinorelbine,NAUSEA,834
vinorelbine,DIARRHOEA,772
vinorelbine,FATIGUE,714
vinorelbine,DEATH,626
vinorelbine,VOMITING,626
vinorelbine,ANAEMIA,587
vinorelbine,FEBRILE NEUTROPENIA,582
vinorelbine,PYREXIA,566
vinorelbine,DRUG INEFFECTIVE,558
vinorelbine,DYSPNOEA,549
vinorelbine,THROMBOCYTOPENIA,504
vinorelbine,ASTHENIA,462
vinorelbine,NEUROPATHY PERIPHERAL,355
vinorelbine,COUGH,339
vinorelbine,DECREASED APPETITE,338
vinorelbine,PNEUMONIA,335
vinorelbine,CONSTIPATION,327
vinorelbine,METASTASES TO LIVER,323
vinorelbine,METASTASES TO BONE,322
vinorelbine,BREAST CANCER METASTATIC,314
vinorelbine,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,310
vinorelbine,PRODUCT USE IN UNAPPROVED INDICATION,305
vinorelbine,NEOPLASM PROGRESSION,300
vinorelbine,PLEURAL EFFUSION,293
vinorelbine,PAIN,292
vinorelbine,MUCOSAL INFLAMMATION,280
vinorelbine,LEUKOPENIA,274
vinorelbine,RASH,269
vinorelbine,BREAST CANCER,253
vinorelbine,HEADACHE,244
vinorelbine,GENERAL PHYSICAL HEALTH DETERIORATION,243
vinorelbine,METASTASES TO LUNG,239
vinorelbine,WEIGHT DECREASED,231
vinorelbine,SEPSIS,219
vinorelbine,ALOPECIA,218
vinorelbine,ABDOMINAL PAIN,215
vinorelbine,METASTASES TO CENTRAL NERVOUS SYSTEM,213
vinorelbine,PULMONARY EMBOLISM,212
vinorelbine,PANCYTOPENIA,203
vinorelbine,DIZZINESS,192
vinorelbine,WHITE BLOOD CELL COUNT DECREASED,190
vinorelbine,STOMATITIS,188
vinorelbine,INFECTION,185
vinorelbine,NEUTROPENIC SEPSIS,183
vinorelbine,BONE MARROW FAILURE,178
vinorelbine,METASTASES TO LYMPH NODES,171
vinorelbine,ASCITES,170
vinorelbine,MALAISE,169
vinorelbine,INTERSTITIAL LUNG DISEASE,167
vinorelbine,HAEMATOTOXICITY,166
vinorelbine,ACUTE KIDNEY INJURY,164
vinorelbine,BACK PAIN,164
vinorelbine,OSTEONECROSIS OF JAW,163
vinorelbine,PNEUMONITIS,154
vinorelbine,ALANINE AMINOTRANSFERASE INCREASED,148
vinorelbine,DEHYDRATION,148
vinorelbine,EJECTION FRACTION DECREASED,146
vinorelbine,CHEST PAIN,143
vinorelbine,HYPERTENSION,141
vinorelbine,PAIN IN EXTREMITY,141
vinorelbine,MYELOSUPPRESSION,140
vinorelbine,CONDITION AGGRAVATED,135
vinorelbine,DRUG INTOLERANCE,131
vinorelbine,PARAESTHESIA,131
vinorelbine,TOXICITY TO VARIOUS AGENTS,129
vinorelbine,SEPTIC SHOCK,125
vinorelbine,ERYTHEMA,124
vinorelbine,ARTHRALGIA,121
vinorelbine,BONE PAIN,120
vinorelbine,OEDEMA PERIPHERAL,120
vinorelbine,PRURITUS,120
vinorelbine,RESPIRATORY FAILURE,120
vinorelbine,ASPARTATE AMINOTRANSFERASE INCREASED,119
vinorelbine,PLATELET COUNT DECREASED,116
vinorelbine,NEUTROPHIL COUNT DECREASED,115
vinorelbine,DISEASE RECURRENCE,113
vinorelbine,HYPOKALAEMIA,113
vinorelbine,HYPOAESTHESIA,112
vinorelbine,HYPERSENSITIVITY,111
vinorelbine,HYPOTENSION,108
vinorelbine,DYSPNOEA EXERTIONAL,106
vinorelbine,HAEMOGLOBIN DECREASED,103
vinorelbine,CONFUSIONAL STATE,102
vinorelbine,OSTEONECROSIS,102
vinorelbine,DYSPHAGIA,98
vinorelbine,BLOOD LACTATE DEHYDROGENASE INCREASED,97
vinorelbine,DRUG RESISTANCE,97
vinorelbine,HEPATOTOXICITY,96
vinorelbine,CARDIAC FAILURE,95
vinorelbine,PERIPHERAL SWELLING,95
vinorelbine,DYSPEPSIA,94
vinorelbine,CHILLS,91
vinorelbine,POLYNEUROPATHY,91
vinorelbine,BLOOD CREATININE INCREASED,89
vinorelbine,EPISTAXIS,87
vinorelbine,ABDOMINAL PAIN UPPER,86
pemetrexed,MALIGNANT NEOPLASM PROGRESSION,2860
pemetrexed,OFF LABEL USE,1965
pemetrexed,ANAEMIA,1893
pemetrexed,NAUSEA,1735
pemetrexed,DIARRHOEA,1630
pemetrexed,DEATH,1599
pemetrexed,NEUTROPENIA,1521
pemetrexed,PANCYTOPENIA,1476
pemetrexed,THROMBOCYTOPENIA,1449
pemetrexed,FATIGUE,1317
pemetrexed,VOMITING,1303
pemetrexed,DISEASE PROGRESSION,1261
pemetrexed,DYSPNOEA,1228
pemetrexed,PYREXIA,1165
pemetrexed,PNEUMONIA,1124
pemetrexed,FEBRILE NEUTROPENIA,1116
pemetrexed,RASH,1082
pemetrexed,ACUTE KIDNEY INJURY,1057
pemetrexed,ASTHENIA,1043
pemetrexed,DECREASED APPETITE,940
pemetrexed,DRUG INEFFECTIVE,927
pemetrexed,GENERAL PHYSICAL HEALTH DETERIORATION,884
pemetrexed,INTERSTITIAL LUNG DISEASE,771
pemetrexed,PLATELET COUNT DECREASED,663
pemetrexed,RENAL FAILURE,642
pemetrexed,DEHYDRATION,633
pemetrexed,PNEUMONITIS,629
pemetrexed,SEPSIS,617
pemetrexed,PLEURAL EFFUSION,614
pemetrexed,PULMONARY EMBOLISM,587
pemetrexed,CONSTIPATION,572
pemetrexed,LEUKOPENIA,569
pemetrexed,NEOPLASM PROGRESSION,534
pemetrexed,MYELOSUPPRESSION,526
pemetrexed,WHITE BLOOD CELL COUNT DECREASED,523
pemetrexed,RESPIRATORY FAILURE,512
pemetrexed,MUCOSAL INFLAMMATION,511
pemetrexed,RENAL IMPAIRMENT,476
pemetrexed,NEUTROPHIL COUNT DECREASED,445
pemetrexed,BONE MARROW FAILURE,434
pemetrexed,BLOOD CREATININE INCREASED,431
pemetrexed,TUBULOINTERSTITIAL NEPHRITIS,420
pemetrexed,MALAISE,417
pemetrexed,COUGH,414
pemetrexed,HAEMOGLOBIN DECREASED,403
pemetrexed,HYPOTENSION,400
pemetrexed,WEIGHT DECREASED,389
pemetrexed,ABDOMINAL PAIN,378
pemetrexed,PAIN,378
pemetrexed,DIZZINESS,377
pemetrexed,OEDEMA PERIPHERAL,377
pemetrexed,SEPTIC SHOCK,369
pemetrexed,HYPERTENSION,357
pemetrexed,HEADACHE,355
pemetrexed,COLITIS,349
pemetrexed,PRURITUS,347
pemetrexed,ERYTHEMA,331
pemetrexed,EPISTAXIS,329
pemetrexed,CONDITION AGGRAVATED,325
pemetrexed,THERAPY PARTIAL RESPONDER,317
pemetrexed,HYPOKALAEMIA,315
pemetrexed,CHEST PAIN,310
pemetrexed,INFECTION,310
pemetrexed,HAEMOPTYSIS,307
pemetrexed,STOMATITIS,306
pemetrexed,NON-SMALL CELL LUNG CANCER,300
pemetrexed,ALANINE AMINOTRANSFERASE INCREASED,298
pemetrexed,ATRIAL FIBRILLATION,296
pemetrexed,DRUG RESISTANCE,296
pemetrexed,PRODUCT USE IN UNAPPROVED INDICATION,294
pemetrexed,HYPONATRAEMIA,291
pemetrexed,ASPARTATE AMINOTRANSFERASE INCREASED,285
pemetrexed,HYPOTHYROIDISM,271
pemetrexed,METASTASES TO CENTRAL NERVOUS SYSTEM,271
pemetrexed,NEUROPATHY PERIPHERAL,270
pemetrexed,HAEMATOTOXICITY,268
pemetrexed,TOXICITY TO VARIOUS AGENTS,266
pemetrexed,BACK PAIN,261
pemetrexed,HEPATIC FUNCTION ABNORMAL,261
pemetrexed,DYSPHAGIA,252
pemetrexed,CONFUSIONAL STATE,249
pemetrexed,DEEP VEIN THROMBOSIS,248
pemetrexed,ARTHRALGIA,239
pemetrexed,HEPATITIS,239
pemetrexed,FEBRILE BONE MARROW APLASIA,225
pemetrexed,RASH MACULO-PAPULAR,225
pemetrexed,RENAL FAILURE ACUTE,217
pemetrexed,LUNG DISORDER,208
pemetrexed,PERICARDIAL EFFUSION,207
pemetrexed,RENAL TUBULAR NECROSIS,204
pemetrexed,DRUG INTERACTION,202
pemetrexed,MYOCARDIAL INFARCTION,201
pemetrexed,C-REACTIVE PROTEIN INCREASED,199
pemetrexed,HEPATIC CYTOLYSIS,198
pemetrexed,HEPATOTOXICITY,198
pemetrexed,CARDIAC FAILURE,196
pemetrexed,CEREBROVASCULAR ACCIDENT,196
pemetrexed,TACHYCARDIA,196
pemetrexed,HEPATOCELLULAR INJURY,186
pemetrexed,HYPERSENSITIVITY,186
binimetinib,OFF LABEL USE,846
binimetinib,DEATH,670
binimetinib,NAUSEA,629
binimetinib,FATIGUE,534
binimetinib,PRODUCT USE IN UNAPPROVED INDICATION,516
binimetinib,DIARRHOEA,497
binimetinib,PYREXIA,477
binimetinib,NEOPLASM PROGRESSION,392
binimetinib,VOMITING,365
binimetinib,RASH,360
binimetinib,SEROUS RETINAL DETACHMENT,258
binimetinib,DISEASE PROGRESSION,205
binimetinib,ARTHRALGIA,196
binimetinib,VISION BLURRED,193
binimetinib,DECREASED APPETITE,191
binimetinib,MALAISE,186
binimetinib,CONSTIPATION,156
binimetinib,VISUAL IMPAIRMENT,149
binimetinib,ASTHENIA,148
binimetinib,ACUTE KIDNEY INJURY,146
binimetinib,ANAEMIA,139
binimetinib,PAIN,138
binimetinib,HEADACHE,132
binimetinib,ABDOMINAL PAIN,123
binimetinib,DYSPNOEA,120
binimetinib,MALIGNANT NEOPLASM PROGRESSION,118
binimetinib,COLITIS,115
binimetinib,MYALGIA,115
binimetinib,PRURITUS,113
binimetinib,CHILLS,101
binimetinib,DIZZINESS,98
binimetinib,BLOOD CREATINE PHOSPHOKINASE INCREASED,95
binimetinib,DEHYDRATION,90
binimetinib,DRUG INEFFECTIVE,89
binimetinib,HYPOTENSION,87
binimetinib,ABDOMINAL PAIN UPPER,85
binimetinib,WEIGHT DECREASED,84
binimetinib,ALANINE AMINOTRANSFERASE INCREASED,80
binimetinib,ALOPECIA,80
binimetinib,SEIZURE,80
binimetinib,RENAL IMPAIRMENT,75
binimetinib,RETINAL DETACHMENT,73
binimetinib,ASPARTATE AMINOTRANSFERASE INCREASED,71
binimetinib,LIVER DISORDER,71
binimetinib,BLOOD CREATININE INCREASED,69
binimetinib,URINARY TRACT INFECTION,69
binimetinib,ABDOMINAL DISCOMFORT,67
binimetinib,HEPATIC FUNCTION ABNORMAL,66
binimetinib,PERIPHERAL SWELLING,65
binimetinib,PRODUCT DOSE OMISSION,65
binimetinib,SECOND PRIMARY MALIGNANCY,64
binimetinib,PRODUCT USE ISSUE,62
binimetinib,RENAL FAILURE,62
binimetinib,BACK PAIN,61
binimetinib,DYSPHAGIA,61
binimetinib,ILLNESS,61
binimetinib,CONFUSIONAL STATE,60
binimetinib,PAIN IN EXTREMITY,60
binimetinib,PNEUMONIA,60
binimetinib,UVEITIS,58
binimetinib,HYPERTENSION,57
binimetinib,HEPATIC ENZYME INCREASED,56
binimetinib,DRY SKIN,54
binimetinib,NEUROPATHY PERIPHERAL,54
binimetinib,MUSCLE SPASMS,52
binimetinib,SEROUS RETINOPATHY,51
binimetinib,DRUG INTOLERANCE,50
binimetinib,FALL,50
binimetinib,GENERAL PHYSICAL HEALTH DETERIORATION,49
binimetinib,PNEUMONITIS,48
binimetinib,RASH MACULO-PAPULAR,48
binimetinib,HEPATITIS,46
binimetinib,COVID-19,45
binimetinib,MUSCULAR WEAKNESS,45
binimetinib,SEPSIS,45
binimetinib,RENAL DISORDER,44
binimetinib,DERMATITIS ACNEIFORM,43
binimetinib,COUGH,40
binimetinib,PRODUCT DOSE OMISSION ISSUE,40
binimetinib,EYE DISORDER,39
binimetinib,HOSPICE CARE,38
binimetinib,INTERSTITIAL LUNG DISEASE,38
binimetinib,LIVER FUNCTION TEST INCREASED,38
binimetinib,MEMORY IMPAIRMENT,38
binimetinib,ERYTHEMA,37
binimetinib,OEDEMA PERIPHERAL,37
binimetinib,SOMNOLENCE,37
binimetinib,THERAPY INTERRUPTED,37
binimetinib,EJECTION FRACTION DECREASED,36
binimetinib,HYPERSENSITIVITY,36
binimetinib,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,36
binimetinib,RETINOPATHY,36
binimetinib,GAMMA-GLUTAMYLTRANSFERASE INCREASED,35
binimetinib,HYPOTHYROIDISM,35
binimetinib,PANCREATITIS,35
binimetinib,ADVERSE EVENT,34
binimetinib,INFECTION,34
binimetinib,INSOMNIA,34
binimetinib,PLATELET COUNT DECREASED,34
binimetinib,RHABDOMYOLYSIS,34
carboplatin,OFF LABEL USE,7265
carboplatin,NAUSEA,6759
carboplatin,NEUTROPENIA,6734
carboplatin,ANAEMIA,6632
carboplatin,ALOPECIA,6210
carboplatin,FEBRILE NEUTROPENIA,6031
carboplatin,DIARRHOEA,5790
carboplatin,DISEASE PROGRESSION,5516
carboplatin,THROMBOCYTOPENIA,5496
carboplatin,DYSPNOEA,5459
carboplatin,MALIGNANT NEOPLASM PROGRESSION,5411
carboplatin,VOMITING,5045
carboplatin,PYREXIA,4516
carboplatin,FATIGUE,4391
carboplatin,DEATH,4135
carboplatin,DRUG INEFFECTIVE,3699
carboplatin,ASTHENIA,3480
carboplatin,PANCYTOPENIA,3331
carboplatin,PNEUMONIA,3040
carboplatin,RASH,2886
carboplatin,SEPSIS,2635
carboplatin,DECREASED APPETITE,2614
carboplatin,NEUTROPHIL COUNT DECREASED,2582
carboplatin,PLATELET COUNT DECREASED,2480
carboplatin,WHITE BLOOD CELL COUNT DECREASED,2391
carboplatin,PRODUCT USE IN UNAPPROVED INDICATION,2377
carboplatin,ABDOMINAL PAIN,2330
carboplatin,ERYTHEMA,2327
carboplatin,DEHYDRATION,2322
carboplatin,NEUROPATHY PERIPHERAL,2305
carboplatin,HYPOTENSION,2288
carboplatin,ACUTE KIDNEY INJURY,2253
carboplatin,MYELOSUPPRESSION,2250
carboplatin,PAIN,2139
carboplatin,HAIR TEXTURE ABNORMAL,2091
carboplatin,HAIR COLOUR CHANGES,2088
carboplatin,LEUKOPENIA,2066
carboplatin,CONSTIPATION,2055
carboplatin,GENERAL PHYSICAL HEALTH DETERIORATION,2034
carboplatin,HAIR DISORDER,1948
carboplatin,MADAROSIS,1935
carboplatin,MALAISE,1803
carboplatin,PSYCHOLOGICAL TRAUMA,1794
carboplatin,PRURITUS,1792
carboplatin,MUCOSAL INFLAMMATION,1745
carboplatin,COUGH,1637
carboplatin,HYPERTENSION,1596
carboplatin,INTERSTITIAL LUNG DISEASE,1580
carboplatin,HYPERSENSITIVITY,1576
carboplatin,PULMONARY EMBOLISM,1562
carboplatin,INFECTION,1555
carboplatin,ANXIETY,1511
carboplatin,DIZZINESS,1504
carboplatin,HAEMOGLOBIN DECREASED,1498
carboplatin,HYPOKALAEMIA,1493
carboplatin,NEOPLASM PROGRESSION,1488
carboplatin,PLEURAL EFFUSION,1479
carboplatin,RESPIRATORY FAILURE,1334
carboplatin,CHEST PAIN,1328
carboplatin,HEADACHE,1281
carboplatin,WEIGHT DECREASED,1264
carboplatin,PNEUMONITIS,1257
carboplatin,SEPTIC SHOCK,1229
carboplatin,RENAL FAILURE,1223
carboplatin,BACK PAIN,1191
carboplatin,TACHYCARDIA,1184
carboplatin,FLUSHING,1182
carboplatin,BONE MARROW FAILURE,1176
carboplatin,HYPONATRAEMIA,1176
carboplatin,ARTHRALGIA,1146
carboplatin,ATRIAL FIBRILLATION,1142
carboplatin,CONDITION AGGRAVATED,1139
carboplatin,URINARY TRACT INFECTION,1062
carboplatin,COLITIS,1046
carboplatin,DYSPHAGIA,1046
carboplatin,THERAPY PARTIAL RESPONDER,1023
carboplatin,INFUSION RELATED REACTION,1016
carboplatin,RENAL IMPAIRMENT,986
carboplatin,EMOTIONAL DISTRESS,983
carboplatin,TOXICITY TO VARIOUS AGENTS,977
carboplatin,EPISTAXIS,961
carboplatin,ACUTE MYELOID LEUKAEMIA,949
carboplatin,ALANINE AMINOTRANSFERASE INCREASED,946
carboplatin,DEEP VEIN THROMBOSIS,938
carboplatin,PARAESTHESIA,927
carboplatin,HAEMATOTOXICITY,914
carboplatin,STOMATITIS,914
carboplatin,CHILLS,910
carboplatin,NEUTROPENIC SEPSIS,904
carboplatin,CONFUSIONAL STATE,897
carboplatin,OEDEMA PERIPHERAL,888
carboplatin,BLOOD CREATININE INCREASED,883
carboplatin,CHEST DISCOMFORT,876
carboplatin,HYPOTHYROIDISM,859
carboplatin,ASPARTATE AMINOTRANSFERASE INCREASED,821
carboplatin,DISEASE RECURRENCE,818
carboplatin,MYELODYSPLASTIC SYNDROME,816
carboplatin,PAIN IN EXTREMITY,807
carboplatin,SYNCOPE,797
carboplatin,OXYGEN SATURATION DECREASED,794
abiraterone,DEATH,6114
abiraterone,FATIGUE,2334
abiraterone,PROSTATIC SPECIFIC ANTIGEN INCREASED,2001
abiraterone,DRUG INEFFECTIVE,1987
abiraterone,THERAPY CESSATION,1599
abiraterone,DISEASE PROGRESSION,1232
abiraterone,ASTHENIA,1160
abiraterone,HOT FLUSH,1113
abiraterone,OFF LABEL USE,1065
abiraterone,HOSPITALISATION,1064
abiraterone,NAUSEA,969
abiraterone,FALL,906
abiraterone,DIARRHOEA,905
abiraterone,PROSTATE CANCER,848
abiraterone,DIZZINESS,794
abiraterone,DYSPNOEA,778
abiraterone,DECREASED APPETITE,755
abiraterone,HYPERTENSION,740
abiraterone,PNEUMONIA,722
abiraterone,URINARY TRACT INFECTION,715
abiraterone,MALIGNANT NEOPLASM PROGRESSION,712
abiraterone,HYPOKALAEMIA,692
abiraterone,VOMITING,661
abiraterone,ANAEMIA,629
abiraterone,PROSTATE CANCER METASTATIC,625
abiraterone,PAIN,610
abiraterone,WEIGHT DECREASED,581
abiraterone,MALAISE,562
abiraterone,DRUG DOSE OMISSION,557
abiraterone,ARTHRALGIA,537
abiraterone,THERAPY INTERRUPTED,526
abiraterone,OEDEMA PERIPHERAL,516
abiraterone,CONSTIPATION,514
abiraterone,INCORRECT DOSE ADMINISTERED,490
abiraterone,BACK PAIN,488
abiraterone,HEADACHE,459
abiraterone,PERIPHERAL SWELLING,440
abiraterone,DYSPHAGIA,422
abiraterone,ADVERSE EVENT,396
abiraterone,PAIN IN EXTREMITY,395
abiraterone,METASTASES TO BONE,389
abiraterone,ATRIAL FIBRILLATION,387
abiraterone,DEHYDRATION,385
abiraterone,SEPSIS,376
abiraterone,WEIGHT INCREASED,375
abiraterone,PYREXIA,360
abiraterone,MYOCARDIAL INFARCTION,352
abiraterone,BLOOD PRESSURE INCREASED,349
abiraterone,MUSCULAR WEAKNESS,348
abiraterone,DRUG INTERACTION,342
abiraterone,CARDIAC FAILURE,328
abiraterone,GENERAL PHYSICAL HEALTH DETERIORATION,325
abiraterone,ACUTE KIDNEY INJURY,323
abiraterone,THROMBOCYTOPENIA,321
abiraterone,RASH,319
abiraterone,CEREBROVASCULAR ACCIDENT,306
abiraterone,CONFUSIONAL STATE,305
abiraterone,INSOMNIA,299
abiraterone,BLOOD GLUCOSE INCREASED,280
abiraterone,ALANINE AMINOTRANSFERASE INCREASED,261
abiraterone,SYNCOPE,260
abiraterone,CHEST PAIN,257
abiraterone,COVID-19,251
abiraterone,HOSPICE CARE,251
abiraterone,HYPOTENSION,250
abiraterone,BLOOD POTASSIUM DECREASED,246
abiraterone,MYALGIA,243
abiraterone,OSTEONECROSIS OF JAW,243
abiraterone,HAEMATURIA,241
abiraterone,HEPATIC ENZYME INCREASED,241
abiraterone,BONE PAIN,236
abiraterone,ADVERSE DRUG REACTION,233
abiraterone,COUGH,233
abiraterone,FEELING ABNORMAL,228
abiraterone,MUSCLE SPASMS,228
abiraterone,HAEMOGLOBIN DECREASED,227
abiraterone,OEDEMA,227
abiraterone,PLATELET COUNT DECREASED,226
abiraterone,RENAL FAILURE,224
abiraterone,INFECTION,219
abiraterone,RHABDOMYOLYSIS,218
abiraterone,ABDOMINAL PAIN,216
abiraterone,HEPATIC FUNCTION ABNORMAL,213
abiraterone,ABDOMINAL DISCOMFORT,210
abiraterone,GAIT DISTURBANCE,206
abiraterone,ABDOMINAL PAIN UPPER,205
abiraterone,DIABETES MELLITUS,204
abiraterone,PRODUCT DOSE OMISSION,204
abiraterone,ASPARTATE AMINOTRANSFERASE INCREASED,201
abiraterone,PULMONARY EMBOLISM,200
abiraterone,FLUID RETENTION,196
abiraterone,HYPERHIDROSIS,194
abiraterone,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,192
abiraterone,CARDIAC DISORDER,191
abiraterone,CONDITION AGGRAVATED,189
abiraterone,JOINT SWELLING,189
abiraterone,BLOOD ALKALINE PHOSPHATASE INCREASED,188
abiraterone,CONTUSION,186
abiraterone,POLLAKIURIA,178
abiraterone,PRODUCT DOSE OMISSION ISSUE,177
denosumab,OFF LABEL USE,36065
denosumab,DEATH,19314
denosumab,OSTEONECROSIS OF JAW,9343
denosumab,ARTHRALGIA,8363
denosumab,FATIGUE,6999
denosumab,PAIN IN EXTREMITY,6718
denosumab,PAIN,6594
denosumab,BACK PAIN,6557
denosumab,NAUSEA,5040
denosumab,DIARRHOEA,4860
denosumab,FALL,4751
denosumab,RASH,4099
denosumab,MYALGIA,4047
denosumab,BONE PAIN,3876
denosumab,ASTHENIA,3778
denosumab,PRODUCT STORAGE ERROR,3649
denosumab,MALAISE,3587
denosumab,DYSPNOEA,3409
denosumab,HEADACHE,3336
denosumab,HYPOCALCAEMIA,3215
denosumab,TOOTH DISORDER,3075
denosumab,DRUG INEFFECTIVE,2910
denosumab,DIZZINESS,2765
denosumab,PRURITUS,2735
denosumab,SPINAL FRACTURE,2619
denosumab,PAIN IN JAW,2614
denosumab,PNEUMONIA,2519
denosumab,VOMITING,2466
denosumab,MUSCLE SPASMS,2460
denosumab,WEIGHT DECREASED,2442
denosumab,URINARY TRACT INFECTION,2435
denosumab,HOSPITALISATION,2360
denosumab,DECREASED APPETITE,2336
denosumab,ALOPECIA,2282
denosumab,GAIT DISTURBANCE,2267
denosumab,PYREXIA,2247
denosumab,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,2099
denosumab,CONSTIPATION,2093
denosumab,MALIGNANT NEOPLASM PROGRESSION,2024
denosumab,ANAEMIA,1942
denosumab,COUGH,1914
denosumab,HYPERTENSION,1824
denosumab,MUSCULOSKELETAL PAIN,1750
denosumab,FEELING ABNORMAL,1743
denosumab,INSOMNIA,1742
denosumab,PARAESTHESIA,1672
denosumab,METASTASES TO BONE,1664
denosumab,MOBILITY DECREASED,1622
denosumab,NEUTROPENIA,1602
denosumab,HYPOAESTHESIA,1581
denosumab,TOOTH EXTRACTION,1525
denosumab,FEMUR FRACTURE,1513
denosumab,FRACTURE,1506
denosumab,WHITE BLOOD CELL COUNT DECREASED,1477
denosumab,DRUG DOSE OMISSION,1461
denosumab,PERIPHERAL SWELLING,1381
denosumab,ACCIDENTAL EXPOSURE TO PRODUCT,1351
denosumab,HIP FRACTURE,1334
denosumab,ERYTHEMA,1324
denosumab,ADVERSE EVENT,1299
denosumab,ADVERSE DRUG REACTION,1290
denosumab,ABDOMINAL PAIN,1267
denosumab,DISEASE PROGRESSION,1265
denosumab,NASOPHARYNGITIS,1244
denosumab,INTERCEPTED PRODUCT ADMINISTRATION ERROR,1205
denosumab,INJECTION SITE PAIN,1187
denosumab,OSTEOPOROSIS,1180
denosumab,TOOTHACHE,1180
denosumab,ABDOMINAL PAIN UPPER,1178
denosumab,GENERAL PHYSICAL HEALTH DETERIORATION,1141
denosumab,ANXIETY,1112
denosumab,MUSCULAR WEAKNESS,1110
denosumab,ABDOMINAL DISCOMFORT,1090
denosumab,BLOOD CALCIUM DECREASED,1089
denosumab,NEUROPATHY PERIPHERAL,1085
denosumab,ARTHRITIS,1081
denosumab,INFECTION,1080
denosumab,DEPRESSION,1076
denosumab,BONE DENSITY DECREASED,1072
denosumab,TOOTH FRACTURE,1070
denosumab,NEOPLASM PROGRESSION,1041
denosumab,BLOOD PRESSURE INCREASED,1033
denosumab,CEREBROVASCULAR ACCIDENT,1030
denosumab,INFLUENZA LIKE ILLNESS,1028
denosumab,URTICARIA,1027
denosumab,WEIGHT INCREASED,1024
denosumab,CYSTITIS,1022
denosumab,IMPAIRED HEALING,1013
denosumab,DRY SKIN,1000
denosumab,CHEST PAIN,989
denosumab,CONDITION AGGRAVATED,987
denosumab,UNEVALUABLE EVENT,987
denosumab,HYPERSENSITIVITY,986
denosumab,DEHYDRATION,975
denosumab,STOMATITIS,958
denosumab,COVID-19,954
denosumab,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,952
denosumab,OEDEMA PERIPHERAL,950
denosumab,ATYPICAL FEMUR FRACTURE,938
denosumab,NECK PAIN,934
everolimus,DEATH,6417
everolimus,MALIGNANT NEOPLASM PROGRESSION,4474
everolimus,DIARRHOEA,4059
everolimus,FATIGUE,3738
everolimus,STOMATITIS,3176
everolimus,NAUSEA,2771
everolimus,DYSPNOEA,2660
everolimus,DRUG INEFFECTIVE,2429
everolimus,PYREXIA,2264
everolimus,VOMITING,2115
everolimus,DECREASED APPETITE,2072
everolimus,RASH,1939
everolimus,COUGH,1923
everolimus,WEIGHT DECREASED,1904
everolimus,MALAISE,1903
everolimus,ASTHENIA,1901
everolimus,PNEUMONIA,1731
everolimus,OFF LABEL USE,1604
everolimus,PAIN,1575
everolimus,DISEASE PROGRESSION,1504
everolimus,ANAEMIA,1499
everolimus,HEADACHE,1372
everolimus,ABDOMINAL PAIN,1207
everolimus,PRODUCT USE IN UNAPPROVED INDICATION,1169
everolimus,METASTASES TO LIVER,1162
everolimus,PNEUMONITIS,1161
everolimus,DEHYDRATION,1103
everolimus,GENERAL PHYSICAL HEALTH DETERIORATION,1055
everolimus,OEDEMA PERIPHERAL,1046
everolimus,NEOPLASM PROGRESSION,1037
everolimus,PLEURAL EFFUSION,1029
everolimus,BLOOD PRESSURE INCREASED,1012
everolimus,HYPERTENSION,1007
everolimus,METASTASES TO BONE,984
everolimus,DIZZINESS,954
everolimus,ARTHRALGIA,921
everolimus,PRURITUS,879
everolimus,PERIPHERAL SWELLING,867
everolimus,BACK PAIN,851
everolimus,HAEMOGLOBIN DECREASED,834
everolimus,ABDOMINAL PAIN UPPER,830
everolimus,CONSTIPATION,822
everolimus,BLOOD GLUCOSE INCREASED,812
everolimus,BLOOD CREATININE INCREASED,805
everolimus,THROMBOCYTOPENIA,794
everolimus,PAIN IN EXTREMITY,790
everolimus,RENAL IMPAIRMENT,788
everolimus,ACUTE KIDNEY INJURY,785
everolimus,NEOPLASM MALIGNANT,764
everolimus,EPISTAXIS,763
everolimus,ORAL PAIN,749
everolimus,INTERSTITIAL LUNG DISEASE,746
everolimus,URINARY TRACT INFECTION,744
everolimus,PLATELET COUNT DECREASED,725
everolimus,RENAL FAILURE,725
everolimus,MUCOSAL INFLAMMATION,724
everolimus,DRUG INTERACTION,722
everolimus,BREAST CANCER METASTATIC,684
everolimus,BREAST CANCER,682
everolimus,SEIZURE,673
everolimus,NEUTROPENIA,655
everolimus,METASTASES TO LUNG,652
everolimus,HYPERGLYCAEMIA,613
everolimus,MOUTH ULCERATION,612
everolimus,CHEST PAIN,596
everolimus,FALL,587
everolimus,TOXICITY TO VARIOUS AGENTS,576
everolimus,LUNG DISORDER,565
everolimus,INFECTION,562
everolimus,DRUG INTOLERANCE,551
everolimus,NASOPHARYNGITIS,539
everolimus,ASCITES,531
everolimus,DIABETES MELLITUS,521
everolimus,SEPSIS,511
everolimus,ABDOMINAL DISCOMFORT,509
everolimus,HYPOTENSION,505
everolimus,INSOMNIA,495
everolimus,ERYTHEMA,491
everolimus,BLOOD CHOLESTEROL INCREASED,477
everolimus,ACNE,469
everolimus,PRODUCT USE ISSUE,469
everolimus,WHITE BLOOD CELL COUNT DECREASED,463
everolimus,DYSGEUSIA,451
everolimus,ABDOMINAL DISTENSION,449
everolimus,FEELING ABNORMAL,446
everolimus,RESPIRATORY FAILURE,441
everolimus,GAIT DISTURBANCE,429
everolimus,DRY SKIN,427
everolimus,COVID-19,418
everolimus,DYSPHAGIA,411
everolimus,OEDEMA,410
everolimus,OSTEONECROSIS OF JAW,409
everolimus,OROPHARYNGEAL PAIN,408
everolimus,CONFUSIONAL STATE,406
everolimus,ALOPECIA,403
everolimus,PULMONARY EMBOLISM,401
everolimus,C-REACTIVE PROTEIN INCREASED,400
everolimus,BONE PAIN,398
everolimus,ANXIETY,396
everolimus,CHILLS,396
filgrastim,FEBRILE NEUTROPENIA,4616
filgrastim,NEUTROPENIA,3797
filgrastim,PYREXIA,3205
filgrastim,OFF LABEL USE,3122
filgrastim,DEATH,2896
filgrastim,DIARRHOEA,2556
filgrastim,NAUSEA,2308
filgrastim,PNEUMONIA,2059
filgrastim,FATIGUE,2046
filgrastim,THROMBOCYTOPENIA,2043
filgrastim,ANAEMIA,1927
filgrastim,WHITE BLOOD CELL COUNT DECREASED,1772
filgrastim,VOMITING,1631
filgrastim,SEPSIS,1608
filgrastim,PANCYTOPENIA,1400
filgrastim,DYSPNOEA,1365
filgrastim,PLATELET COUNT DECREASED,1287
filgrastim,DRUG INEFFECTIVE,1228
filgrastim,ASTHENIA,1202
filgrastim,BONE PAIN,1176
filgrastim,INFECTION,1090
filgrastim,RASH,1042
filgrastim,NEUTROPHIL COUNT DECREASED,1034
filgrastim,DISEASE PROGRESSION,947
filgrastim,PAIN,935
filgrastim,HYPOTENSION,903
filgrastim,MUCOSAL INFLAMMATION,874
filgrastim,LEUKOPENIA,853
filgrastim,ABDOMINAL PAIN,848
filgrastim,DECREASED APPETITE,832
filgrastim,HEADACHE,817
filgrastim,CONSTIPATION,797
filgrastim,BACK PAIN,793
filgrastim,MALAISE,790
filgrastim,COUGH,764
filgrastim,HAEMOGLOBIN DECREASED,754
filgrastim,SEPTIC SHOCK,745
filgrastim,NEUROPATHY PERIPHERAL,717
filgrastim,ACUTE KIDNEY INJURY,686
filgrastim,ARTHRALGIA,669
filgrastim,WEIGHT DECREASED,664
filgrastim,PRODUCT USE IN UNAPPROVED INDICATION,636
filgrastim,DIZZINESS,625
filgrastim,STOMATITIS,603
filgrastim,DEHYDRATION,598
filgrastim,RESPIRATORY FAILURE,597
filgrastim,HYPOKALAEMIA,592
filgrastim,PLEURAL EFFUSION,572
filgrastim,ALOPECIA,567
filgrastim,RENAL FAILURE,539
filgrastim,BACTERIAL INFECTION,529
filgrastim,URINARY TRACT INFECTION,520
filgrastim,PRURITUS,507
filgrastim,CYTOKINE RELEASE SYNDROME,494
filgrastim,BONE MARROW FAILURE,485
filgrastim,CONDITION AGGRAVATED,484
filgrastim,CHILLS,483
filgrastim,GENERAL PHYSICAL HEALTH DETERIORATION,479
filgrastim,CHEST PAIN,476
filgrastim,PAIN IN EXTREMITY,470
filgrastim,ATRIAL FIBRILLATION,467
filgrastim,HYPOXIA,460
filgrastim,ACUTE MYELOID LEUKAEMIA,448
filgrastim,CELLULITIS,448
filgrastim,CLOSTRIDIUM DIFFICILE COLITIS,447
filgrastim,PRODUCT STORAGE ERROR,437
filgrastim,MALIGNANT NEOPLASM PROGRESSION,433
filgrastim,PLASMA CELL MYELOMA,419
filgrastim,OEDEMA PERIPHERAL,416
filgrastim,HYPERTENSION,413
filgrastim,NEUTROPENIC SEPSIS,411
filgrastim,MYALGIA,410
filgrastim,INSOMNIA,407
filgrastim,TACHYCARDIA,396
filgrastim,ALANINE AMINOTRANSFERASE INCREASED,385
filgrastim,DEEP VEIN THROMBOSIS,382
filgrastim,HOSPITALISATION,382
filgrastim,PULMONARY EMBOLISM,377
filgrastim,CONFUSIONAL STATE,376
filgrastim,COVID-19,376
filgrastim,CARDIAC FAILURE,371
filgrastim,FALL,367
filgrastim,EPISTAXIS,366
filgrastim,ERYTHEMA,362
filgrastim,MYELODYSPLASTIC SYNDROME,362
filgrastim,HYPONATRAEMIA,361
filgrastim,FUNGAL INFECTION,352
filgrastim,MULTIPLE ORGAN DYSFUNCTION SYNDROME,351
filgrastim,SYNCOPE,341
filgrastim,VIRAL INFECTION,333
filgrastim,WHITE BLOOD CELL COUNT INCREASED,332
filgrastim,ASPARTATE AMINOTRANSFERASE INCREASED,329
filgrastim,RENAL IMPAIRMENT,329
filgrastim,BLOOD CREATININE INCREASED,328
filgrastim,CYTOMEGALOVIRUS INFECTION,325
filgrastim,INTERSTITIAL LUNG DISEASE,324
filgrastim,COLITIS,318
filgrastim,ABDOMINAL PAIN UPPER,317
filgrastim,THROMBOSIS,317
filgrastim,LYMPHOPENIA,307
fluorouracil,DIARRHOEA,8344
fluorouracil,NEUTROPENIA,6088
fluorouracil,NAUSEA,6045
fluorouracil,VOMITING,4862
fluorouracil,OFF LABEL USE,3835
fluorouracil,FATIGUE,3700
fluorouracil,PYREXIA,3679
fluorouracil,THROMBOCYTOPENIA,3542
fluorouracil,DISEASE PROGRESSION,3513
fluorouracil,NEUROPATHY PERIPHERAL,3459
fluorouracil,FEBRILE NEUTROPENIA,3367
fluorouracil,ANAEMIA,3147
fluorouracil,ASTHENIA,3049
fluorouracil,DEATH,2913
fluorouracil,DECREASED APPETITE,2572
fluorouracil,DYSPNOEA,2449
fluorouracil,ABDOMINAL PAIN,2387
fluorouracil,MALIGNANT NEOPLASM PROGRESSION,2373
fluorouracil,MUCOSAL INFLAMMATION,2322
fluorouracil,DEHYDRATION,2103
fluorouracil,DRUG INEFFECTIVE,2093
fluorouracil,LEUKOPENIA,2016
fluorouracil,STOMATITIS,1944
fluorouracil,RASH,1884
fluorouracil,PULMONARY EMBOLISM,1665
fluorouracil,GENERAL PHYSICAL HEALTH DETERIORATION,1655
fluorouracil,SEPSIS,1611
fluorouracil,HYPERTENSION,1569
fluorouracil,PNEUMONIA,1481
fluorouracil,MALAISE,1460
fluorouracil,ACUTE KIDNEY INJURY,1428
fluorouracil,PAIN,1404
fluorouracil,ALOPECIA,1392
fluorouracil,INTERSTITIAL LUNG DISEASE,1388
fluorouracil,HYPOTENSION,1353
fluorouracil,NEUTROPHIL COUNT DECREASED,1306
fluorouracil,WHITE BLOOD CELL COUNT DECREASED,1301
fluorouracil,WEIGHT DECREASED,1295
fluorouracil,PARAESTHESIA,1246
fluorouracil,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1243
fluorouracil,HYPOKALAEMIA,1226
fluorouracil,CONSTIPATION,1210
fluorouracil,NEUROTOXICITY,1129
fluorouracil,ERYTHEMA,1116
fluorouracil,CHEST PAIN,1109
fluorouracil,DIZZINESS,1106
fluorouracil,NEOPLASM PROGRESSION,1106
fluorouracil,METASTASES TO LIVER,1094
fluorouracil,PLATELET COUNT DECREASED,1091
fluorouracil,CHILLS,1077
fluorouracil,TOXICITY TO VARIOUS AGENTS,1068
fluorouracil,PRODUCT USE IN UNAPPROVED INDICATION,943
fluorouracil,DEEP VEIN THROMBOSIS,941
fluorouracil,HEADACHE,922
fluorouracil,SEPTIC SHOCK,917
fluorouracil,MYELOSUPPRESSION,916
fluorouracil,HAEMOGLOBIN DECREASED,911
fluorouracil,HYPERSENSITIVITY,909
fluorouracil,RENAL FAILURE,908
fluorouracil,CONDITION AGGRAVATED,892
fluorouracil,PANCYTOPENIA,874
fluorouracil,DERMATITIS ACNEIFORM,864
fluorouracil,PRURITUS,852
fluorouracil,BONE MARROW FAILURE,851
fluorouracil,INFECTION,850
fluorouracil,SKIN TOXICITY,839
fluorouracil,RESPIRATORY FAILURE,770
fluorouracil,DYSPHAGIA,764
fluorouracil,EPISTAXIS,748
fluorouracil,COUGH,741
fluorouracil,BACK PAIN,732
fluorouracil,PLEURAL EFFUSION,730
fluorouracil,HYPOMAGNESAEMIA,727
fluorouracil,ABDOMINAL PAIN UPPER,719
fluorouracil,ATRIAL FIBRILLATION,706
fluorouracil,TACHYCARDIA,697
fluorouracil,CARDIAC FAILURE,693
fluorouracil,POLYNEUROPATHY,679
fluorouracil,ASCITES,678
fluorouracil,HYPONATRAEMIA,678
fluorouracil,PROTEINURIA,654
fluorouracil,METASTASES TO LUNG,650
fluorouracil,URINARY TRACT INFECTION,648
fluorouracil,RENAL IMPAIRMENT,643
fluorouracil,INTESTINAL OBSTRUCTION,636
fluorouracil,FALL,624
fluorouracil,OEDEMA PERIPHERAL,622
fluorouracil,BLOOD CREATININE INCREASED,616
fluorouracil,COLORECTAL CANCER METASTATIC,581
fluorouracil,COLITIS,577
fluorouracil,HAEMATOTOXICITY,575
fluorouracil,PERIPHERAL SENSORY NEUROPATHY,565
fluorouracil,CONFUSIONAL STATE,561
fluorouracil,THERAPY PARTIAL RESPONDER,555
fluorouracil,CARDIOTOXICITY,552
fluorouracil,ALANINE AMINOTRANSFERASE INCREASED,550
fluorouracil,SYNCOPE,550
fluorouracil,ARTERIOSPASM CORONARY,537
fluorouracil,INFUSION RELATED REACTION,533
fluorouracil,ASPARTATE AMINOTRANSFERASE INCREASED,532
doxorubicin,FEBRILE NEUTROPENIA,11219
doxorubicin,OFF LABEL USE,9350
doxorubicin,NEUTROPENIA,8107
doxorubicin,DISEASE PROGRESSION,7082
doxorubicin,PYREXIA,5538
doxorubicin,ALOPECIA,5437
doxorubicin,DRUG INEFFECTIVE,5124
doxorubicin,ANAEMIA,4752
doxorubicin,THROMBOCYTOPENIA,4667
doxorubicin,NAUSEA,4526
doxorubicin,DEATH,4171
doxorubicin,PNEUMONIA,3650
doxorubicin,PRODUCT USE IN UNAPPROVED INDICATION,3638
doxorubicin,SEPSIS,3634
doxorubicin,DIARRHOEA,3597
doxorubicin,VOMITING,3544
doxorubicin,FATIGUE,3314
doxorubicin,DYSPNOEA,2906
doxorubicin,PANCYTOPENIA,2823
doxorubicin,INFECTION,2800
doxorubicin,NEUROPATHY PERIPHERAL,2691
doxorubicin,MALIGNANT NEOPLASM PROGRESSION,2686
doxorubicin,MUCOSAL INFLAMMATION,2620
doxorubicin,PAIN,2348
doxorubicin,ASTHENIA,2281
doxorubicin,LEUKOPENIA,2196
doxorubicin,PSYCHOLOGICAL TRAUMA,2131
doxorubicin,WHITE BLOOD CELL COUNT DECREASED,2066
doxorubicin,SEPTIC SHOCK,1871
doxorubicin,ACUTE MYELOID LEUKAEMIA,1847
doxorubicin,ABDOMINAL PAIN,1804
doxorubicin,PLATELET COUNT DECREASED,1779
doxorubicin,INTERSTITIAL LUNG DISEASE,1768
doxorubicin,HYPOTENSION,1719
doxorubicin,CARDIAC FAILURE,1669
doxorubicin,MYELODYSPLASTIC SYNDROME,1625
doxorubicin,TOXICITY TO VARIOUS AGENTS,1599
doxorubicin,NEUTROPHIL COUNT DECREASED,1596
doxorubicin,RESPIRATORY FAILURE,1582
doxorubicin,CONSTIPATION,1554
doxorubicin,ACUTE KIDNEY INJURY,1544
doxorubicin,DECREASED APPETITE,1533
doxorubicin,ANXIETY,1477
doxorubicin,PRODUCT USE ISSUE,1459
doxorubicin,STOMATITIS,1457
doxorubicin,CARDIOTOXICITY,1424
doxorubicin,NEOPLASM PROGRESSION,1423
doxorubicin,PLEURAL EFFUSION,1413
doxorubicin,BONE MARROW FAILURE,1410
doxorubicin,GENERAL PHYSICAL HEALTH DETERIORATION,1408
doxorubicin,PULMONARY EMBOLISM,1398
doxorubicin,HAEMATOTOXICITY,1383
doxorubicin,HAIR COLOUR CHANGES,1331
doxorubicin,HEADACHE,1321
doxorubicin,HAIR TEXTURE ABNORMAL,1320
doxorubicin,COUGH,1293
doxorubicin,RASH,1262
doxorubicin,HAIR DISORDER,1254
doxorubicin,COVID-19,1244
doxorubicin,MYELOSUPPRESSION,1244
doxorubicin,DIFFUSE LARGE B-CELL LYMPHOMA,1243
doxorubicin,DEHYDRATION,1224
doxorubicin,SECOND PRIMARY MALIGNANCY,1222
doxorubicin,CONDITION AGGRAVATED,1208
doxorubicin,EMOTIONAL DISTRESS,1189
doxorubicin,WEIGHT DECREASED,1184
doxorubicin,RENAL FAILURE,1180
doxorubicin,HAEMOGLOBIN DECREASED,1166
doxorubicin,MADAROSIS,1146
doxorubicin,HYPERTENSION,1145
doxorubicin,MALAISE,1101
doxorubicin,DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT,1092
doxorubicin,DISEASE RECURRENCE,1086
doxorubicin,BACK PAIN,1083
doxorubicin,ATRIAL FIBRILLATION,1031
doxorubicin,DIZZINESS,1030
doxorubicin,EJECTION FRACTION DECREASED,1029
doxorubicin,DEEP VEIN THROMBOSIS,1020
doxorubicin,HYPOKALAEMIA,992
doxorubicin,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,990
doxorubicin,TUMOUR LYSIS SYNDROME,984
doxorubicin,PLASMA CELL MYELOMA,979
doxorubicin,CARDIOMYOPATHY,949
doxorubicin,URINARY TRACT INFECTION,941
doxorubicin,BONE PAIN,939
doxorubicin,LYMPHADENOPATHY,917
doxorubicin,CYTOKINE RELEASE SYNDROME,912
doxorubicin,THERAPY PARTIAL RESPONDER,898
doxorubicin,NEUTROPENIC SEPSIS,881
doxorubicin,ARTHRALGIA,879
doxorubicin,PNEUMONITIS,873
doxorubicin,CHILLS,852
doxorubicin,IMPAIRED QUALITY OF LIFE,844
doxorubicin,TACHYCARDIA,839
doxorubicin,BLOOD LACTATE DEHYDROGENASE INCREASED,834
doxorubicin,INFUSION RELATED REACTION,829
doxorubicin,MULTIPLE ORGAN DYSFUNCTION SYNDROME,823
doxorubicin,PNEUMOCYSTIS JIROVECII PNEUMONIA,822
doxorubicin,ALANINE AMINOTRANSFERASE INCREASED,817
doxorubicin,CYTOPENIA,798
gemcitabine,DISEASE PROGRESSION,4751
gemcitabine,OFF LABEL USE,4574
gemcitabine,THROMBOCYTOPENIA,4015
gemcitabine,NEUTROPENIA,3508
gemcitabine,ANAEMIA,3381
gemcitabine,MALIGNANT NEOPLASM PROGRESSION,3171
gemcitabine,NAUSEA,3093
gemcitabine,PYREXIA,2905
gemcitabine,DEATH,2747
gemcitabine,DRUG INEFFECTIVE,2515
gemcitabine,VOMITING,2488
gemcitabine,FATIGUE,2462
gemcitabine,DIARRHOEA,2375
gemcitabine,DYSPNOEA,1959
gemcitabine,FEBRILE NEUTROPENIA,1881
gemcitabine,ASTHENIA,1828
gemcitabine,PNEUMONIA,1583
gemcitabine,ABDOMINAL PAIN,1461
gemcitabine,PANCYTOPENIA,1362
gemcitabine,SEPSIS,1343
gemcitabine,PLATELET COUNT DECREASED,1319
gemcitabine,LEUKOPENIA,1274
gemcitabine,NEUROPATHY PERIPHERAL,1272
gemcitabine,DECREASED APPETITE,1266
gemcitabine,GENERAL PHYSICAL HEALTH DETERIORATION,1200
gemcitabine,RASH,1122
gemcitabine,NEOPLASM PROGRESSION,1118
gemcitabine,PULMONARY EMBOLISM,1078
gemcitabine,DEHYDRATION,1045
gemcitabine,ACUTE KIDNEY INJURY,1041
gemcitabine,MYELOSUPPRESSION,1027
gemcitabine,PLEURAL EFFUSION,994
gemcitabine,CONSTIPATION,967
gemcitabine,PRODUCT USE IN UNAPPROVED INDICATION,966
gemcitabine,PAIN,931
gemcitabine,THROMBOTIC MICROANGIOPATHY,924
gemcitabine,WHITE BLOOD CELL COUNT DECREASED,913
gemcitabine,OEDEMA PERIPHERAL,887
gemcitabine,HAEMOGLOBIN DECREASED,881
gemcitabine,NEUTROPHIL COUNT DECREASED,832
gemcitabine,INFECTION,754
gemcitabine,TOXICITY TO VARIOUS AGENTS,740
gemcitabine,WEIGHT DECREASED,736
gemcitabine,HYPOTENSION,734
gemcitabine,DEEP VEIN THROMBOSIS,733
gemcitabine,COUGH,726
gemcitabine,HYPERTENSION,700
gemcitabine,INTERSTITIAL LUNG DISEASE,688
gemcitabine,ASCITES,683
gemcitabine,MALAISE,667
gemcitabine,METASTASES TO LIVER,639
gemcitabine,RENAL FAILURE,635
gemcitabine,DIZZINESS,630
gemcitabine,MUCOSAL INFLAMMATION,612
gemcitabine,ERYTHEMA,611
gemcitabine,RESPIRATORY FAILURE,607
gemcitabine,HAEMATOTOXICITY,603
gemcitabine,CONDITION AGGRAVATED,592
gemcitabine,HEADACHE,578
gemcitabine,CHILLS,576
gemcitabine,BONE MARROW FAILURE,568
gemcitabine,PNEUMONITIS,567
gemcitabine,URINARY TRACT INFECTION,566
gemcitabine,ALOPECIA,560
gemcitabine,SEPTIC SHOCK,556
gemcitabine,PRURITUS,550
gemcitabine,ALANINE AMINOTRANSFERASE INCREASED,543
gemcitabine,CHEST PAIN,504
gemcitabine,CHOLANGITIS,491
gemcitabine,ASPARTATE AMINOTRANSFERASE INCREASED,479
gemcitabine,DRUG INTOLERANCE,472
gemcitabine,HYPONATRAEMIA,472
gemcitabine,CARDIAC FAILURE,466
gemcitabine,DISEASE RECURRENCE,460
gemcitabine,CONFUSIONAL STATE,458
gemcitabine,EPISTAXIS,449
gemcitabine,GASTROINTESTINAL HAEMORRHAGE,448
gemcitabine,PAIN IN EXTREMITY,443
gemcitabine,BACK PAIN,442
gemcitabine,TREATMENT FAILURE,440
gemcitabine,HYPOKALAEMIA,431
gemcitabine,BLOOD CREATININE INCREASED,430
gemcitabine,NEUTROPENIC SEPSIS,424
gemcitabine,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,422
gemcitabine,RENAL IMPAIRMENT,416
gemcitabine,METASTASES TO LUNG,409
gemcitabine,NEUROTOXICITY,407
gemcitabine,CYTOKINE RELEASE SYNDROME,397
gemcitabine,ATRIAL FIBRILLATION,394
gemcitabine,STOMATITIS,392
gemcitabine,PARAESTHESIA,391
gemcitabine,TACHYCARDIA,375
gemcitabine,THERAPY PARTIAL RESPONDER,367
gemcitabine,BLOOD LACTATE DEHYDROGENASE INCREASED,366
gemcitabine,HYPERSENSITIVITY,366
gemcitabine,METASTASES TO BONE,365
gemcitabine,COLITIS,363
gemcitabine,PANCREATIC CARCINOMA METASTATIC,363
gemcitabine,ACUTE MYELOID LEUKAEMIA,360
gemcitabine,ABDOMINAL PAIN UPPER,356
regorafenib,OFF LABEL USE,2025
regorafenib,FATIGUE,1704
regorafenib,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1405
regorafenib,DIARRHOEA,1368
regorafenib,DECREASED APPETITE,1058
regorafenib,ASTHENIA,913
regorafenib,DEATH,880
regorafenib,DYSPHONIA,804
regorafenib,NAUSEA,788
regorafenib,PYREXIA,734
regorafenib,PAIN IN EXTREMITY,732
regorafenib,HYPERTENSION,677
regorafenib,WEIGHT DECREASED,614
regorafenib,VOMITING,553
regorafenib,RASH,538
regorafenib,PAIN,510
regorafenib,HEPATOCELLULAR CARCINOMA,487
regorafenib,NEUROPATHY PERIPHERAL,480
regorafenib,ABDOMINAL PAIN,468
regorafenib,DYSPNOEA,446
regorafenib,DEHYDRATION,445
regorafenib,BLOOD PRESSURE INCREASED,437
regorafenib,BLISTER,435
regorafenib,DRUG INEFFECTIVE,421
regorafenib,HEADACHE,420
regorafenib,CONSTIPATION,406
regorafenib,MALAISE,397
regorafenib,ABDOMINAL PAIN UPPER,350
regorafenib,COLON CANCER,342
regorafenib,GAIT DISTURBANCE,339
regorafenib,SKIN EXFOLIATION,338
regorafenib,STOMATITIS,325
regorafenib,METASTASES TO LUNG,319
regorafenib,COLORECTAL CANCER METASTATIC,312
regorafenib,DISEASE PROGRESSION,306
regorafenib,HOSPITALISATION,305
regorafenib,ERYTHEMA,285
regorafenib,COLORECTAL CANCER,284
regorafenib,BACK PAIN,271
regorafenib,METASTASES TO LIVER,271
regorafenib,BLOOD BILIRUBIN INCREASED,260
regorafenib,PLATELET COUNT DECREASED,257
regorafenib,DRY SKIN,254
regorafenib,GENERAL PHYSICAL HEALTH DETERIORATION,254
regorafenib,DIZZINESS,238
regorafenib,PERIPHERAL SWELLING,212
regorafenib,ARTHRALGIA,209
regorafenib,PNEUMONIA,207
regorafenib,ASCITES,203
regorafenib,COUGH,202
regorafenib,MUSCLE SPASMS,196
regorafenib,CONFUSIONAL STATE,188
regorafenib,ANAEMIA,187
regorafenib,HEPATIC FUNCTION ABNORMAL,179
regorafenib,HYPOAESTHESIA,172
regorafenib,MALIGNANT NEOPLASM PROGRESSION,172
regorafenib,ASPARTATE AMINOTRANSFERASE INCREASED,170
regorafenib,ORAL PAIN,166
regorafenib,ALOPECIA,164
regorafenib,PRODUCT USE IN UNAPPROVED INDICATION,164
regorafenib,DRY MOUTH,163
regorafenib,CHEST PAIN,154
regorafenib,MUCOSAL INFLAMMATION,153
regorafenib,THROMBOCYTOPENIA,153
regorafenib,URINARY TRACT INFECTION,151
regorafenib,PRURITUS,149
regorafenib,ADVERSE DRUG REACTION,146
regorafenib,HYPERKERATOSIS,146
regorafenib,JAUNDICE,145
regorafenib,ALANINE AMINOTRANSFERASE INCREASED,144
regorafenib,SEPSIS,143
regorafenib,OROPHARYNGEAL PAIN,141
regorafenib,MYALGIA,140
regorafenib,FALL,139
regorafenib,OEDEMA PERIPHERAL,136
regorafenib,PARAESTHESIA,135
regorafenib,HEPATIC FAILURE,131
regorafenib,ABDOMINAL DISTENSION,129
regorafenib,INSOMNIA,129
regorafenib,DRUG INTOLERANCE,127
regorafenib,GASTROINTESTINAL STROMAL TUMOUR,126
regorafenib,EPISTAXIS,123
regorafenib,GAIT INABILITY,116
regorafenib,MYELOSUPPRESSION,115
regorafenib,DYSPHAGIA,114
regorafenib,SKIN FISSURES,111
regorafenib,BURNING SENSATION,109
regorafenib,CHILLS,109
regorafenib,LIVER DISORDER,109
regorafenib,RENAL IMPAIRMENT,108
regorafenib,HYPOTENSION,107
regorafenib,FEELING ABNORMAL,104
regorafenib,ABDOMINAL DISCOMFORT,102
regorafenib,ACUTE KIDNEY INJURY,102
regorafenib,MOBILITY DECREASED,102
regorafenib,MUSCULAR WEAKNESS,101
regorafenib,CARCINOEMBRYONIC ANTIGEN INCREASED,100
regorafenib,NEUTROPENIA,99
regorafenib,RECTAL CANCER,98
regorafenib,HEPATIC ENCEPHALOPATHY,94
selpercatinib,MALIGNANT NEOPLASM PROGRESSION,92
selpercatinib,DEATH,84
selpercatinib,FATIGUE,49
selpercatinib,HYPERSENSITIVITY,49
selpercatinib,RASH,49
selpercatinib,DIARRHOEA,48
selpercatinib,HYPERTENSION,48
selpercatinib,HEPATIC FUNCTION ABNORMAL,39
selpercatinib,PYREXIA,36
selpercatinib,DRUG INEFFECTIVE,34
selpercatinib,ALANINE AMINOTRANSFERASE INCREASED,32
selpercatinib,ELECTROCARDIOGRAM QT PROLONGED,32
selpercatinib,ASPARTATE AMINOTRANSFERASE INCREASED,31
selpercatinib,ASCITES,27
selpercatinib,DRY MOUTH,27
selpercatinib,BLOOD CREATININE INCREASED,26
selpercatinib,COUGH,26
selpercatinib,OFF LABEL USE,26
selpercatinib,THROMBOCYTOPENIA,26
selpercatinib,URINARY TRACT INFECTION,26
selpercatinib,NAUSEA,23
selpercatinib,ASTHENIA,22
selpercatinib,PLEURAL EFFUSION,22
selpercatinib,PULMONARY EMBOLISM,22
selpercatinib,BLOOD PRESSURE INCREASED,21
selpercatinib,LIVER FUNCTION TEST INCREASED,21
selpercatinib,OEDEMA PERIPHERAL,21
selpercatinib,DECREASED APPETITE,20
selpercatinib,GENERAL PHYSICAL HEALTH DETERIORATION,20
selpercatinib,HEADACHE,20
selpercatinib,PLATELET COUNT DECREASED,20
selpercatinib,HEPATOTOXICITY,17
selpercatinib,INFECTION,17
selpercatinib,DISEASE PROGRESSION,16
selpercatinib,OEDEMA,16
selpercatinib,DYSPHAGIA,15
selpercatinib,THERAPY INTERRUPTED,15
selpercatinib,VOMITING,15
selpercatinib,DIZZINESS,13
selpercatinib,PROTEINURIA,13
selpercatinib,WEIGHT DECREASED,13
selpercatinib,WEIGHT INCREASED,13
selpercatinib,DRUG-INDUCED LIVER INJURY,12
selpercatinib,HAEMATURIA,12
selpercatinib,HEPATIC ENZYME INCREASED,12
selpercatinib,HEPATIC FAILURE,12
selpercatinib,INFLAMMATORY MARKER INCREASED,12
selpercatinib,LIVER DISORDER,12
selpercatinib,THERAPY PARTIAL RESPONDER,12
selpercatinib,ABDOMINAL PAIN UPPER,11
selpercatinib,ARTHRALGIA,11
selpercatinib,DEHYDRATION,11
selpercatinib,FEBRILE INFECTION,11
selpercatinib,HYPERTRANSAMINASAEMIA,11
selpercatinib,PNEUMONIA,11
selpercatinib,TUMOUR ASSOCIATED FEVER,11
selpercatinib,URINARY TRACT INFECTION ENTEROCOCCAL,11
selpercatinib,ABDOMINAL PAIN,10
selpercatinib,ACUTE KIDNEY INJURY,10
selpercatinib,DYSPNOEA,10
selpercatinib,MALAISE,10
selpercatinib,SWELLING FACE,10
selpercatinib,COVID-19,9
selpercatinib,NEUTROPENIA,9
selpercatinib,PERICARDIAL EFFUSION,9
selpercatinib,PNEUMONITIS,9
selpercatinib,RENAL FAILURE,9
selpercatinib,RENAL IMPAIRMENT,9
selpercatinib,ABDOMINAL DISTENSION,8
selpercatinib,ANAEMIA,8
selpercatinib,ANXIETY,8
selpercatinib,CEREBROVASCULAR ACCIDENT,8
selpercatinib,CHYLOTHORAX,8
selpercatinib,DRUG RESISTANCE,8
selpercatinib,HYPONATRAEMIA,8
selpercatinib,MUCOSAL INFLAMMATION,8
selpercatinib,NEPHROPATHY TOXIC,8
selpercatinib,PARAESTHESIA,8
selpercatinib,PERIPHERAL SWELLING,8
selpercatinib,STOMATITIS,8
selpercatinib,TRANSAMINASES INCREASED,8
selpercatinib,WHITE BLOOD CELL COUNT DECREASED,8
selpercatinib,BLOOD BILIRUBIN INCREASED,7
selpercatinib,CHEST PAIN,7
selpercatinib,CONSTIPATION,7
selpercatinib,FUNGAL INFECTION,7
selpercatinib,GASTROOESOPHAGEAL REFLUX DISEASE,7
selpercatinib,HEART RATE INCREASED,7
selpercatinib,HYPERCALCAEMIA,7
selpercatinib,HYPOCALCAEMIA,7
selpercatinib,JOINT SWELLING,7
selpercatinib,NEUROPATHY PERIPHERAL,7
selpercatinib,PAIN,7
selpercatinib,VISUAL IMPAIRMENT,7
selpercatinib,ALOPECIA,6
selpercatinib,BLOOD ALKALINE PHOSPHATASE INCREASED,6
selpercatinib,BLOOD CALCITONIN INCREASED,6
selpercatinib,CHRONIC KIDNEY DISEASE,6
selpercatinib,CUSHING^S SYNDROME,6
selpercatinib,DEEP VEIN THROMBOSIS,6
remdesivir,OFF LABEL USE,2140
remdesivir,ALANINE AMINOTRANSFERASE INCREASED,1079
remdesivir,COVID-19,919
remdesivir,DEATH,838
remdesivir,ASPARTATE AMINOTRANSFERASE INCREASED,743
remdesivir,DRUG INEFFECTIVE,713
remdesivir,ACUTE KIDNEY INJURY,688
remdesivir,BRADYCARDIA,672
remdesivir,RESPIRATORY FAILURE,521
remdesivir,COVID-19 PNEUMONIA,512
remdesivir,LIVER FUNCTION TEST INCREASED,467
remdesivir,BLOOD CREATININE INCREASED,368
remdesivir,CONDITION AGGRAVATED,358
remdesivir,PNEUMONIA,316
remdesivir,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,311
remdesivir,HYPOTENSION,296
remdesivir,CARDIAC ARREST,289
remdesivir,RENAL IMPAIRMENT,279
remdesivir,HYPOXIA,268
remdesivir,SEPTIC SHOCK,268
remdesivir,DYSPNOEA,256
remdesivir,HEPATIC ENZYME INCREASED,229
remdesivir,MULTIPLE ORGAN DYSFUNCTION SYNDROME,228
remdesivir,THERAPY CESSATION,226
remdesivir,OXYGEN SATURATION DECREASED,221
remdesivir,MATERNAL EXPOSURE DURING PREGNANCY,216
remdesivir,PRODUCT USE IN UNAPPROVED INDICATION,210
remdesivir,TRANSAMINASES INCREASED,206
remdesivir,DRUG INTERACTION,204
remdesivir,BRONCHOPULMONARY ASPERGILLOSIS,188
remdesivir,ACUTE RESPIRATORY DISTRESS SYNDROME,186
remdesivir,PYREXIA,185
remdesivir,SEPSIS,179
remdesivir,ACUTE RESPIRATORY FAILURE,174
remdesivir,RENAL FAILURE,170
remdesivir,NO ADVERSE EVENT,157
remdesivir,FOETAL EXPOSURE DURING PREGNANCY,148
remdesivir,INFUSION SITE EXTRAVASATION,144
remdesivir,INFUSION RELATED REACTION,137
remdesivir,GENERAL PHYSICAL HEALTH DETERIORATION,135
remdesivir,EXPOSURE DURING PREGNANCY,130
remdesivir,PULMONARY EMBOLISM,130
remdesivir,SINUS BRADYCARDIA,128
remdesivir,ATRIAL FIBRILLATION,122
remdesivir,GLOMERULAR FILTRATION RATE DECREASED,122
remdesivir,PNEUMONIA BACTERIAL,119
remdesivir,PREMATURE DELIVERY,118
remdesivir,PRODUCT USE ISSUE,117
remdesivir,THERAPY INTERRUPTED,117
remdesivir,PNEUMOTHORAX,113
remdesivir,PREMATURE BABY,113
remdesivir,NAUSEA,112
remdesivir,THROMBOCYTOPENIA,112
remdesivir,ELECTROCARDIOGRAM QT PROLONGED,110
remdesivir,INTENTIONAL PRODUCT USE ISSUE,105
remdesivir,DISEASE PROGRESSION,104
remdesivir,HEPATIC FUNCTION ABNORMAL,102
remdesivir,SHOCK,101
remdesivir,CARDIO-RESPIRATORY ARREST,97
remdesivir,INTERNATIONAL NORMALISED RATIO INCREASED,97
remdesivir,RASH,95
remdesivir,TACHYCARDIA,95
remdesivir,SARS-COV-2 TEST POSITIVE,90
remdesivir,HEART RATE DECREASED,88
remdesivir,PRODUCT PREPARATION ERROR,85
remdesivir,BLOOD ALKALINE PHOSPHATASE INCREASED,81
remdesivir,HYPERTENSION,81
remdesivir,COUGH,80
remdesivir,RESPIRATORY DISTRESS,80
remdesivir,THERAPY NON-RESPONDER,80
remdesivir,VOMITING,80
remdesivir,PULSELESS ELECTRICAL ACTIVITY,79
remdesivir,BLOOD BILIRUBIN INCREASED,77
remdesivir,ASPERGILLUS INFECTION,74
remdesivir,DISSEMINATED INTRAVASCULAR COAGULATION,74
remdesivir,DIARRHOEA,73
remdesivir,MUCORMYCOSIS,73
remdesivir,LEUKOPENIA,72
remdesivir,HYPERTRANSAMINASAEMIA,71
remdesivir,CHILLS,70
remdesivir,DRUG-INDUCED LIVER INJURY,69
remdesivir,HYPERGLYCAEMIA,69
remdesivir,GASTROINTESTINAL HAEMORRHAGE,68
remdesivir,RESPIRATORY DISORDER,68
remdesivir,PNEUMONIA ASPIRATION,67
remdesivir,ASTHENIA,66
remdesivir,STAPHYLOCOCCAL INFECTION,66
remdesivir,LIVER INJURY,65
remdesivir,METABOLIC ACIDOSIS,63
remdesivir,ANAEMIA,62
remdesivir,HYPERKALAEMIA,62
remdesivir,BLOOD UREA INCREASED,61
remdesivir,HAEMODIALYSIS,61
remdesivir,NEUTROPENIA,61
remdesivir,PAIN,61
remdesivir,RECALLED PRODUCT ADMINISTERED,61
remdesivir,DEEP VEIN THROMBOSIS,60
remdesivir,SHOCK HAEMORRHAGIC,60
remdesivir,BLOOD PRESSURE DECREASED,59
remdesivir,CHEST PAIN,59
enoxaparin,OFF LABEL USE,4271
enoxaparin,DYSPNOEA,3794
enoxaparin,NAUSEA,3592
enoxaparin,DIARRHOEA,3465
enoxaparin,PYREXIA,3458
enoxaparin,ANAEMIA,3329
enoxaparin,FATIGUE,2994
enoxaparin,THROMBOCYTOPENIA,2876
enoxaparin,VOMITING,2851
enoxaparin,PNEUMONIA,2769
enoxaparin,ACUTE KIDNEY INJURY,2760
enoxaparin,DEATH,2662
enoxaparin,PULMONARY EMBOLISM,2548
enoxaparin,HYPOTENSION,2385
enoxaparin,ASTHENIA,2255
enoxaparin,PAIN,2108
enoxaparin,FALL,2104
enoxaparin,DRUG INTERACTION,2067
enoxaparin,DRUG INEFFECTIVE,2031
enoxaparin,DEEP VEIN THROMBOSIS,2006
enoxaparin,HAEMORRHAGE,1927
enoxaparin,ABDOMINAL PAIN,1881
enoxaparin,HEADACHE,1871
enoxaparin,SEPSIS,1848
enoxaparin,HAEMOGLOBIN DECREASED,1834
enoxaparin,NEUTROPENIA,1832
enoxaparin,DIZZINESS,1721
enoxaparin,RASH,1689
enoxaparin,RENAL FAILURE,1648
enoxaparin,EXPOSURE DURING PREGNANCY,1511
enoxaparin,HAEMATOMA,1489
enoxaparin,GENERAL PHYSICAL HEALTH DETERIORATION,1488
enoxaparin,CONDITION AGGRAVATED,1481
enoxaparin,MALAISE,1453
enoxaparin,THROMBOSIS,1435
enoxaparin,DECREASED APPETITE,1409
enoxaparin,ATRIAL FIBRILLATION,1390
enoxaparin,CONFUSIONAL STATE,1377
enoxaparin,GASTROINTESTINAL HAEMORRHAGE,1370
enoxaparin,PRURITUS,1363
enoxaparin,ARTHRALGIA,1362
enoxaparin,COUGH,1339
enoxaparin,FEBRILE NEUTROPENIA,1313
enoxaparin,OEDEMA PERIPHERAL,1300
enoxaparin,TACHYCARDIA,1300
enoxaparin,URINARY TRACT INFECTION,1284
enoxaparin,RESPIRATORY FAILURE,1273
enoxaparin,DEHYDRATION,1260
enoxaparin,FOETAL EXPOSURE DURING PREGNANCY,1252
enoxaparin,CHEST PAIN,1246
enoxaparin,PAIN IN EXTREMITY,1244
enoxaparin,MATERNAL EXPOSURE DURING PREGNANCY,1200
enoxaparin,WEIGHT DECREASED,1181
enoxaparin,BACK PAIN,1129
enoxaparin,HYPERTENSION,1129
enoxaparin,CONSTIPATION,1054
enoxaparin,ANXIETY,1049
enoxaparin,HAEMATURIA,1034
enoxaparin,PLEURAL EFFUSION,1007
enoxaparin,ALANINE AMINOTRANSFERASE INCREASED,994
enoxaparin,CEREBROVASCULAR ACCIDENT,994
enoxaparin,SOMNOLENCE,993
enoxaparin,SYNCOPE,993
enoxaparin,ERYTHEMA,967
enoxaparin,PANCYTOPENIA,961
enoxaparin,PLATELET COUNT DECREASED,959
enoxaparin,PRODUCT USE IN UNAPPROVED INDICATION,950
enoxaparin,CARDIAC ARREST,944
enoxaparin,HYPOKALAEMIA,918
enoxaparin,CHILLS,913
enoxaparin,CONTUSION,876
enoxaparin,HYPOXIA,876
enoxaparin,ABDOMINAL PAIN UPPER,861
enoxaparin,MYOCARDIAL INFARCTION,860
enoxaparin,PREMATURE BABY,858
enoxaparin,RENAL FAILURE ACUTE,858
enoxaparin,HYPONATRAEMIA,852
enoxaparin,EPISTAXIS,848
enoxaparin,INTERNATIONAL NORMALISED RATIO INCREASED,841
enoxaparin,INJECTION SITE PAIN,834
enoxaparin,BLOOD CREATININE INCREASED,824
enoxaparin,LEUKOPENIA,821
enoxaparin,SEPTIC SHOCK,819
enoxaparin,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,815
enoxaparin,RASH MACULO-PAPULAR,805
enoxaparin,CHOLESTASIS,804
enoxaparin,COVID-19,801
enoxaparin,INSOMNIA,800
enoxaparin,ASPARTATE AMINOTRANSFERASE INCREASED,793
enoxaparin,DISEASE PROGRESSION,789
enoxaparin,LOSS OF CONSCIOUSNESS,788
enoxaparin,CARDIO-RESPIRATORY ARREST,772
enoxaparin,CARDIAC FAILURE,766
enoxaparin,INFECTION,761
enoxaparin,HEPATOCELLULAR INJURY,760
enoxaparin,HEPARIN-INDUCED THROMBOCYTOPENIA,752
enoxaparin,MALIGNANT NEOPLASM PROGRESSION,714
enoxaparin,RENAL IMPAIRMENT,705
enoxaparin,BRADYCARDIA,696
enoxaparin,HAEMATEMESIS,687
irinotecan,DIARRHOEA,6328
irinotecan,NAUSEA,3541
irinotecan,NEUTROPENIA,3421
irinotecan,VOMITING,3076
irinotecan,DISEASE PROGRESSION,3041
irinotecan,OFF LABEL USE,2717
irinotecan,DEATH,2223
irinotecan,FATIGUE,2192
irinotecan,FEBRILE NEUTROPENIA,1830
irinotecan,PYREXIA,1813
irinotecan,ANAEMIA,1752
irinotecan,ASTHENIA,1750
irinotecan,THROMBOCYTOPENIA,1729
irinotecan,DECREASED APPETITE,1620
irinotecan,NEUROPATHY PERIPHERAL,1565
irinotecan,ABDOMINAL PAIN,1554
irinotecan,MALIGNANT NEOPLASM PROGRESSION,1447
irinotecan,DEHYDRATION,1380
irinotecan,DRUG INEFFECTIVE,1183
irinotecan,HYPERTENSION,1165
irinotecan,DYSPNOEA,1086
irinotecan,LEUKOPENIA,1059
irinotecan,RASH,1049
irinotecan,STOMATITIS,1028
irinotecan,PULMONARY EMBOLISM,1010
irinotecan,GENERAL PHYSICAL HEALTH DETERIORATION,941
irinotecan,MUCOSAL INFLAMMATION,890
irinotecan,SEPSIS,825
irinotecan,WEIGHT DECREASED,804
irinotecan,NEUTROPHIL COUNT DECREASED,792
irinotecan,WHITE BLOOD CELL COUNT DECREASED,771
irinotecan,CONSTIPATION,769
irinotecan,NEOPLASM PROGRESSION,766
irinotecan,MALAISE,756
irinotecan,MYELOSUPPRESSION,747
irinotecan,PNEUMONIA,726
irinotecan,PRODUCT USE IN UNAPPROVED INDICATION,687
irinotecan,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,683
irinotecan,HYPOKALAEMIA,676
irinotecan,HYPOTENSION,674
irinotecan,METASTASES TO LIVER,647
irinotecan,ALOPECIA,641
irinotecan,PAIN,625
irinotecan,INTERSTITIAL LUNG DISEASE,608
irinotecan,PLATELET COUNT DECREASED,570
irinotecan,PROTEINURIA,563
irinotecan,ACUTE KIDNEY INJURY,560
irinotecan,TOXICITY TO VARIOUS AGENTS,560
irinotecan,DEEP VEIN THROMBOSIS,555
irinotecan,BONE MARROW FAILURE,542
irinotecan,HAEMOGLOBIN DECREASED,540
irinotecan,DERMATITIS ACNEIFORM,527
irinotecan,EPISTAXIS,526
irinotecan,DIZZINESS,503
irinotecan,PARAESTHESIA,500
irinotecan,INTESTINAL OBSTRUCTION,492
irinotecan,CHILLS,487
irinotecan,NEUROTOXICITY,487
irinotecan,HEADACHE,481
irinotecan,INFECTION,473
irinotecan,ASCITES,451
irinotecan,COLORECTAL CANCER METASTATIC,448
irinotecan,HYPERSENSITIVITY,436
irinotecan,HYPOMAGNESAEMIA,421
irinotecan,PANCYTOPENIA,419
irinotecan,SKIN TOXICITY,413
irinotecan,SEPTIC SHOCK,410
irinotecan,ABDOMINAL PAIN UPPER,409
irinotecan,DYSARTHRIA,397
irinotecan,CONDITION AGGRAVATED,394
irinotecan,CHEST PAIN,372
irinotecan,METASTASES TO LUNG,362
irinotecan,BACK PAIN,357
irinotecan,PRURITUS,357
irinotecan,URINARY TRACT INFECTION,356
irinotecan,ERYTHEMA,347
irinotecan,RENAL FAILURE,344
irinotecan,ILEUS,343
irinotecan,COLITIS,342
irinotecan,HAEMATOTOXICITY,337
irinotecan,INFUSION RELATED REACTION,333
irinotecan,HYPERHIDROSIS,322
irinotecan,TACHYCARDIA,321
irinotecan,CONFUSIONAL STATE,320
irinotecan,ALANINE AMINOTRANSFERASE INCREASED,318
irinotecan,THERAPY PARTIAL RESPONDER,313
irinotecan,HYPONATRAEMIA,311
irinotecan,HAEMORRHAGE,304
irinotecan,RESPIRATORY FAILURE,304
irinotecan,OEDEMA PERIPHERAL,303
irinotecan,DRY SKIN,302
irinotecan,ASPARTATE AMINOTRANSFERASE INCREASED,298
irinotecan,DYSPHAGIA,294
irinotecan,GASTROINTESTINAL HAEMORRHAGE,294
irinotecan,POLYNEUROPATHY,294
irinotecan,BLOOD CREATININE INCREASED,293
irinotecan,GASTROINTESTINAL TOXICITY,286
irinotecan,PERIPHERAL SENSORY NEUROPATHY,284
irinotecan,GASTROINTESTINAL DISORDER,283
irinotecan,TREATMENT FAILURE,279
nintedanib,DIARRHOEA,9013
nintedanib,NAUSEA,4212
nintedanib,DYSPNOEA,3412
nintedanib,DECREASED APPETITE,2787
nintedanib,DEATH,2732
nintedanib,FATIGUE,2601
nintedanib,WEIGHT DECREASED,2575
nintedanib,VOMITING,2554
nintedanib,COUGH,2521
nintedanib,IDIOPATHIC PULMONARY FIBROSIS,1821
nintedanib,CONSTIPATION,1758
nintedanib,ABDOMINAL PAIN UPPER,1638
nintedanib,HEADACHE,1614
nintedanib,ASTHENIA,1527
nintedanib,ABDOMINAL DISCOMFORT,1424
nintedanib,PNEUMONIA,1323
nintedanib,DIZZINESS,1263
nintedanib,PRODUCTIVE COUGH,1072
nintedanib,MALAISE,982
nintedanib,ABDOMINAL PAIN,886
nintedanib,OXYGEN SATURATION DECREASED,884
nintedanib,DYSPNOEA EXERTIONAL,878
nintedanib,FLATULENCE,830
nintedanib,FALL,715
nintedanib,OFF LABEL USE,688
nintedanib,MALIGNANT NEOPLASM PROGRESSION,676
nintedanib,DEHYDRATION,665
nintedanib,EPISTAXIS,664
nintedanib,COVID-19,653
nintedanib,PAIN,636
nintedanib,CHEST PAIN,593
nintedanib,GASTROINTESTINAL DISORDER,591
nintedanib,HYPERTENSION,568
nintedanib,FEELING ABNORMAL,567
nintedanib,ILLNESS,557
nintedanib,PYREXIA,545
nintedanib,NASOPHARYNGITIS,544
nintedanib,HEPATIC ENZYME INCREASED,530
nintedanib,ABDOMINAL DISTENSION,515
nintedanib,DRUG INEFFECTIVE,510
nintedanib,ARTHRALGIA,486
nintedanib,DYSPEPSIA,483
nintedanib,BACK PAIN,472
nintedanib,INTERSTITIAL LUNG DISEASE,444
nintedanib,RESPIRATORY FAILURE,435
nintedanib,INSOMNIA,429
nintedanib,GASTROOESOPHAGEAL REFLUX DISEASE,419
nintedanib,HAEMATOCHEZIA,417
nintedanib,DRUG INTOLERANCE,413
nintedanib,URINARY TRACT INFECTION,413
nintedanib,BLOOD PRESSURE INCREASED,411
nintedanib,GENERAL PHYSICAL HEALTH DETERIORATION,401
nintedanib,HYPOTENSION,397
nintedanib,RASH,395
nintedanib,PERIPHERAL SWELLING,383
nintedanib,DEPRESSION,375
nintedanib,LUNG DISORDER,374
nintedanib,MUSCLE SPASMS,372
nintedanib,CEREBROVASCULAR ACCIDENT,370
nintedanib,ANAEMIA,365
nintedanib,PAIN IN EXTREMITY,364
nintedanib,PULMONARY EMBOLISM,354
nintedanib,GASTRIC DISORDER,340
nintedanib,PULMONARY FIBROSIS,332
nintedanib,ANXIETY,318
nintedanib,ALOPECIA,312
nintedanib,PRURITUS,308
nintedanib,PNEUMOTHORAX,307
nintedanib,DISEASE PROGRESSION,302
nintedanib,DRY MOUTH,295
nintedanib,LIVER DISORDER,290
nintedanib,GASTROINTESTINAL HAEMORRHAGE,286
nintedanib,HAEMOPTYSIS,286
nintedanib,CHEST DISCOMFORT,284
nintedanib,WEIGHT INCREASED,275
nintedanib,CONDITION AGGRAVATED,274
nintedanib,TASTE DISORDER,270
nintedanib,FAECES SOFT,267
nintedanib,RECTAL HAEMORRHAGE,267
nintedanib,INFLUENZA,266
nintedanib,CONTUSION,264
nintedanib,PULMONARY HYPERTENSION,262
nintedanib,INFECTION,261
nintedanib,LIVER FUNCTION TEST INCREASED,260
nintedanib,MYOCARDIAL INFARCTION,259
nintedanib,RHINORRHOEA,255
nintedanib,GAIT DISTURBANCE,249
nintedanib,ATRIAL FIBRILLATION,245
nintedanib,FAECES DISCOLOURED,243
nintedanib,SOMNOLENCE,240
nintedanib,HYPOXIA,239
nintedanib,DYSPHONIA,238
nintedanib,OEDEMA PERIPHERAL,237
nintedanib,SEPSIS,237
nintedanib,OROPHARYNGEAL PAIN,231
nintedanib,MUSCULAR WEAKNESS,230
nintedanib,HEART RATE INCREASED,228
nintedanib,ABNORMAL LOSS OF WEIGHT,226
nintedanib,LOSS OF CONSCIOUSNESS,226
nintedanib,ACUTE KIDNEY INJURY,217
plerixafor,FEBRILE NEUTROPENIA,143
plerixafor,OFF LABEL USE,121
plerixafor,DIARRHOEA,104
plerixafor,PYREXIA,93
plerixafor,NAUSEA,88
plerixafor,MUCOSAL INFLAMMATION,83
plerixafor,THROMBOCYTOPENIA,77
plerixafor,PNEUMONIA,58
plerixafor,VOMITING,55
plerixafor,DEATH,54
plerixafor,DRUG INEFFECTIVE,52
plerixafor,DYSPNOEA,51
plerixafor,NEUTROPENIA,49
plerixafor,INFECTION,47
plerixafor,ANAEMIA,45
plerixafor,THERAPEUTIC PRODUCT EFFECT INCOMPLETE,43
plerixafor,HYPOTENSION,42
plerixafor,THERAPY NON-RESPONDER,42
plerixafor,ACUTE KIDNEY INJURY,40
plerixafor,FATIGUE,40
plerixafor,SEPSIS,36
plerixafor,BONE PAIN,32
plerixafor,PANCYTOPENIA,31
plerixafor,PLASMA CELL MYELOMA,31
plerixafor,PLEURAL EFFUSION,31
plerixafor,ASCITES,30
plerixafor,RENAL FAILURE,29
plerixafor,TREATMENT FAILURE,28
plerixafor,VENOOCCLUSIVE LIVER DISEASE,28
plerixafor,ABDOMINAL PAIN,27
plerixafor,HEADACHE,27
plerixafor,PRODUCT USE IN UNAPPROVED INDICATION,26
plerixafor,RESPIRATORY FAILURE,26
plerixafor,STOMATITIS,26
plerixafor,BLOOD STEM CELL HARVEST FAILURE,25
plerixafor,PLATELET COUNT DECREASED,25
plerixafor,RASH,25
plerixafor,ASTHENIA,24
plerixafor,HYPOKALAEMIA,24
plerixafor,NEUROPATHY PERIPHERAL,24
plerixafor,BACK PAIN,23
plerixafor,CONSTIPATION,23
plerixafor,SEPTIC SHOCK,23
plerixafor,WHITE BLOOD CELL COUNT DECREASED,23
plerixafor,ACUTE RESPIRATORY DISTRESS SYNDROME,22
plerixafor,ACUTE MYELOID LEUKAEMIA,21
plerixafor,DISEASE PROGRESSION,20
plerixafor,DIZZINESS,20
plerixafor,FUNGAL INFECTION,20
plerixafor,ALANINE AMINOTRANSFERASE INCREASED,19
plerixafor,COLITIS,19
plerixafor,CYTOMEGALOVIRUS INFECTION,19
plerixafor,ESCHERICHIA INFECTION,19
plerixafor,PERICARDIAL EFFUSION,19
plerixafor,ATRIAL FIBRILLATION,18
plerixafor,DECREASED APPETITE,18
plerixafor,DEHYDRATION,18
plerixafor,HERPES SIMPLEX,18
plerixafor,PULMONARY EMBOLISM,18
plerixafor,CYTOPENIA,17
plerixafor,HYPERTENSION,17
plerixafor,PAIN,17
plerixafor,TOXICITY TO VARIOUS AGENTS,17
plerixafor,WEIGHT INCREASED,17
plerixafor,ADVERSE EVENT,16
plerixafor,CHEST PAIN,16
plerixafor,COUGH,16
plerixafor,INSOMNIA,16
plerixafor,PULMONARY OEDEMA,16
plerixafor,TACHYCARDIA,16
plerixafor,DEEP VEIN THROMBOSIS,15
plerixafor,ARTHRALGIA,14
plerixafor,CHILLS,14
plerixafor,HYPERSENSITIVITY,14
plerixafor,HYPOXIA,14
plerixafor,LEUKOCYTOSIS,14
plerixafor,PALPITATIONS,14
plerixafor,THROMBOTIC MICROANGIOPATHY,14
plerixafor,ENGRAFTMENT SYNDROME,13
plerixafor,HAEMOGLOBIN DECREASED,13
plerixafor,MOBILITY DECREASED,13
plerixafor,MYELODYSPLASTIC SYNDROME,13
plerixafor,PARAESTHESIA,13
plerixafor,STAPHYLOCOCCAL INFECTION,13
plerixafor,THERAPEUTIC RESPONSE DECREASED,13
plerixafor,CELLULITIS,12
plerixafor,CLOSTRIDIUM DIFFICILE COLITIS,12
plerixafor,CYTOMEGALOVIRUS INFECTION REACTIVATION,12
plerixafor,ENGRAFT FAILURE,12
plerixafor,GRAFT VERSUS HOST DISEASE,12
plerixafor,HERPES ZOSTER,12
plerixafor,LEUKOPENIA,12
plerixafor,MULTIPLE ORGAN DYSFUNCTION SYNDROME,12
plerixafor,NASOPHARYNGITIS,12
plerixafor,SEIZURE,12
plerixafor,THROMBOSIS,12
plerixafor,ACUTE GRAFT VERSUS HOST DISEASE,11
plerixafor,BONE MARROW FAILURE,11
plerixafor,HYPOMAGNESAEMIA,11
plerixafor,MALIGNANT NEOPLASM PROGRESSION,11
alpelisib,HYPERGLYCAEMIA,1565
alpelisib,RASH,1396
alpelisib,DIARRHOEA,1334
alpelisib,BLOOD GLUCOSE INCREASED,1110
alpelisib,DEATH,915
alpelisib,NAUSEA,867
alpelisib,FATIGUE,834
alpelisib,DECREASED APPETITE,550
alpelisib,WEIGHT DECREASED,512
alpelisib,MALIGNANT NEOPLASM PROGRESSION,508
alpelisib,VOMITING,479
alpelisib,DRUG INEFFECTIVE,352
alpelisib,ASTHENIA,347
alpelisib,STOMATITIS,345
alpelisib,PYREXIA,275
alpelisib,PRURITUS,272
alpelisib,BREAST CANCER METASTATIC,245
alpelisib,PAIN,241
alpelisib,DISEASE PROGRESSION,238
alpelisib,DIABETES MELLITUS,233
alpelisib,MALAISE,218
alpelisib,ALOPECIA,212
alpelisib,DYSPNOEA,206
alpelisib,DEHYDRATION,203
alpelisib,DRY MOUTH,202
alpelisib,HEADACHE,188
alpelisib,METASTASES TO LIVER,176
alpelisib,METASTASES TO BONE,170
alpelisib,OFF LABEL USE,158
alpelisib,HYPERSENSITIVITY,152
alpelisib,BREAST CANCER,143
alpelisib,DIZZINESS,143
alpelisib,DIABETIC KETOACIDOSIS,137
alpelisib,ABDOMINAL DISCOMFORT,133
alpelisib,DRUG INTOLERANCE,133
alpelisib,ILLNESS,133
alpelisib,ORAL PAIN,130
alpelisib,PNEUMONIA,129
alpelisib,PRODUCT DOSE OMISSION ISSUE,122
alpelisib,DRY SKIN,117
alpelisib,TASTE DISORDER,117
alpelisib,ABDOMINAL PAIN UPPER,116
alpelisib,COVID-19,116
alpelisib,ABDOMINAL PAIN,108
alpelisib,CONSTIPATION,108
alpelisib,FEELING ABNORMAL,108
alpelisib,BLOOD CREATININE INCREASED,103
alpelisib,BLOOD GLUCOSE ABNORMAL,103
alpelisib,URTICARIA,99
alpelisib,COUGH,96
alpelisib,DYSPHAGIA,96
alpelisib,ERYTHEMA,95
alpelisib,FEEDING DISORDER,93
alpelisib,PERIPHERAL SWELLING,90
alpelisib,MUCOSAL INFLAMMATION,89
alpelisib,BACK PAIN,87
alpelisib,EATING DISORDER,83
alpelisib,GENERAL PHYSICAL HEALTH DETERIORATION,83
alpelisib,PRODUCT USE IN UNAPPROVED INDICATION,82
alpelisib,URINARY TRACT INFECTION,82
alpelisib,NEUTROPENIA,79
alpelisib,TUMOUR MARKER INCREASED,79
alpelisib,PLEURAL EFFUSION,76
alpelisib,INSOMNIA,72
alpelisib,NEOPLASM MALIGNANT,71
alpelisib,PAIN IN EXTREMITY,71
alpelisib,CHILLS,70
alpelisib,MUSCLE SPASMS,70
alpelisib,VISION BLURRED,70
alpelisib,RENAL IMPAIRMENT,69
alpelisib,THIRST,69
alpelisib,DYSPEPSIA,67
alpelisib,DYSGEUSIA,65
alpelisib,SKIN EXFOLIATION,65
alpelisib,ARTHRALGIA,63
alpelisib,RASH PRURITIC,62
alpelisib,COLITIS,61
alpelisib,GLYCOSYLATED HAEMOGLOBIN INCREASED,61
alpelisib,SWELLING FACE,61
alpelisib,INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION,60
alpelisib,FALL,58
alpelisib,GAIT DISTURBANCE,56
alpelisib,ADVERSE DRUG REACTION,55
alpelisib,LIP SWELLING,55
alpelisib,SOMNOLENCE,55
alpelisib,METASTASES TO LUNG,54
alpelisib,NEUROPATHY PERIPHERAL,54
alpelisib,ACUTE KIDNEY INJURY,52
alpelisib,CONFUSIONAL STATE,52
alpelisib,HYPERTENSION,52
alpelisib,INCORRECT DOSE ADMINISTERED,52
alpelisib,INFECTION,51
alpelisib,SWELLING,51
alpelisib,THERAPY INTERRUPTED,51
alpelisib,ABDOMINAL DISTENSION,50
alpelisib,ANAEMIA,50
alpelisib,CONDITION AGGRAVATED,50
alpelisib,HYPOTENSION,49
alpelisib,NEOPLASM PROGRESSION,49
alpelisib,TOXICITY TO VARIOUS AGENTS,49
rucaparib,FATIGUE,2520
rucaparib,NAUSEA,2245
rucaparib,MALIGNANT NEOPLASM PROGRESSION,1182
rucaparib,DECREASED APPETITE,792
rucaparib,DIARRHOEA,777
rucaparib,VOMITING,776
rucaparib,CONSTIPATION,774
rucaparib,ASTHENIA,667
rucaparib,ADVERSE EVENT,569
rucaparib,CARBOHYDRATE ANTIGEN 125 INCREASED,565
rucaparib,DYSGEUSIA,561
rucaparib,ANAEMIA,542
rucaparib,PRODUCT DOSE OMISSION ISSUE,535
rucaparib,PLATELET COUNT DECREASED,534
rucaparib,DRUG INEFFECTIVE,510
rucaparib,HEADACHE,433
rucaparib,MALAISE,404
rucaparib,DIZZINESS,399
rucaparib,DYSPNOEA,395
rucaparib,ABDOMINAL PAIN,386
rucaparib,ABDOMINAL PAIN UPPER,364
rucaparib,PRODUCT DOSE OMISSION,362
rucaparib,HAEMOGLOBIN DECREASED,354
rucaparib,ABDOMINAL DISCOMFORT,344
rucaparib,DEATH,341
rucaparib,WHITE BLOOD CELL COUNT DECREASED,314
rucaparib,WEIGHT DECREASED,293
rucaparib,PAIN,290
rucaparib,RED BLOOD CELL COUNT DECREASED,284
rucaparib,DRUG INTOLERANCE,271
rucaparib,TASTE DISORDER,271
rucaparib,BLOOD CREATININE INCREASED,264
rucaparib,INSOMNIA,259
rucaparib,TUMOUR MARKER INCREASED,259
rucaparib,PRURITUS,257
rucaparib,OFF LABEL USE,250
rucaparib,PRODUCT USE IN UNAPPROVED INDICATION,235
rucaparib,UNDERDOSE,231
rucaparib,ARTHRALGIA,225
rucaparib,NEUROPATHY PERIPHERAL,225
rucaparib,DRUG DOSE OMISSION,217
rucaparib,ABDOMINAL DISTENSION,213
rucaparib,BLOOD COUNT ABNORMAL,197
rucaparib,DEHYDRATION,195
rucaparib,RASH,195
rucaparib,BACK PAIN,190
rucaparib,THROMBOCYTOPENIA,187
rucaparib,PERIPHERAL SWELLING,180
rucaparib,COUGH,177
rucaparib,HEPATIC ENZYME INCREASED,177
rucaparib,PAIN IN EXTREMITY,176
rucaparib,FEELING ABNORMAL,170
rucaparib,PHOTOSENSITIVITY REACTION,170
rucaparib,LABORATORY TEST ABNORMAL,168
rucaparib,ANXIETY,162
rucaparib,TOXICITY TO VARIOUS AGENTS,162
rucaparib,URINARY TRACT INFECTION,158
rucaparib,OVARIAN CANCER RECURRENT,157
rucaparib,SOMNOLENCE,157
rucaparib,PRESCRIBED UNDERDOSE,156
rucaparib,DYSPEPSIA,154
rucaparib,ALOPECIA,149
rucaparib,DEPRESSION,144
rucaparib,LIVER FUNCTION TEST INCREASED,140
rucaparib,PYREXIA,138
rucaparib,ALANINE AMINOTRANSFERASE INCREASED,137
rucaparib,THERAPY PARTIAL RESPONDER,136
rucaparib,GAIT DISTURBANCE,135
rucaparib,ASPARTATE AMINOTRANSFERASE INCREASED,126
rucaparib,STOMATITIS,125
rucaparib,FLATULENCE,122
rucaparib,NASOPHARYNGITIS,122
rucaparib,DRY MOUTH,112
rucaparib,MYALGIA,109
rucaparib,FALL,108
rucaparib,PRODUCT DOSE OMISSION IN ERROR,108
rucaparib,RENAL FUNCTION TEST ABNORMAL,108
rucaparib,ACCIDENTAL UNDERDOSE,106
rucaparib,DRY SKIN,101
rucaparib,NEUTROPENIA,96
rucaparib,INTESTINAL OBSTRUCTION,93
rucaparib,RENAL IMPAIRMENT,90
rucaparib,BLOOD PRESSURE INCREASED,89
rucaparib,MUSCLE SPASMS,88
rucaparib,BLOOD MAGNESIUM DECREASED,86
rucaparib,MUSCULAR WEAKNESS,86
rucaparib,PNEUMONIA,86
rucaparib,HYPOPHAGIA,84
rucaparib,HYPOAESTHESIA,83
rucaparib,PARAESTHESIA,83
rucaparib,WEIGHT INCREASED,83
rucaparib,TREMOR,82
rucaparib,HOT FLUSH,79
rucaparib,GASTROOESOPHAGEAL REFLUX DISEASE,78
rucaparib,CONTUSION,77
rucaparib,SUNBURN,77
rucaparib,RENAL DISORDER,76
rucaparib,BONE PAIN,75
rucaparib,MEMORY IMPAIRMENT,75
rucaparib,HYPERTENSION,72
temozolomide,DISEASE PROGRESSION,1986
temozolomide,DEATH,1955
temozolomide,THROMBOCYTOPENIA,1728
temozolomide,OFF LABEL USE,1721
temozolomide,NAUSEA,1573
temozolomide,PRODUCT USE IN UNAPPROVED INDICATION,1280
temozolomide,DRUG INEFFECTIVE,1227
temozolomide,FATIGUE,1217
temozolomide,VOMITING,1115
temozolomide,NEUTROPENIA,1078
temozolomide,MALIGNANT NEOPLASM PROGRESSION,1043
temozolomide,DIARRHOEA,807
temozolomide,FEBRILE NEUTROPENIA,792
temozolomide,ANAEMIA,755
temozolomide,PLATELET COUNT DECREASED,739
temozolomide,ASTHENIA,721
temozolomide,PYREXIA,709
temozolomide,HEADACHE,640
temozolomide,SEIZURE,581
temozolomide,PANCYTOPENIA,575
temozolomide,INFECTION,549
temozolomide,CONSTIPATION,544
temozolomide,PNEUMONIA,492
temozolomide,NEOPLASM PROGRESSION,478
temozolomide,PULMONARY EMBOLISM,470
temozolomide,CONFUSIONAL STATE,443
temozolomide,HAEMORRHAGE,442
temozolomide,DECREASED APPETITE,411
temozolomide,DEHYDRATION,409
temozolomide,RASH,399
temozolomide,WEIGHT DECREASED,398
temozolomide,WHITE BLOOD CELL COUNT DECREASED,391
temozolomide,FALL,386
temozolomide,DYSPNOEA,382
temozolomide,SEPSIS,377
temozolomide,ATRIAL FIBRILLATION,373
temozolomide,LYMPHOPENIA,367
temozolomide,CYTOPENIA,352
temozolomide,CONVULSION,345
temozolomide,LEUKOPENIA,345
temozolomide,PAIN,342
temozolomide,BONE MARROW FAILURE,336
temozolomide,ABDOMINAL PAIN,328
temozolomide,ASPERGILLUS INFECTION,326
temozolomide,DISEASE RECURRENCE,313
temozolomide,DEEP VEIN THROMBOSIS,293
temozolomide,TOXICITY TO VARIOUS AGENTS,268
temozolomide,HOSPITALISATION,263
temozolomide,GLIOBLASTOMA,258
temozolomide,PRODUCT USE ISSUE,257
temozolomide,HYPERTENSION,252
temozolomide,MYELOSUPPRESSION,252
temozolomide,MALAISE,250
temozolomide,HYPOTENSION,249
temozolomide,METASTASES TO LIVER,248
temozolomide,DIZZINESS,242
temozolomide,GAIT DISTURBANCE,242
temozolomide,GENERAL PHYSICAL HEALTH DETERIORATION,242
temozolomide,BRAIN OEDEMA,240
temozolomide,HAEMOGLOBIN DECREASED,240
temozolomide,ALANINE AMINOTRANSFERASE INCREASED,224
temozolomide,MUSCULAR WEAKNESS,220
temozolomide,NEUTROPHIL COUNT DECREASED,209
temozolomide,HEMIPARESIS,208
temozolomide,SOMNOLENCE,204
temozolomide,URINARY TRACT INFECTION,204
temozolomide,COUGH,198
temozolomide,MENTAL STATUS CHANGES,194
temozolomide,LYMPHOCYTE COUNT DECREASED,188
temozolomide,DYSPHAGIA,187
temozolomide,PRURITUS,187
temozolomide,HOSPICE CARE,182
temozolomide,HAEMATOTOXICITY,181
temozolomide,DRUG INTERACTION,180
temozolomide,ACUTE KIDNEY INJURY,179
temozolomide,TUMOUR PSEUDOPROGRESSION,179
temozolomide,CONDITION AGGRAVATED,178
temozolomide,PAIN IN EXTREMITY,169
temozolomide,CHILLS,165
temozolomide,HYPERGLYCAEMIA,164
temozolomide,APLASTIC ANAEMIA,162
temozolomide,HYPONATRAEMIA,162
temozolomide,THERAPY CESSATION,162
temozolomide,GLIOBLASTOMA MULTIFORME,161
temozolomide,THROMBOSIS,161
temozolomide,THERAPY PARTIAL RESPONDER,160
temozolomide,HYPOKALAEMIA,157
temozolomide,BACK PAIN,156
temozolomide,ASPARTATE AMINOTRANSFERASE INCREASED,154
temozolomide,CHEST PAIN,154
temozolomide,OEDEMA PERIPHERAL,153
temozolomide,APHASIA,152
temozolomide,EPISTAXIS,152
temozolomide,ARTHRALGIA,151
temozolomide,ALOPECIA,146
temozolomide,ERYTHEMA,142
temozolomide,COGNITIVE DISORDER,140
temozolomide,LETHARGY,139
temozolomide,TREATMENT FAILURE,139
temozolomide,CEREBRAL HAEMORRHAGE,135
oxaliplatin,DIARRHOEA,7200
oxaliplatin,NAUSEA,5655
oxaliplatin,VOMITING,4774
oxaliplatin,NEUTROPENIA,4286
oxaliplatin,DISEASE PROGRESSION,4201
oxaliplatin,OFF LABEL USE,4144
oxaliplatin,NEUROPATHY PERIPHERAL,4079
oxaliplatin,THROMBOCYTOPENIA,3575
oxaliplatin,DYSPNOEA,3469
oxaliplatin,PYREXIA,3134
oxaliplatin,FATIGUE,2715
oxaliplatin,ASTHENIA,2535
oxaliplatin,ANAEMIA,2517
oxaliplatin,DEATH,2359
oxaliplatin,ABDOMINAL PAIN,2259
oxaliplatin,DECREASED APPETITE,2160
oxaliplatin,FEBRILE NEUTROPENIA,1836
oxaliplatin,PARAESTHESIA,1809
oxaliplatin,DRUG INEFFECTIVE,1743
oxaliplatin,DEHYDRATION,1722
oxaliplatin,RASH,1649
oxaliplatin,HYPOTENSION,1633
oxaliplatin,ERYTHEMA,1577
oxaliplatin,MALAISE,1575
oxaliplatin,HYPERTENSION,1563
oxaliplatin,MALIGNANT NEOPLASM PROGRESSION,1562
oxaliplatin,NEUROTOXICITY,1515
oxaliplatin,CHILLS,1374
oxaliplatin,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1373
oxaliplatin,MUCOSAL INFLAMMATION,1371
oxaliplatin,HYPERSENSITIVITY,1356
oxaliplatin,LEUKOPENIA,1353
oxaliplatin,ACUTE KIDNEY INJURY,1345
oxaliplatin,GENERAL PHYSICAL HEALTH DETERIORATION,1333
oxaliplatin,SEPSIS,1323
oxaliplatin,PLATELET COUNT DECREASED,1299
oxaliplatin,PRURITUS,1291
oxaliplatin,PNEUMONIA,1189
oxaliplatin,MYELOSUPPRESSION,1165
oxaliplatin,PULMONARY EMBOLISM,1144
oxaliplatin,STOMATITIS,1112
oxaliplatin,INTERSTITIAL LUNG DISEASE,1104
oxaliplatin,WHITE BLOOD CELL COUNT DECREASED,1096
oxaliplatin,DIZZINESS,1058
oxaliplatin,PRODUCT USE IN UNAPPROVED INDICATION,1052
oxaliplatin,HYPOKALAEMIA,1007
oxaliplatin,NEUTROPHIL COUNT DECREASED,1006
oxaliplatin,WEIGHT DECREASED,986
oxaliplatin,TOXICITY TO VARIOUS AGENTS,970
oxaliplatin,INFUSION RELATED REACTION,946
oxaliplatin,PAIN,930
oxaliplatin,HYPERHIDROSIS,919
oxaliplatin,CONSTIPATION,912
oxaliplatin,CHEST PAIN,892
oxaliplatin,METASTASES TO LIVER,872
oxaliplatin,TACHYCARDIA,858
oxaliplatin,NEOPLASM PROGRESSION,818
oxaliplatin,BONE MARROW FAILURE,799
oxaliplatin,FLUSHING,795
oxaliplatin,ASCITES,784
oxaliplatin,HYPOAESTHESIA,768
oxaliplatin,OXYGEN SATURATION DECREASED,768
oxaliplatin,POLYNEUROPATHY,757
oxaliplatin,SEPTIC SHOCK,747
oxaliplatin,HAEMOGLOBIN DECREASED,732
oxaliplatin,CONDITION AGGRAVATED,717
oxaliplatin,INFECTION,705
oxaliplatin,PANCYTOPENIA,690
oxaliplatin,DYSPHAGIA,679
oxaliplatin,LOSS OF CONSCIOUSNESS,675
oxaliplatin,RESPIRATORY FAILURE,675
oxaliplatin,DEEP VEIN THROMBOSIS,659
oxaliplatin,RENAL FAILURE,659
oxaliplatin,COUGH,656
oxaliplatin,CHEST DISCOMFORT,650
oxaliplatin,PERIPHERAL SENSORY NEUROPATHY,650
oxaliplatin,TREMOR,641
oxaliplatin,ANAPHYLACTIC REACTION,639
oxaliplatin,SKIN TOXICITY,639
oxaliplatin,BACK PAIN,628
oxaliplatin,ABDOMINAL PAIN UPPER,621
oxaliplatin,DERMATITIS ACNEIFORM,606
oxaliplatin,MUSCLE SPASMS,595
oxaliplatin,DYSARTHRIA,594
oxaliplatin,HEADACHE,583
oxaliplatin,PLEURAL EFFUSION,554
oxaliplatin,CARDIAC ARREST,553
oxaliplatin,HAEMATOTOXICITY,547
oxaliplatin,ATRIAL FIBRILLATION,539
oxaliplatin,INTESTINAL OBSTRUCTION,536
oxaliplatin,VENOOCCLUSIVE LIVER DISEASE,524
oxaliplatin,HYPOMAGNESAEMIA,521
oxaliplatin,ARTERIOSPASM CORONARY,519
oxaliplatin,LARYNGOSPASM,516
oxaliplatin,HEPATIC FUNCTION ABNORMAL,510
oxaliplatin,PROTEINURIA,502
oxaliplatin,EPISTAXIS,501
oxaliplatin,THERAPY PARTIAL RESPONDER,501
oxaliplatin,CYTOKINE RELEASE SYNDROME,500
oxaliplatin,ASPARTATE AMINOTRANSFERASE INCREASED,497
sotorasib,NON-SMALL CELL LUNG CANCER,427
sotorasib,DISEASE PROGRESSION,315
sotorasib,DEATH,280
sotorasib,DIARRHOEA,265
sotorasib,OFF LABEL USE,182
sotorasib,NAUSEA,94
sotorasib,NON-SMALL CELL LUNG CANCER METASTATIC,89
sotorasib,FATIGUE,83
sotorasib,HEPATOTOXICITY,82
sotorasib,HEPATIC FUNCTION ABNORMAL,72
sotorasib,ALANINE AMINOTRANSFERASE INCREASED,57
sotorasib,ASPARTATE AMINOTRANSFERASE INCREASED,57
sotorasib,DRUG INEFFECTIVE,57
sotorasib,LUNG NEOPLASM MALIGNANT,54
sotorasib,DECREASED APPETITE,51
sotorasib,DYSPNOEA,44
sotorasib,LIVER FUNCTION TEST INCREASED,43
sotorasib,ASTHENIA,40
sotorasib,VOMITING,40
sotorasib,HEPATIC ENZYME INCREASED,39
sotorasib,LUNG ADENOCARCINOMA,36
sotorasib,THERAPY PARTIAL RESPONDER,35
sotorasib,HEPATIC CYTOLYSIS,34
sotorasib,LIVER DISORDER,34
sotorasib,PNEUMONIA,33
sotorasib,ADVERSE EVENT,29
sotorasib,PAIN,29
sotorasib,CHOLESTASIS,28
sotorasib,PNEUMONITIS,28
sotorasib,PULMONARY EMBOLISM,27
sotorasib,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,26
sotorasib,COLITIS,26
sotorasib,COUGH,26
sotorasib,MALAISE,26
sotorasib,BLOOD ALKALINE PHOSPHATASE INCREASED,25
sotorasib,CONSTIPATION,25
sotorasib,PRODUCT STORAGE ERROR,25
sotorasib,PYREXIA,24
sotorasib,RASH,24
sotorasib,GAMMA-GLUTAMYLTRANSFERASE INCREASED,23
sotorasib,ANAEMIA,22
sotorasib,GENERAL PHYSICAL HEALTH DETERIORATION,22
sotorasib,HOSPITALISATION,22
sotorasib,MYALGIA,22
sotorasib,MALIGNANT NEOPLASM PROGRESSION,21
sotorasib,ABDOMINAL PAIN,20
sotorasib,HYPERTRANSAMINASAEMIA,20
sotorasib,METASTASES TO CENTRAL NERVOUS SYSTEM,20
sotorasib,DEHYDRATION,19
sotorasib,DRUG-INDUCED LIVER INJURY,19
sotorasib,GASTROINTESTINAL DISORDER,19
sotorasib,PLEURAL EFFUSION,19
sotorasib,BLOOD BILIRUBIN INCREASED,18
sotorasib,DRUG INTERACTION,18
sotorasib,ARTHRALGIA,17
sotorasib,COLORECTAL CANCER METASTATIC,17
sotorasib,HEADACHE,17
sotorasib,LUNG CANCER METASTATIC,17
sotorasib,SOMNOLENCE,17
sotorasib,ACUTE KIDNEY INJURY,16
sotorasib,ADVERSE DRUG REACTION,16
sotorasib,INTERSTITIAL LUNG DISEASE,16
sotorasib,DRUG INTOLERANCE,15
sotorasib,HEPATITIS,15
sotorasib,ABDOMINAL DISCOMFORT,14
sotorasib,CEREBROVASCULAR ACCIDENT,14
sotorasib,PANCREATITIS,14
sotorasib,PRURITUS,14
sotorasib,THERAPY NON-RESPONDER,14
sotorasib,BACK PAIN,13
sotorasib,HYPERTENSION,13
sotorasib,ILL-DEFINED DISORDER,13
sotorasib,JAUNDICE,13
sotorasib,NEUROPATHY PERIPHERAL,13
sotorasib,RENAL IMPAIRMENT,13
sotorasib,UNEVALUABLE EVENT,13
sotorasib,WEIGHT DECREASED,13
sotorasib,AUTOIMMUNE HEPATITIS,12
sotorasib,ELECTROCARDIOGRAM QT PROLONGED,12
sotorasib,FALL,12
sotorasib,GASTROINTESTINAL TOXICITY,12
sotorasib,HYPOKALAEMIA,12
sotorasib,INFECTION,12
sotorasib,NEUTROPENIA,12
sotorasib,THERAPY CESSATION,12
sotorasib,HYPOCALCAEMIA,11
sotorasib,METASTASES TO BONE,11
sotorasib,MUSCULAR WEAKNESS,11
sotorasib,NEOPLASM MALIGNANT,11
sotorasib,NEOPLASM PROGRESSION,11
sotorasib,OEDEMA PERIPHERAL,11
sotorasib,PAIN IN EXTREMITY,11
sotorasib,PULMONARY TOXICITY,11
sotorasib,COVID-19,10
sotorasib,HEPATIC FAILURE,10
sotorasib,ILLNESS,10
sotorasib,PRODUCT DOSE OMISSION ISSUE,10
sotorasib,RADIOTHERAPY,10
sotorasib,THERAPY INTERRUPTED,10
sotorasib,ANXIETY,9
